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Abstract 
The present research focuses on the development of a Me2SO and serum-free non-toxic freezing 
solution from natural cryoprotective agents (CPAs) in a suitable carrier media for preserving 
adipose tissue and adipose tissue-derived stem cells (hADSCs) with long shelve-life. The 
efficiency of the various hydrocolloids and organic osmolytes as CPAs and individual PBS 
components such as NaCl, Na2HPO4, KCl and KH2PO4 were evaluated to select the potential 
CPAs and carrier media. Among these, trehalose and NaCl were found to be the most efficient 
extracellular CPAs and carrier media. The freezing solution comprising of 160mM NaCl/90mM 
trehalose achieved adipose tissue viability of 84%. The efficiency of the freezing solution (89% 
viability) was increased by the addition of curcumin as antioxidant. The cryopreservation 
efficiency was further improved by optimizing the control freezing parameters, which resulted in 
93% cell viability. Thus, the formulated freezing solution comprising of 160mM NaCl/90mM 
trehalose/1mg/ml curcumin has been proven to have the ability in maintaining the viability for a 
long time and provides the isolated hADSCs from cryopreserved adipose tissue with desired 
proliferation and differentiation potential.  
 
An effort has also been given to isolate hADSCs from adipose tissue and develop a 
cryopreservation strategy for their preservation by formulating an effective freezing solution 
similar to adipose tissue. A cell viability of 81% was achieved with 10%PVP/0.9%NaCl/60mM 
ectoin. The cryopreservation efficacy of the formulated freezing solution was optimized by 
following Taguchi orthogonal design method thereby optimal composition of the freezing solution 
was obtained as 160 mM NaCl/10% PVP/90mM ectoin/100µg/ml catalase, providing the post-
thaw viability of 85%. The viability was further enhanced to 89% in control rate freezing with the 
optimized condition at -1°C/min. The freezing solution has the ability to maintain cell viability, 
proliferation and differentiation capability of hADSCs for long storage time.  
 
Thus, it has been demonstrated that the formulated serum-free and non-toxic freezing solutions 
comprising of 160mM NaCl/90mM trehalose/1mg/ml curcumin and 160 mM NaCl/10% 
PVP/90mM ectoin/100µg/ml catalase are effective for long-term preservation of adipose tissue 
and hADSCs respectively. These solutions may provide effective cryopreservation strategy for the 
supply of these products for clinical application in future. 
 
Keywords: Cryopreservation; Adipose tissue; Adipose tissue derived stem cells; Non-toxic 
freezing solution. 
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1.1 Background and Significance of study 
 
Lipofilling is an important surgical procedure in reconstructive and aesthetic surgery that 
is used to fill up the depressed region or scar of a patient body. The procedure involves the 
surgical removal of excess adipose tissue from one region and injecting or placing it back 
to the desired location. Because of the resorption of the adipose tissue with time, the 
procedure requires repetition for good contour build up at the desired location, which 
increases the patient morbidity and decreases the comfort of both doctor and patient [1].  
One of the solutions to this problem is to cryopreserve the adipose tissue at the time of the 
first harvest and inject the tissue as per the requirement over the time.  
 
Similar to the need of adipose tissue in reconstructive procedures, there is also a lot of 
demand for mesenchymal stem cells (MSCs) for tissue engineering and stem cell therapy 
applications. Tissue engineering and stem cells based therapy have the potential to 
alleviate the suffering of millions of people worldwide who are affected by various tissue 
and blood-related diseases such as diabetes, Parkinson diseases, osteoarthritis, bone, 
cartilage, tendon, muscle, neuronal, etc. Besides lipofilling, adipose tissue can also cater 
the demand of adipose tissue-derived mesenchymal stem cells (hADSCs) for the above 
purpose [2]. hADSCs are used for tissue regeneration because they differentiate into 
different cell types including osteoblasts, adipocytes, chondrocytes, myoblasts, etc. 
Therefore, to reduce patient morbidity during collection and for advancements towards 
clinical applications, developing an effective cryopreservation strategy is of utmost 
importance for preserving both adipose tissue and hADSCs with long shelve-life.  
 
Cryopreservation is a complex process, which often leads to cryoinjury mediated cell 
death, and therefore, the successful cryopreservation requires suitable freezing solution for 
specific cells and tissues [3]. Cryopreservation using a conventional freezing solution 
containing dimethyl sulfoxide (Me2SO) and fetal bovine serum (FBS) has several 
detrimental effects including, the acute and chronic toxicity to patients and genotoxicity to 
preserved cells [4]. Furthermore, the most commonly used DMEM carrier media having 
multicomponent constituents creates a more complex and unpredictable cell environment 
at sub-zero temperature because of ice crystallization [5]. Hence, the development of a 
Me2SO and serum-free freezing solution in a suitable carrier media for cryopreserving 
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both adipose tissue and hADSCs is inevitable to meet the growing demand of successful 
lipofilling operation and hADSCs for therapeutic and tissue regeneration applications. 
1.2 Cryopreservation of cells and tissues 
1.2.1 Principle of cryopreservation 
Cryopreservation is deﬁned as the maintenance of cells and tissues at temperatures below 
–80°C and in freezing condition whereas hypothermic storage includes maintenance at 
temperatures above 0°C but below 32°C [6]. Both these preservation methods are based 
on the principle of low-temperature effect on the metabolism of a living system. 
Metabolism which involves both anabolism and catabolism is essentially controlled by 
thermal energy governed molecular mobility and activity. At lower thermal energy, 
molecular motion and activity slowed down. In fact, a decrease of 10°C equals a 3% 
decrease in metabolic activities [7]. By slowing down the biophysical processes and 
reducing the metabolic activity, the living systems can be preserved for a very long time. 
Hence, cryopreservation can preserve cells and tissues for a longer duration of time than 
hypothermic preservation without alteration of their characteristics. 
1.2.2 History of cryopreservation 
In 1776, Spallanzani reported the maintenance of sperm motility even after low-
temperature exposure [8]. Subsequently, Mantegazza in 1866 suggested the need of sperm 
cryobanks [9]. However, the real works on cryopreservation started after the discovery of 
glycerol as cryoprotective agents by Polge and colleagues in 1949 [10]. James Lovelock 
proposed that damage to cells occur because of osmotic stress [11]. In 1960, Peter Mazur 
demonstrated the significance of solute concentration effect in cryopreservation and 
proposed that slow freezing could allow sufficient time to permit water to leave the cells 
and thus could avoid intracellular ice formation [12]. In 1972, the strategy for the 
maintenance of embryos in freezing condition was developed and in-vitro fertilization was 
adopted [13]. Routine cryopreservation of various cells and tissues are common in 
laboratory setting and numbers of both profit and non-profit banking systems exist 
worldwide.  
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1.3 Important factors involved in cryopreservation 
1.3.1 Ice formation in a cell suspension 
During freezing, aqueous cell suspension tends to undercool or supercool until the 
crystallization of water molecules starts because of heterogeneous nucleating agents and 
then ice crystals form [14]. The supercooling effect is because of reduction of freezing 
point by the solutes necessary for the osmotic equilibrium of cells. Furthermore, the 
intracellular solute concentration is higher than the extracellular solute concentration and 
thermal conduction through lipid bilayer hinders the intracellular ice formation. Thus, 
extracellular freezing usually precedes the intracellular freezing, as the intracellular 
solution tends to supercool more than the extracellular solution. The ice formation process 
involves the progressive growth of the ice crystals extracellularly initially and separation 
of remaining unfrozen solution from frozen water. This progressive ice formation process 
increases the concentration of solutes in unfrozen solution progressively resulting in 
osmosis out of water from intracellular to the extracellular environment [15]. The loss of 
water and consequent shrinkage induces stress to the structure and components of the cells 
resulting loss of viability of cells. Furthermore, both intracellular and extracellular 
hexagonal strong ice crystals also damage the structure of cells mechanically resulting 
lysis of the cells [16]. 
1.3.2 Rate of cooling 
A rate of cooling is a very important factor that affects cell survival during freezing. At the 
slow cooling rate, extracellular ice formation proceeds much earlier than intracellular ice 
formation and hence more solute concentration related injury occurs to cells whereas, at a 
rapid cooling rate, a higher amount of intracellular ice formation occurs causing damage to 
cells. Hence, an optimal cooling rate is necessary during cryopreservation [17]. Each cell 
type has its characteristic optimum cooling rate, which is determined by the water 
permeability of the cell and the freezing solution composition. The optimal cooling rate 
usually lies between 0.3°C and 10°C per min. 
Another important factor during cooling is latent heat of fusion [18]. The phase change 
from liquid water to crystalline ice is an exothermic process, thus increases the localized 
temperature and deregulates the ice nucleation process. Dysregulated ice nucleation 
process causes injury to cells and tissues. To minimize the damage controlled nucleation 
in the form of seeding is required. 
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When the rate of cooling is sufficiently high, liquid water, rather than crystallizes into ice, 
changes into the highly viscous glassy state. The process is called vitrification [19]. 
Vitrification techniques were successfully applied to a variety of complex biological 
materials such as gametes, kidney and liver for effective cryopreservation.   
1.3.3 Rate of thawing 
Though less critical than the rate of cooling, the rate of warming also has a significant 
impact on the viability of cells. During thawing, the reverse of cooling occurs in which the 
extracellular ice melts leads to hypotonic solution formation [20]. Hypotonicity results in 
swelling of cells and loss of viability. Although rapid warming is better for most types of 
cells and tissues, slow warming was reported to increase the viability of embryos and 
RBCs. 
1.3.4 Ion transport 
The intracellular and the extracellular ionic distribution are different. Sodium and chloride 
are the most common extracellular and potassium and phosphates are most common 
intracellular ions [21]. This distribution of ions is maintained by membrane pumps and 
principally by Na+K+ATPase pump [22]. At low temperature, when the pump activity 
decreases, cells swell because of the inward drive of extracellular water resulted in 
colloid-osmotic lysis of the cells. Furthermore, the functionality of ions pumps is affected 
by temperature changes leading to ionic imbalances in low temperature. Moreover, ionic 
imbalances of hydrogen ions cause pH to fall intracellularly resulted in alteration of 
molecular structure [23].  
1.3.5 Generation of free radicals 
Metabolic activity in the respiratory chain of mitochondria is one of the last events to 
cease at cryotemperature. Furthermore, ionic imbalances resulted in an increase in 
intracellular calcium concentration, which activates the free radical generation [24]. The 
generated free radicals remained unchecked because of cold denaturation of free radical 
scavenging enzymes such as superoxide dismutase and catalase [25]. This unrestricted 
formation of free radicals causes damage to a variety of cellular components such as lipid 
membranes, proteins, DNA and RNA. 
1.3.6 Cytoskeleton and cell membrane changes 
Solute concentration dependent shrinkage during cooling and hypotonicity-induced 
swelling of cells impart stress to the skeleton of cells maintained by microtubular systems. 
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Furthermore, cold denaturation is also known to depolymerize the microtubules causing 
additional damage to the cytoskeleton [26]. The normal cytoskeleton is required for 
maintaining the structural and functional integrity of cells.  
During cooling, phospholipids of cell membrane undergo an abrupt change from a 
disordered ﬂuid to a highly ordered hexagonal lattice [27]. However, as cholesterol, 
another lipid of the cell membrane is still in fluid phase, phase separation of the membrane 
occurs, with redistribution of membrane proteins from the organized membrane to the 
disorganized liquid phase of the membrane. The consequence of the resulting packing 
fault induces an alteration in membrane permeability resulting in imbalances in ionic 
distribution and damage to cells.  
1.3.7 Apoptosis and necrosis 
Necrosis and apoptosis are two distinct ways in which cells may die. Necrosis is caused by 
the general failure of cellular homeostatic regulation following injury induced by a variety 
of deleterious stimuli whereas apoptosis is programmed cell death, which is a regulated 
process distinguishable from necrosis by numerous morphological biochemical and 
physiological features. Cryoinjury can lead to both necrosis and apoptosis-mediated cell 
death [28]. 
1.4 Storage systems for cryopreservation 
Storage below -120°C is advisable to stop the metabolic activity completely and avoid the 
recrystallization-induced damage in the temperature range of -80°C to -100°C. For this 
purpose, two types of storage containers are usually used: Mechanical freezers and 
cryogenic freezers. 
1.4.1 Mechanical freezers 
Mechanical freezers use a recirculating refrigerant via heat exchanger coils that exchanges 
heat from air circulating within the freezer to reduce the temperature [29]. Mechanical 
freezers usually operate at a temperature range of -20°C to -80°C.Although such storage 
containers can be used for a short period, it has few advantages. Mechanical freezers 
provide more uniform temperature distribution from top-to-bottom; pose fewer 
contamination risks to samples and less risk to workers. 
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1.4.2 Cryogenic freezers 
Cryogenic freezers usually cool the temperature of storage container through direct 
application of LN2, which has a temperature of -196°C [30]. At this temperature, samples 
can be preserved for years as it provides a wider safety zone of -120°C. However, because 
of the risk of contamination, most of the biobanks prefer storing the samples at vapor 
phase of LN2, which provide a temperature of -150°C, although the margin of safety is 
compromised. 
1.5 Strategy of cryopreservation 
1.5.1 Optimization of freezing solution 
Carrier media 
Carrier media is usually composed of various ionic solutes and buffers to provide optimal 
osmotic equilibrium of cells and tissues for cryopreservation. The role of carrier media 
becomes important in sub-zero temperature [31]. The improper composition may lead to 
ionic disequilibrium and loss of viability of cryopreserved cells and tissues. 
Cryoprotectants 
Cryoprotectants are chemically diverse additive compounds to carrier media that are able 
to protect cells against the stresses of freezing and thawing. They are usually highly 
soluble in water and have low or no toxicity to the tissues and cells. Usually, 
cryoprotectants protect the frozen cells by one or more of the following mechanisms a) 
suppressing high salt concentrations b) reducing cell shrinkage at a given temperature d) 
reducing the fraction of the solution frozen at a given temperature e) minimizing 
intracellular ice formation [32]. Cryoprotectants are divided broadly into two types based 
on whether they permeate cells; membrane-permeating or low molecular weight such as 
glycerol, dimethyl sulfoxide (Me2SO) and membrane non-permeating such as sucrose and 
polyvinylpyrrolidone (PVP). Cell membrane permeating or intracellular cryoprotectants 
are low molecular weight compounds that are more effective in minimizing cell damage in 
slowly frozen biological systems whereas non-membrane permeating, or extracellular 
cryoprotectants are high molecular weight compounds that are usually more effective at 
protecting biological systems cooled at rapid rates [33].  Some of these non-permeating 
cryoprotective agents such as trehalose have direct protective effects on the cell 
membrane. Combinations of cryoprotectants may result in additive or synergistic 
enhancement of cell survival. 
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Ice blockers: Antifreeze proteins act by preferential adsorption to the prism face of 
internal planes of ice in such a manner, that ice crystal growth perpendicular to the prism 
face is inhibited. By synthesizing this antifreeze protein certain animals and plants survive 
in extremely cold climates [16]. 
Organic osmolytes 
Organic Osmolytes are small solutes that are usually synthesized by cells to counteract the 
stresses such as hyperosmolarity, anhydrobiosis, thermal and pressure stresses. They 
protect the cells by acting as antioxidants (e.g. polyols, taurine), providing redox balance 
(e.g. glycerol) and stabilizing the macromolecules such as proteins, DNA and RNA ( e.g. 
ectoin and hydroxyectoin) [34]. Osmolytes act as a protectant of low temperature-induced 
stress and increase the viability of cryopreserved cells and tissues. 
Antioxidants 
As already discussed, the free radicles that generate during cryoprocess may damage the 
cryopreserved cells and tissues. Antioxidants counteract the free radicle mediated damage 
by chelating or neutralizing those free radicles resulted in increased viability of 
cryopreserved cells and tissues. Antioxidants such as Vit C, Vit E, carnitine and curcumin 
have already been used as additive to freezing solutions in cryopreservation of various 
cells and tissues [35]. 
Caspase and Rho kinase inhibitors 
Cryopreservation-induced apoptosis is usually mediated by a caspase-dependent pathway. 
Thus, the inhibitor of caspases such as Z-VAD-FMK is known to decrease the apoptosis 
mediated loss of viability in post-thawed cells and tissues [36]. Rho kinase is mainly 
involved in regulation of shape and movement of cells by acting on the cytoskeleton. 
Thus, Rho kinase inhibitor such as Y-27632 improved the post-thaw viability of cells by 
stabilizing the cytoskeleton [37]. 
1.5.2 Optimization of thermodynamics  
Controlled rate freezer  
Controlled rate freezer offers the widest control options for a freezing protocol. As the 
controlled-rate freezer allows complex, fully controlled temperature versus time profiles to 
be created, protocols can be designed that are appropriate to the cell type and 
cryoprotectant concentration [38]. Slow (<0.1°C/min) to rapid (>50°C/min) cooling rate 
can be achieved and controlled by the controlled rate freezer. Additional steps such as for 
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manual seeding can be added to the profile. With control rate freezer, it is possible to 
optimize cryoprocess for various cell types.  
1.6 Cryoprotectant and toxicity 
Cryoprotectants are reported to have adverse effects on cells due to chemical toxicity, or 
they could be a result of osmotic stress during the addition of the cryoprotectant before 
freezing and during dilution of the cryoprotectant after thawing. Cryopreservation using 
conventional 10% Me2SO supplemented with FBS as freezing solution is warranted with 
several detrimental effects including genotoxicity of preserved cells, the acute and chronic 
toxicity of patients.  Hence, development of an effective freezing solution free from 
Me2SOand serum is inevitable. 
1.7 Adipose tissue 
Adipose tissue or adipose organ is derived from the mesodermal germ layer. The main 
cellular component of adipose tissue is adipocytes, which is lipid-filled. Also, other cells 
like stem cells, endothelial cells, smooth muscle cells, immune cells also exist in the 
tissue. White adipose tissue is the dominant form of adipose tissue in body compared to 
brown adipose tissue and constitutes 15 - 20% of the mass of males and 25 - 30% in 
females. Adipocytes, filled with lipid droplets, store energy for the body. Also, adipose 
tissue secretes many hormones and signaling molecules and thus acts as an endocrine 
gland [39].   
1.8 Importance and application of adipose tissue 
1.8.1 Lipofilling 
Liposuction has become one of the most common procedures in plastic surgery. Most of 
the time the goal is to remove excessive fat to improve the body contour. In such cases, 
the aspirated fat can be transferred to various acceptor sites, e.g., to the thorax after a 
breast segmentectomy or mastectomy. Furthermore, multiple reports show that autologous 
fat grafting can enhance healing and improve scar quality in mature burn wounds, chronic 
ulcers and skin areas affected by radiation therapy. Lipofilling can also be used for soft-
tissue augmentation in hand or facial rejuvenation when injected in volume lacking areas 
[40]. However, the main drawback of this lipofilling technique remains the 
unpredictability of the outcome, mainly due to resorption of injected tissue. This increases 
the need for more grafting operation after initial procedures, which increases the morbidity 
and expenditure of patients [41]. 
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1.8.2 Production of stem cells 
Stem cells are a population of cells possessing self-renewal, long-term viability and 
multilineage potential [42]. Albeit embryonic stem cells have potent ability to differentiate 
into various cells lineages, their practical use is limited due potential problems of cell 
regulation and ethical considerations [43]. In contrast, MSCs are derived from the 
autologous origin and neither have ethical nor immunological problems [44]. The MSCs 
can be isolated from various organs such as fetal liver, umbilical cord blood, adipose 
tissue, and bone marrow.   
 
Isolation of mesenchymal stromal cells from adipose tissue has become prominent in 
recent years as it is abundantly available and the frequency of obtaining MSCs is relatively 
high i.e. 1 fibroblastoid like colony (CFU-F) in every 100 colonies formed. This ratio is 
very high when compared to MSCs obtained from bone marrow i.e. 1 in 100000 CFU 
[45]. Furthermore,  the MSCs from adipose tissue can differentiate into adipogenic, 
osteogenic, myogenic, neurogenic and chondrogenic lineages and these cells are 
genetically stable when compared to bone marrow-derived mesenchymal stem cells [46]. 
Moreover, they are immunocompatible and immunosuppressant, which increases their 
potential as therapeutics for a number diseases and disorders [47].  
1.9 Cryopreservation of adipose tissue 
A possible solution in addressing the problem of resorption after lipofilling is storage of 
the remaining adipose aspirates after the initial liposuction. Studies have been done to 
determine whether cryopreservation is a valid option to store adipocytes. Theoretically, if 
resorption occurs, the previously aspirated adipose tissue could be thawed and injected. 
This procedure could be performed on an outpatient basis and under local anesthesia. The 
main advantage of this method would be that it eliminates the need for more liposuction 
procedures under general anesthesia and, consequently, that it reduces hospitalization 
time, costs and operative or anesthetic risks.  
1.10 Cryopreservation of adipose tissue-derived stem cells 
The advancement in mesenchymal stem cell-based therapeutics calls for an effective 
cryopreservation strategy for preservation of human adipose-derived stem cells with long 
selve-life. Cryopreserved hADSCs will not only cater the emergent and elective 
requirement of hADSCs but also will provide clinically relevant cell numbers for 
therapeutic purposes. 
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2.1 Cryopreservation of adipose tissue 
With increased awareness of aesthetic appeal, lipofilling has grown in popularity as 
dermal fillers and increasingly being used in reconstructive and aesthetic surgery. 
However, because of lipoatrophy in lipofilling, the procedure often needs to be repeated 
increasing the morbidity of the patient. Cryopreservation of left over adipose tissue at the 
time of first lipofilling surgery emerged as a possible solution to improve the patient 
compliance [48]. However, cryopreservation of cells and tissues often requires 
optimization of cryoprocess parameters in the presence of suitable freezing solution to 
prevent low temperature induced damage to cells and tissues [49].  
 
Among the cryoprocess parameters, storage temperature, cooling and thawing rate are 
important factors that influence the viability of cryopreserved adipose tissue. To observe 
the significance of storage temperature on the viability of cryopreserved adipose tissue, 
Lidagoster MI et al., in 2000 implanted the adipose tissue in mice model after preservation 
at -16°C and 1°C.  They observed the signs of inflammation and higher loss of tissue 
viability in the grafted cryopreserved adipose tissue compared to fresh adipose tissue that 
indicates that storage temperature has a significant influence on the cryopreservation of 
adipose tissue [50]. Subsequently, Wolter TP et al. compared the viability of 
cryopreserved fats stored at -20°C and -80°C for different duration. They concluded that -
80°C is a preferable temperature than -20°C [51]. However, Erdim M et al. demonstrated 
that 4°C is enough to maintain the viability of stored fats for 2 weeks without any need of 
freezing solution [52]. In contrasts, Son D et al. in 2010 showed that lipoaspirates retain 
inadequate viability, if stored at -15°C and -70°C [53]. Therefore, the consensus is that 
storage temperature has significance influence on the viability of cryopreserved adipose 
tissue and to prevent ice-related damage at sub-zero temperature, it is preferable to store 
the tissue at less than -70°C.   
 
To find out the suitable cooling rate for adipose tissue cryopreservation, Pu LLQ et al. in 
2005 demonstrated that slow cooling is preferable than fast cooling. They first cooled 
down the samples to -30°C with a constant decline of 1°C/min and then they held it at that 
temperature for 10min and transferred it to -196°C (Liquid nitrogen) [54].  Therefore, 
keeping in view that the not much work has been done to find out optimal cooling rate and 
the importance of rate of cooling in maintaining the viability of cryopreserved tissue, 
further experiments need to be performed to find out the ideal rate of cooling and optimize 
the cryopreservation process for adipose tissue. Similar to cooling rate, the thawing rate of 
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cryopreserved adipose tissue is another important factor that controls viability of post-
thawed tissue. Hwang SM et al. compared the viability of adipose tissue in different 
thawing condition such as natural thawing at 25℃ for 15min; natural thawing at 25C for 
5min, followed by rapid thawing at 37℃ in a water bath for 5min; and rapid thawing at 
37℃ for 10min in a water bath [55]. They demonstrated that rapid thawing at 37°C for 
10min in a water bath was ideal for the thawing the cryopreserved adipose tissue.  
 
A freezing solution is usually composed of cryoprotectants that protect the cell membrane 
and macromolecules of cells and tissues from ice-induced damage. To find out the 
significance of cryoprotectant in the cryopreservation of adipose tissue, in 2004, MacRae 
JW et al. preserved adipose tissue with and without cryoprotectants. They concluded that 
at -196°C, the samples preserved with cryoprotectants showed increased viability of 
adipose tissue than the samples preserved without the cryoprotectants proving the 
necessity of cryoprotectant in the cryopreservation of adipose tissue [56]. Subsequently, 
Wolter TP et al. evaluated various cryoprotectants such as polyvinylpyrrolidone, glycerol, 
dextran and hydroxyethyl starch and stored the tissue at -20°C and -80°C. They revealed 
that storing at -20°C lead to the death of adipose tissue with or without cryoprotectants; 
however cryoprotectants provided slight protection of adipose tissue at -80°C resulting in 
improved viability outcome [51]. To find out most effective cryoprotectant for adipose 
tissue cryopreservation, Moscatello DK et al. compared the effect of Me2SO with PVP and 
glycerol and demonstrated that Me2SO is a better cryoprotectant for adipose tissue than 
other cryoprotectants [57]. Later on, Pu LLQ et al. in a series of experiments showed that 
among the polyols, trehalose is a better cryoprotectant than other polyols and upon 
combination with Me2SO showed the improved viability of cryopreserved adipose tissue 
[58-65]. The adipose tissue cryopreserved with Me2SO (0.5M), and trehalose (0.2M) 
maintained volume, weight and fatty tissue structure of injected free grafts more than the 
tissues cryopreserved without the cryoprotectants. However, another experimental study 
by the same group suggested that 0.35M trehalose is the optimal concentration for 
cryopreservation of adipose tissue. 0.35M trehalose provided similar viability outcome of 
free fat grafts injected in nude mice compared to free fat grafts preserved with 
Me2SO(0.5M) and trehalose (0.2M). Thus, 0.35M trehalose can replace the toxic Me2SO 
containing the freezing solution for cryopreservation of adipose tissue. To correlate the 
effect of harvesting technique with effects of cryoprotectants, they harvested fats with 
Coleman technique and cryopreserved that with Me2SO (0.5M) and trehalose (0.2M). 
14 | P a g e  
 
They observed that the fat retained normal histology albeit with a lower concentration of 
glycerol 3 phosphate dehydrogenase enzyme. However, Li BW et al. when compared the 
fat preserved with normal saline and preserved with hydroxyethyl starch at -20, -80 and -
196 °C, found no differences in cell viability once injected into nude mice [66]. 
Thus, it can be concluded that cryoprotectants protect the adipose tissue from the ice 
related injury during cryopreservation. However, there are studies, which pointed 
otherwise. Most of the studies establish Me2SO and trehalose as preferred cryoprotectants. 
However, ideal concentrations are not conclusive with reports of different concentrations 
of trehalose as optimal concentration, and further research and investigation would be 
preferable. Furthermore, the role of normal saline and other buffers as carrier medium is 
also controversial needing more research on that topic. 
2.1.1 Viability analysis of cryopreserved adipose tissue 
Because of the complexity of adipose tissue, viability measurement becomes complex. 
There is no consensus on the reliable and accurate methods to measure the viability of 
adipocytes in adipose tissue and different methods were used in different experimental 
studies to measure the viability of adipose tissues. In 2005, Lei H et al. demonstrated that 
glucose transportation test could be used to measure the viability of adipose tissue along 
with histology examination [67]. Suga H et al. suggested that single tests might not be 
sufficient to measure the viability of adipose tissue rather a combination of glycerol 3 
phosphate dehydrogenase, XTT and adipocyte staining using fluorescent dyes such as Nile 
Red, Hoescht 33342 and propidium iodide (PI) may be required to predict the viability of 
adipose tissue reliably [68]. Fluorescent staining, XTT and Glycerol 3 Phosphate 
Dehydrogenase (G3PDH) assay provided good correlations between the number of viable 
adipocytes and resulting values and G3PDH assay is a specific test for the viability of 
adipocytes in adipose tissue. In addition, many other tests such as oil ratio analysis, MTT, 
Trypan blue assay were also used to measure the viability of adipose tissue. Therefore, it 
can be concluded that the combination of tests is required to assess the viability of adipose 
tissue reliably. 
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        Table 2.1: Literature review of adipose tissue cryopreservation 
Article Carrier media/ 
Cryoprotectant 
Cooling/Thawing 
rate 
Temperatur
e (°C) 
Duration Conclusion 
Wolter  TP 
[51] 
DMEM/HES, Glycerol, 
Dextran, PVP 
1°C/min to -20C or -
80C/Rapid thawing 
-20/-80 30 days Addition of cryoprotectants 
improved viability 
Pu  LLQ 
/Cui X [48, 
54, 58-61, 
65] 
0.9% NaCl/3.3% Me2SO 
0.9% NaCl/7.5% 
trehalose or.9% 
NaCl/3.3% Me2SO+7.5% 
Trehalose 
In methanol bath till -
30°C then hold 20 min 
and transferred to LN2   
/Rapid thawing 
-196 20/30 
min 
0.9% NaCl/3.3% Me2SO+7.5% 
Trehalose 
Son  D [53] Surgical fluid/NA NA/Slow thawing -15/-70 56 days Most cells died immediately 
Li  BW [66] 0.9% NaCl/HES -1°C/min till -20°C 
and hold for 20 min 
before transferring to 
freezers/Rapid 
thawing 
-20/-80/-196 2/7 days No difference in viability between 
-20°C/-80°C/-196°C; HES no 
benefit compared to normal saline 
Hwang  SM 
[55] 
0.9% NaCl/ No 
cryoprotectants 
NA/different thawing 
rate 
-20 NA Rapid thawing for 10 min in a 
37°C water bath is better 
Lee  HJ[69] 0.9% NaCl/No 
cryoprotectants 
NA/Rapid thawing 4 22 
months 
No difference between 0.9% NaCl 
preserved  and fresh tissue 
16 | P a g e  
 
2.1.2 Isolation of mesenchymal stem cells from cryopreserved adipose tissue 
Successful strategy for cryobank of adipose tissue is not only important for the supply of 
adipose tissue but also important for the supply of adipose tissue-derived mesenchymal 
stem cells when the need arises. Thus, in 2006, Matsumoto D et al. evaluated the effect of 
storage temperature on the retrievability of adipose- derived stem cells from cryopreserved 
adipose tissue. They concluded that adipose-derived stem cell yield was significantly 
reduced by preservation at room temperature for 24h and by preservation at 4°C for 2 or 3 
days [70]. Furthermore, the adipose-derived stem cell yield from cryopreserved fat was 
much lower than that of freshly aspirated fat when preserved at -80°C for 1 month. 
However, in the same year, Pu LLQ et al. cryopreserved human adipose tissue with 0.5M 
dimethyl sulfoxide and 0.2M trehalose in LN2 and retrieved 90% of stem cells from the 
cryopreserved tissue [71]. However, they observed a latency of hADSCs growth with the 
retrieved hADSCs after two weeks of culture. To find out the significance of 
cryoprotectants on the retrievability of hADSCs from cryopreserved adipose tissue, Lee JE 
et al. in 2010 cryopreserved adipose tissue in -20°C and -80°C for 1 year and concluded 
that no stem cells were viable in tissue cryopreserved without cryoprotectants. However, 
stem cells survived successfully for 1 year in adipose tissue stored with 10% Me2SO and 
differentiated into adipocytes [69]. Contrasting the findings of Lee JE et al., Kim JB et al. 
did not observe any adherent hADSCs when human adipose tissues were preserved at -
20°C and -80°C in the presence of 10% Me2SO [72]. However, they observed that stem 
cells isolation is possible when the adipose tissue was stored in at -190°C (LN2) in the 
presence of 10% Me2SO. They further reported that the growth rate of the stem cells is 
low when the tissue was preserved in 10% Me2SO + 10% FBS compared to 10% Me2SO 
+ 90% FBS. hADSCs isolated from adipose tissue preserved with 10% Me2SO + 90% 
FBS exhibits similar growth pattern compared to stem cells isolated from fresh tissue. In 
2013, Choudhery MS et al. demonstrated that stem cells from fresh and cryopreserved 
tissues with 10% Me2SO displayed similar fibroblastic morphology [73]. 
Cryopreservation did not alter expression of phenotypic markers, the proliferative 
potential of MSCs, the differentiation capability of MSCs. Devitt SM et al. in 2014  
reported that longer cryopreservation negatively impacts initial live adipose-derived stem 
cell isolation; however, this effect is neutralized with continued cell growth [74]. 
Furthermore, patient age does not significantly affect stem cell isolation, viability, or 
growth. 
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       Table 2.2: Literature review isolation of stem cells from cryopreserved adipose tissue 
Article Carrier 
media/Cryoprote
ctant 
Cooling /Thawing rate Temperature 
(°C) 
Duration Conclusion 
Pu LLQ [71] 0.9% NaCl/ 0.5M 
Me2SO and 0.2M 
trehalose 
In methanol bath till -30°C, 
then hold 20 min and 
transferred to LN2 
 /Rapid thawing 
-196 20min Good yield of hADSCs, 
however, there is a latency of 
cell growth  
Matsumoto  D 
[70] 
Proprietary 
formulation  
1°C/15 min till -80C/Rapid 
thawing  
25/4/-80 1 month No/low yield of hADSCs 
 
 
Lee JE [69] DMEM/10% 
Me2SO 
 
NA -20C/-80 1 year No yield without Me2SO 
JB Kim[72] DMEM/ 10% 
Me2SO +80% HS 
NA -20/-70/- 196 7 days No yield at lower 
temperature; latency of 
growth with 10% FBS but 
not with 80% FBS 
Choudhery  
MS[73] 
DMEM/10% 
Me2SO 
NA -196 1 month Good yield; no latency of 
growth; retain differentiation 
ability 
Devitt SM[74] No 
cryoprotectants 
NA -70 3 years Good yield; latency of 
growth initially but not with 
subsequent passaging 
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Table 2.3: Literature review on cryopreservation of adipose tissue derived stem cells 
 
Article Cooling /Thawing rate Carrier 
media/Cryoprotectant 
Temperatu
re (°C) 
Durati
on  
Viability 
Goh BC [87] NA DMEM/10% Me2SO 
+80% FBS 
-196 1 
month 
81% with 5x105 cells/ml 
Oishi  K 
[88] 
Rapidly cooled NA/ 10% Me2SO 
 
-80 7 days 70% with 10% Me2SO 
 
Liu G [89] Cooling rate o f −0.5°C /min from 4 to 
−20°C. The vials were then put into a 
−80°C freezer. After 24h at −80°C, 
the cells were transferred into a LN2 
DMEM/10% Me2SO 
+20% FBS 
-196 2 wks NA 
Rossa  AD 
[90] 
-20°C for 30min,then at -80°C for 1 h 
and transferred to LN2 
NA / 4% Me2SO 
+6% trehalose+90% FBS  
-196 1 year 92.5% in 1 month, 84.6% 
% in 6 months and 70% 
after 1 year with solution 2 
Thirumala  S 
[91] 
Frozen overnight in a −80°C freezer 
inside ethanol  jacketed container  and 
transferred to LN2 
DMEM/ 1% MC  or 10% PVP  
+ 80% of either HS or FCS  
-196 2 wks 54% with 10% PVP and 
DMEM a, 63% with 10% 
Me2SO ,37% with MC 
Thirumala  S 
[92] 
Frozen overnight in a −80°C freezer 
inside ethanol jacketed container  and 
transferred to LN2.  
DMEM/1% MC + 10% of 
either HS or FCS  
-196 2 wks 84% with 2% Me2SO ; 
84% with 10% Me2SO 
 +80% HS/FBS 
Thirumala  S 
[93] 
−80°C freezer inside ethanol jacketed 
container and transferred to LN2. 
DMEM/ 10% PVP  +  80% of 
either HS or FCS 
-196 2 wks 70% with 10% PVP 
Dariolli  R 
[94] 
NA DMEM/10% Me2SO 
+10% FBS 
-196 1 year 90–95% 
James  AW 
[95]  
With and without Mr.Frosty overnight 
and then transferred to LN2 
NA/ 10% Me2SO 
+90% FBS 
-196 2 wks 96% 
Miyamato  
Y [96] 
-1°C/min to -80°C DMEM/10% Me2SO 
+1% sericin+0.1M maltose 
-80 1-4 
wks 
95% 
Ginani  F 18h at -20°C, and then, storage at - 10% Me2SO -80 30 90% 
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[97] 80°C +20% FBS days 
Minonzio G 
[98]   
From 4°C to 0°C in 6min, then hold 
for 15min at 0 °C. From 0°C to −2 °C 
in 9min and then hold for 2min at −2 
°C. From −2°C to −35°C in 25.5min 
and finally from −35°C to −100°C in 
13 min. 
5% albumin solution in 
cryobag/5% Me2SO 
 
-196 6 
month
s 
 89.6% 
Fernandez  
MLG [99] 
Kept at −80°C overnight and 
transferred to LN2 (−196°C) the next 
day 
DMEM/ 10% Me2SO 
+ 80% FBS 
-196 90 
days 
5% Me2SO 
 gives 75% 
And all others near about 
80% 
Yong  KW 
[100-102] 
24h at −80 °C, then transferred to LN2 DMEM/ 5% Me2SO 
 + 20% FBS  
-196 90 
days 
90% with 10% Me2SO 
/ 90% FBS  
López  M 
[103] 
0°C and cooled to -7°C at 2°C/min. 
After seeding of extracellular ice and 
holding at -7°C for 10 min, the straws 
were cooled to -70°C at 1°C/min and 
then plunged into liquid nitrogen 
DMEM in ½-cc straws / 
0.1mM EGTA+ 0.25 M 
trehalose+2% PVA and 5% 
ficoll + 5% Me2SO 
+5% EG+3mM reduced 
glutathione+5mM ascorbic 
acid 2-phosphate  
-196 NA 90.0% and 98.7% 
Irioda AC 
[104] 
First stage (Program 3–15 min) 
reaches the temperature −30°C; in the 
end of step 2 (Program 5–45 min), the 
temperature is −60°C; finally, in the 
last stage, step 3 (Program 9-10min), 
the temperature is −110°C and then 
transferred to LN2 
DMEM/10% Me2SO 
+ 80% of FBS 
-196 20 
days 
74.99% 
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2.2 Cryopreservation of mesenchymal stem cells 
Mesenchymal stem cells (MSCs) are multipotent adult stromal cells with capability of 
self-renewal and differentiation to mesoderm or non-mesoderm derived tissues [75]. 
Because of their unique properties such as easy isolation and culture, immunotoleranancy 
to allogenic transplantation and differential ability, it emerged as one of the leading 
candidates for cell therapy in regenerative and tissue engineering [76]. Because of 
diversity of adult stem cells, the Mesenchymal and Tissue Stem Cell Committee of the 
International Society for Cellular Therapy proposed the minimal criteria to define human 
MSCs as: (i) MSCs must be plastic–adherent when maintained in standard culture 
conditions  (ii) MSCs must express CD105, CD73 and CD 90 and lack expression of 
CD45, CD34, CD14 or CD11b, CD79alpha or CD19 and HLA-DR surface molecules and 
(iii) MSCs must also demonstrate tri-lineage differentiation into osteocytes, adipocytes 
and chondrocytes in vitro [77].  
MSCs from bone marrow, cord blood and dental pulp are cryopreservable by slow 
freezing protocols utilizing Me2SO and FBS as cryoprotectants is in use by many groups 
[78-82]. Many of the alternative cryoprotectant formulations have also attempted to 
remove Me2SO and animal serum from the cryoprotectant solution; both to reduce cost 
and to improve clinical utility through reducing toxicity and possibility of zoonotic 
infections. Human serum and human serum albumin was tried as an alternative to FBS. 
However, this too is costly and introduces the risk of transmission of human pathogens. 
Attempts were also given to reduce or eliminate Me2SO in freezing solution by replacing 
it with polyethylene glycol, polylysine, glycerol, methylcellulose and trehalose [83-85]. 
Therefore, these laboratory studies indicate that there is a potential for the development of 
xeno-free and serum-free freezing solution for cryopreservation of MSCs. 
The incidence of mesenchymal stem cells in various tissues is extremely low, ranging 
from around 0.00003% of nucleated cells in cord blood to 0.001–0.01% of nucleated cells 
in the marrow, though this decreases with age. However, adipose tissue has been shown to 
have a higher proportion of MSCs (approximately 2% in the stromal vascular fraction) 
offering an advantage over MSCs from another tissue source [86]. 
Choice of the storage container is important in ensuring proper thermodynamics and 
volume of cell suspension for the appropriate cost-benefit ratio of cryopreservation. 
Usually, for biobanking of stem cells cryovials are the most commonly used container and 
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straws are used for preservation of germ cells. Cryobags are mainly used for large-scale 
cryopreservation.  Although most of the study used cryovials for the storage of hADSCs, 
Minonzio G et al. used 25ml cryobags and López M et al. preserved hADSCs in ½-cc 
straws [98, 103]. 
The significance of carrier medium is evident from the role of extenders in the outcome of 
sperm cryopreservation. Inappropriate extenders as carrier medium lead to loss of post-
thaw sperm viability and functionality. However, not much work has been carried out to 
optimize the carrier medium for mesenchymal stem cell cryopreservation. Almost all the 
study for cryopreservation of hADSCs used DMEM/F-12 as carrier media except in one 
study where 5% albumin solution was used as carrier medium [98]. 
Concentrations of cells are a very important factor that influences the outcome of a 
preservation strategy. Goh BC et al. in 2007 demonstrated that for cryopreservation of 
adipose-derived stromal cells in a cryovial at -196°C in the presence of 10% Me2SO+80% 
FBS freezing media, the optimum concentrations of cells should be 5x105 cells/ml [87]. 
However, the optimal concentration of cells depends on upon the type of storage 
container, the stage of cells and the freezing solution composition. Therefore, the 
concentrations of cells differ from study to study. Out of 16 studies mentioned, 8 studies 
conducted their study with 1x106 cells/ml and 1 study used 5x105 cells/ml. Most of the 
other studies used cell concentration higher than 1x106 cells/ml. 
Cryoprotectants are a very important component of freezing solution, which prevents 
freezing related damage to biological samples. Almost 50% of total studies, Me2SO with 
or without FBS was used for the cryopreservation of hADSCs, whereas another 40% 
studies were conducted to reduce or eliminate Me2SO from freezing solution. To reduce 
the concentration of Me2SO, in 2009, Rossa AD et al. reported that 4% Me2SO+6% 
trehalose+90% FBS is sufficient in maintaining more than 90% viability of hADSCs even 
after 1 month of storage. However, the viability reduces to 70% after 1 year [90]. 
Furthermore, in 2014 Minonzio G et al. demonstrated that 5% Me2SOand 5% human 
albumin freezing solution gave viability of 90% [98]. In an another recent study, López M 
et al. optimized a freezing solution cocktail by the addition of antioxidants glutathione and 
ascorbic acid, extracellular cryoprotectants polyvinyl alcohol (PVA) and ficoll, reduced 
concentration of Me2SO and a calcium chelator EGTA  along with trehalose [103]. The 
optimized solution (0.1mM EGTA + 0.25M trehalose + 2% PVA and 5% ficoll + 5% 
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Me2SO + 5% EG + 3mM reduced glutathione + 5mM ascorbic acid 2-phosphate) gave 
viability of more than 98%. Thirumala S at al. in a series of the study revealed that 10% 
PVP, which gave viability of 70% could replace Me2SO [91, 93]. In another significant 
finding of their study, 2% Me2SO gave the remarkable cryoprotective ability to preserve 
hADSCs [92]. Recently, Yong KW et al. also observed that 5% Me2SO maintained a high 
cell viability (75%) comparable to those preserved in standard cryomedium (10% 
Me2SO + 90% FBS) [100-102]. Miyamato Y et al. reported that supplementation of 1% 
sericin and 0.1M maltose with 10% Me2SO gave more than 95% viability of 
cryopreserved hADSCs [96]. 
As with other biological samples, cooling rate during cryopreservation is an important 
factor that determines the viability of post-thawed hADSCs. Except the study by Oishi K 
et al. in 2008, where they cooled the samples rapidly, all other study used the slow cooling 
method. Liu Q et al.  kept the samples at -20°C freezer to achieve a cooling rate of 
0.5°C/min and transferred it to -80°C freezer to expose the samples to -1°C/min till -80°C. 
They kept the samples for 24h in -80°C freezer before transferring them to LN2. Rossa AD 
et al. also followed similar cooling protocol. In all the three studies by Thirumala S et al., 
they used an ethanol-jacketed container to freeze the cells overnight in a -80°C freezer 
before transferring them to LN2. In the ethanol-jacketed container, ice nucleation was 
observed around −5°C, and a cooling rate of ∼1.1°C/min was achieved at a temperature of 
−40°C. Subsequently, the cooling rates drop to 0.3°C/min and 0.1°C/min, before reaching 
−80°C. James AW et al., Yong KW et al. and Fernandez MLG et al. also followed similar 
cooling protocol with slight modifications. Minonzio G et al. and Irioda AC et al. used a 
control rate freezer to achieve predictable and reliable cooling rate. Minonzio G et al. 
cooled the cryobags from 4°C to 0°C in 6min (hold for 15min), from 0 °C to −2°C in 9 
min (hold for 2min), from −2°C to −35°C in 25.5min and finally from −35°C to −100°C in 
13min before transferring them to LN2. Irioda AC et al. took 15 min to reach -30°C, then 
45min to reach -60°C and finally 10min to reach -110°C before transferring the samples to 
LN2.  All the study used rapid thawing rate at -37°C water bath. 
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2.2.1 Effect of freezing on functionality of adipose-derived stem cells 
Retention of adhesion to plastics, proliferation ability, differentiation potential, surface 
marker expression and chromosomal normality is essential for further application of 
cryopreserved hADSCs. Out of total 16 studies mentioned, 10 studies performed 
proliferation kinetics of frozen hADSCs. Out of 10 studies, 6 studies reported normal 
proliferation kinetics, whereas four studies reported delay or accelerated proliferation of 
frozen cells. Three studies also conducted colony forming unit assay with frozen stem 
cells with one study each reported normal, decrease and increased colony formation. All 
studies reported normal morphology of cryopreserved hADSCs except one by James AW 
et al. The authors reported the presence of unusual morphology of the frozen cells upon 
culture and proliferation. Oishi K et al., in 2008 showed that the proliferation rate of 
hADSCs decreases if frozen with 10% Me2SO. However, in the same year, Liu Q et al. 
demonstrated that frozen cells maintain their capability of proliferation compared to 
freshly cultured cells. Again, in 2009, Rosa AD et al. reported that there is an initial delay 
in the proliferation of frozen hADSCs till passage 2 and from passage 3 the growth 
characteristics of frozen cells are similar to fresh cells. However, James AW et al. showed 
that there is a significant impairment of cell attachment and proliferation of hADSCs 
frozen with 10% Me2SO and 90% FBS. Contrary to James AW et al., in the same year, 
Dariolli R et al. reported that that the growth characteristics of porcine hADSCs are not 
influenced by long-term preservation with 10% Me2SO. Miyamato Y et al. reported higher 
proliferation rate of hADSCs after cryopreservation with 10% Me2SO + 1% sericin + 
0.1M maltose. Ginani F et al. also reported normal growth characteristics of hADSCs after 
freezing with 10% Me2SO. However, Minonzio G et al. showed that frozen adipose 
stromal cells maintain normal proliferation but higher the colony forming units if 
preserved with 5% Me2SO and 5% human albumin solution. Contrasting with Minonzio G 
et al., Irioda AC et al. demonstrated that there is a decrease in colony forming unit by 
frozen cells preserved using 10% Me2SO and 80% FBS. 
 
Out of 16 studies, 15 studies differentiated the frozen cells to osteogenic and adipogenic 
lineages, out of which, 13 studies reported normal differentiation with frozen hADSCs. 
Among the other two study, Goh BC et al. demonstrated that although there is a decrease 
in the osteogenic differentiation, adipogenesis remains normal after storing the stem cells 
in LN2 for 1 month in the presence of 10% Me2SO and 80% FBS. However, even the 
decrease in osteogenesis is non-significant compared to the fresh cells. In both in-vitro and 
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in vivo study, James AW et al. showed that passage 1 cells frozen with 10% Me2SO + 
90% FBS in LN2 for 2 weeks showed the deleterious effect on both osteogenic and 
adipogenic differentiation. However, they demonstrated that IGF-1 and BMP-4 rescued 
the deleterious effect on osteogenic differentiation in vivo. 
Out of 16 studies, 5 studies conducted the expression of surface markers after freezing 
hADSCs. Four of which reported similar surface marker expression as fresh cells, 
whereas, in one study by Irioda AC et al. there was a significant reduction in expression of 
CD49d expression in cells frozen with 10% Me2SO and 80% FBS. 
Five studies evaluated the effect of freezing on chromosome and gene expression. Dariolli 
R et al. demonstrated that long-term cryostorage using 10% Me2SO do not influence 
karyotype and senescence cues. Ginani F at al. reported no morphological changes in the 
nuclei of frozen hADSCs (nuclear fragmentation or the presence of pyknotic nuclei). 
Yong KW et al. observed significantly higher (p<0.05) expression level in stemness 
genes including OCT-4, REX-1, SOX-2 and NANOG of cryopreserved hADSCs 
compared to fresh hADSCs, indicating the frozen cells have greater ability to maintain 
their stemness properties. They also observed normal levels of the tumor suppressor 
markers p53, p21, p16 and pRb, hTERT, telomerase activity and telomere length in frozen 
cells compared to fresh cells.  
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Chapter 3 
 
 
Scope &Objective 
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Cryopreservation using Me2SO as potential CPA is the most well known and efficient 
method for preserving cells and tissues. However, keeping in view of the harmful effect of 
this conventional freezing solution, recent research has focussed in the search of potential 
non-toxic CPAs of natural origin for developing freezing solutions. Therefore, the present 
dissertation work has been undertaken to explore potential natural CPAs and suitable 
carrier media thereby develop a freezing solution that can be used as an effective 
cryopreservation strategy for preserving much needed adipose tissue and adipose tissue 
derived stem cells. 
Adipose tissues harvested by liposuction are important tissue source, the large quantity of 
which is required for reconstructive and aesthetic surgery for making fat grafts. However, 
the absorption rate of adipose tissue grafts result in poor clinical outcome requiring 
repeated harvesting procedures, which leads to not only surgical risk but also increase in 
hospital expenditure. Once it is harvested, cryopreserving spare adipose tissue with high 
survival rate for long time can avoid the problem of repeated harvesting. Besides fat 
grafts, adipose tissue is considered as a promising source for providing mesenchymal stem 
cells for various therapeutic and upcoming tissue-engineering applications. As a result, 
there is a growing demand worldwide for adipose tissue and hADSCs for the various 
clinical applications. For catering the great demand of adipose tissue and hADSCs, as 
important tissue and cell source, the development of an appropriate strategy for preserving 
such clinical products with long shelve-life without change in their desired property is of 
paramount importance. Keeping in view of their actual use when need arises, 
cryopreservation with Me2SO and serum in freezing medium is conventionally used. 
However, the use of these components in cryopreservation soluting is harmful to the 
patient by causing cell death. 
In the context, developing a freezing solution, which is devoid of Me2SO and serum is one 
of the key challenges as promising cryopreservation strategy for adipose tissue and 
hADSCs. 
Therefore, the main aim of the present dissertation work is the development of effective 
cryopreservation strategies by exploring suitable non-toxic natural CPAs and carrier media 
for cryopreservation of adipose tissue and hADSCs with maintained cells viability, 
structural and functional ability for long-term basis.  
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The specific objectives of the present research work are as follows. 
i. Screening of potential natural cryoprotective agents, carrier media and 
antioxidants to formulate an effective freezing solution 
 
ii. To evaluate the performance of the formulated freezing solution for preserving 
adipose tissue and hADSCs 
 
 
iii. To optimize the controlled rate freezing for cryopreservation of adipose tissue and 
hADSCs 
 
iv. To evaluate the long-term preservation of adipose tissue and hADSCs using the 
developed freezing solutions 
 
 
Scope of work 
 
The specific scope of this present research work is as follows- 
 
A. CRYOPRESERVATION OF ADIPOSE TISSUE  
 
I. Screening of CPAs and carrier media 
In this phase, efforts will be given to explore the potential hydrocolloids and natural 
organic osmolytes as extracellular and intracellular CPAs as well as individual PBS 
components such as NaCl, Na2HPO4, KCl and KH2PO4 as possible carrier media for the 
formulation of freezing solution. The cryopreservation experiments with adipose tissue 
will be performed to evaluate the effectiveness of the individual CPAs and individual PBS 
components (ionic compounds) as carrier media. The screening of CPAs and carrier media 
will be done by measuring oil ratio as a preliminary screening criteria and final selection 
will be based on XTT, G3PDH and TBARS assays.  
 
II. Formulation and evaluation of freezing solutions  
Different batches of freezing solutions will be prepared by using the selected CPAs and 
carrier media with varying concentrations. The freezing solutions will be tested for their 
performance towards cryopreservation of adipose tissue by conducting series of 
experiments in Mr. Frosty. The most effective freezing solution cocktail will be selected 
based on a battery of assays as mentioned above.   
 
III. Improvement of cryopreservation by the addition of anti-oxidant 
The oxidative stress mediated cellular damage is reported to be a critical phenomenon in 
low temperature storage, which is expected to be higher in case of adipose tissue than 
other body tissues. The supplement of suitable antioxidants in freezing solution is reported 
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to improve the cryopreservation outcome of other tissues. Therefore, efforts will be given 
to explore suitable antioxidants by screening method and most potential antioxidant will 
be selected on the basis of their performance evaluattion by conducting cryopreservation 
experiments using the formulated freezing solution supplemented with various 
antioxidants.  The optimal composition of freezing solution containing the most effective 
antioxidant is expected to give maximum post-thaw tissue viability. 
 
IV. Control rate freezing of Adipose Tissue using the formulated freezing solution 
An effort will be given for further improvement of the cryopreservation efficiency by 
performing cryopreservation of adipose tissue using a control rate freezer . The cooling 
rate has a profound influence in cryopreservation of cells and tissues. Therefore, the 
optimal cooling rate for achieving maximum cell viability in controlled rate freezing will 
be established by performing cryopreservation experiments at varying cooling rates.  
 
V. Assessment of long-term storage viability 
The maintenance of tissue viability for a long time is the most vital aspect in 
cryopreservation. Therefore, the efficiency of the formulated freezing solution towards 
maintaining tissue viability will be evaluated by conducting control rate freezing 
experiments with cryopreserved adipose tissue with long storage time. The structural and 
functional integrity of cryopreserved adipose tissue will the assessed by morphological 
characteristics as well as ability of frozen adipose tissue to provide hADSCs with retained 
metabolic activity, proliferation, and differentiation ability. 
 
B.CRYOPRESERVATION OF ADIPOSE TISSUE DERIVED STEM CELLS 
 
I. Evaluation of hydrocolloids as CPAs 
Effort will be given to isolate hADSCs from adipose tissue and develop a cryopreservation 
strategy for their preservation by formulating an effective freezing solution. Similar to 
adipose tissue, the efficiency of various hydrocolloids and natural organic osmolytes as 
extracellular and intracellular CPAs will be evaluated for their efficiency in maintaining 
viability of adipose tissue by performing cryopreservation experiments. Based on the 
viability results measured by Trypan blue and MTT assays, the most effective freezing 
solution achieving maximum cell viability will be selected. 
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II. Evaluation of PVP in combination with PBS components as carrier media 
PBS as carrier media consists of NaCl, Na2HPO4, KCl and KH2PO4. The specific role of 
these components as carrier media in cryopreservation of stem cells has not been explored 
so far. Therefore, efforts will be given to investigate the effect of individual ionic 
component on the cryopreservation outcome achieved using formulated freezing solution. 
 
III. Improvement of cell viability by addition of organic osmolytes 
An attempt will be made for further improvement of the efficiency of the formulated 
freezing solution as mentioned above by the addition of ectoin and hydroxyectoin as the 
potential organic osmolytes.  
 
IV. Optimization of the freezing solution composition  
The cryopreservation efficacy of the formulated freezing solution will be optimized by 
following Taguchi orthogonal design methodology and thus an optimal composition of the 
freezing solution providing the maximum post-thaw viability is expected to achieve.  
V. Control rate freezing of hADSCs and optimization of freezing parameters 
To achieve optimal cooling rate in controlled rate freezing, the cryopreservation 
experiment will be carried out at different cooling rate.  Further, the effect of long-term 
storage on the viability of hADSCs frozen in the formulated cryopreservation solution will 
be assessed to ensure the ability of the developed freezing solution in maintaining viability 
for a long time. Besides viability study, the structural and functional integrity of post thaw 
hADSCs will also be verified. 
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Chapter 4 
Materials and methods 
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4.1 Chemicals and culture media 
4.1.1 Cryoprotective agents 
Various extracellular cryoprotective agents such as trehalose, mannitol, dextran, raffinose, 
sucrose, arabitol, polyvinylpyrrolidone, methylcellulose, carboxymethylcellulose, inulin, 
guar gum, xanthan gum, acacia gum, tragacanth gum, hydroxyethyl starch, stachyose were 
purchased from Himedia Pvt. Ltd (Mumbai, India). The intracellular cryoprotectants such 
as ectoin, hydroxyectoin, betaine and Me2SO was procured from Sigma Chemical Co. (St. 
Louis, MO, USA). 
4.1.2 Carrier media 
To formulate carrier media different ionic compounds like NaCl, KCl, Na2HPO4, KH2PO4, 
MgCl2 and MgSO4 used in the thesis works were purchased from Himedia Pvt Ltd 
(Mumbai, India). MilliQ water was used for the preparation of carrier media and freezing 
solution. 
4.1.3 Antioxidants and inhibitors 
Curcumin, carnitine, lipoic acid, Vit E, quercetin, gallic acid, and ellagic acid was used as 
antioxidants for cryopreservation of adipose tissue and was bought from Himedia Pvt Ltd 
(Mumbai, India). Catalase, which was used for cryopreservation of adipose-derived stem 
cells was procured from Sigma Chemical Co. (St. Louis, MO, USA). Caspase inhibitor Z-
VAD-FMK and Rho kinase inhibitor Y-27632 were also used of Sigma Chemical Co. (St. 
Louis, MO, USA). 
4.1.4 Cell culture and differential media 
For isolation of culture of hADSCs, collagenase type I, Dulbecco’s modified Eagle 
medium (DMEM), fetal bovine serum (FBS), and 0.25% Trypsin/EDTA solution were 
procured from Gibco (BRL, USA).  For immunophenotypic analysis, BD FACS lysis 
buffer, CD 34-PE, CD45-FITC, CD73-APC, CD90-FITC, CD105- PerCP/cy5.5 and HLA-
DR-PerCP/cy5.5 were purchased from BD pharminogen (Becton Dickenson, San Jose, 
CA, USA). For cytoskeletal and nucleus staining Phalloidin-TRITC, Phalloidin-Alexa 
Fluor 488, Hoechst and DAPI were procured from Invitrogen, USA. Triton X-100, 
formaldehyde and bovine serum albumin (BSA) are from Himedia Pvt. Ltd (Mumbai, 
India). For differentiation and staining of hADSCs, dexamethasone, β-glycerophosphate, 
indomethacin insulin, Isobutylmethylxanthine (IBMX), Oil Red O and Alizarin Red were 
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procured from Sigma-Aldrich (St Louis, MO, USA). L-ascorbate was obtained from 
Himedia Pvt. Ltd (Mumbai, India). All the tissue culture and plastic wares were from 
Tarsons Product Pvt. Ltd. (Kolkata, India).  
4.1.5 Viability assessment   
Trypan blue, MTT, XTT, mercaptoethanol, pyridine, thiobarbituric acid (TBA) assay, 
acetic acid, sodium dodecyl sulfate (SDS) and Tris-HCl was procured from Himedia Pvt. 
Ltd (Mumbai, India).  PMS (N-methylphenazonium methyl sulfate) and 
Tetraethoxypropane was obtained from Sigma-Aldrich (St Louis, MO, USA). Propidium 
iodide (PI) was purchased from Invitrogen, USA. Glycerol 3 phosphate dehydrogenase 
(G3PDH) assay kit (MK426) was procured from Takara Bio Inc, Japan. 
 
4.2 CRYOPRESERVATION OF ADIPOSE TISSUE 
4.2.1 Collection and processing of adipose tissue 
Adipose tissue of twelve patients was collected from Jeewan Memorial Hospital, Raipur, 
Chhattisgarh and Cosmetic Surgery Clinic, Kolkata India and processed in the stem cell 
laboratory of the Department of the Biotechnology & Medical Engineering of the Institute 
with the approval of the Institute Ethical Committee vide No. 
NITRKL/IEC/FORM/2/25/4/11/004 dated 25.04.2011. The collected adipose tissue was 
washed and centrifuged with normal saline at 3000rpm for 5min. After centrifugation, the 
upper layer and lower layer consisting of oils and aqueous cell debris respectively was 
pipetted out and discarded. The middle layer consisting of adipose tissue was used for the 
cryopreservation experiment. 
4.2.2 Preparation of freezing solution 
Freezing solutions containing polyols, organic osmolytes and antioxidants in various 
concentrations individually were prepared in PBS for selection of the best extracellular 
and intracellular cryoprotectant and antioxidants for cryopreservation of adipose tissue. 
Freezing solutions containing 80mM-240mM concentration of ionic compounds was also 
prepared in MilliQ water for the screening of the best carrier media. The selected 
extracellular and intracellular cryoprotectant, carrier media and antioxidants were 
combined in various combinations to obtain the desired Me2SO-free, serum free and 
DMEM free freezing solution. The developed freezing solution was also combined with 
10nM Z-VAD-FMK or 100mM Y-27632. Five ml of the prepared freezing solution in 
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various phases was added to 5gm of adipose tissue in a 15ml centrifuge tube for 
cryopreservation. 
4.2.3 Cryopreservation experiment 
After equilibrating with freezing solutions at 4°C for 1h, the sealed tubes containing fat 
tissues and freezing solutions were placed in -80°C freezer dipped in isopropanol 
containing container. All the samples were stored for 48h before thawing. For 
optimization of cryoprocess thermodynamic, controlled rate freezer (Kryo360-17, Planer 
Inc, UK) was used. To find out the optimal cooling rate, samples were cryopreserved in 
varying cooling rate such as 0.5°C/min, 1°C/min, 2.5°C/min, 5°C/min from 4°C to -120°C 
followed by preservation in LN2 for 48h. Furthermore, seeding at -5°C, -7°C, and -9°C 
was also introduced to find out the optimal seeding temperature. To evaluate the long-term 
efficacy of the developed freezing solution and cryopreservation strategy, adipose tissue 
was also stored for 90 days in LN2. The tissues were thawed rapidly by immersing the 
tubes in a water bath at 37°C. Each batch of experiments was repeated three times. 
 
4.2.4 Adipose tissue viability assessment 
Oil ratio 
After thawing the cryopreserved tissue were centrifuged at 1500rpm for 10min.  Three 
distinct layers including oil, tissue and aqueous part were formed.   The oil ratio was 
calculated by the formula reported by Matsumoto D et al. [70] as follows- 
Oil ratio=Oil volume / (Oil volume+ Fat volume) 
  
XTT assay 
XTT assay shows the metabolic activity of cells and tissues. In brief, after centrifuge, the 
fat was resuspended in phosphate-buffered saline to a total of 7.5ml. The XTT ((2,3-Bis-
(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-Tetrazolium-5-Carboxanilide) and PMS (N-
methylphenazonium methyl sulfate; electron coupling reagent) were mixed at a ratio of 
50:1. 2.5ml of this resultant mixed reagent was added to the fat sample and was incubated 
for four hours at 37°C. After incubation and centrifugation at 1500rpm for 10min, 1ml of 
the aqueous part was transferred to quartz cuvette to measure the optical absorbance using 
a spectrophotometer. The absorbance was measured at a test wavelength of 450nm and a 
reference wavelength of 650nm. Percentage (%) viability was calculated as  
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% viability= (OD of frozen sample / OD of fresh sample) X 100 
G3PDH assay 
, 
G3PDH enzyme activity was measured by following the protocol of G3PDH assay kit 
(Takara Bio Inc; MK426). Briefly, the cryopreserved tissues were centrifuged at 1500rpm 
for 10min to segregate the adipose tissue from the aqueous fraction. 200µl of aqueous 
fraction was added with 200µl of dilution buffer containing 1mM mercaptoethanol to form 
a sample solution. 25µl of the sample solution was added to 100µl of substrate solution 
containing (NADH and dihydroxyacetone phosphate) for spectrophotometric assay. The 
optical absorption at 340nm was measured for 10min and the change in optical density 
(∆OD) from the linear position of the curve was obtained.  The enzyme activity is 
calculated by using the following formula. 
G3PDH activity (
Units
ml
) =
∆OD340 × A(ml) × Dilution ratio of test sample
6.22 × B(ml) × C(cm)
  
Where, 
ΔOD 340: Decrease in the absorbance at 340nm per min  
 A (ml): Total reaction volume 
B (ml): The volume of enzyme solution (diluted sample) added 
C (cm): Optical path length of the cell used 
6.22: Millimolar absorption coefficient of NADH molecules 
 
TBARS assay 
The TBARS assay was performed following the protocol mentioned by Włostowski T et 
al. [105]. In brief, the cryopreserved tissue samples were homogenized in a buffer solution 
containing 50mM Tris-HCl (pH 7.4) and 1.15% KCl followed by centrifugation at 
1500rpm for 10min.  The supernatant was used for the assay. To 200µl of the tissue 
homogenate, 200µl of 8.1% (w/v) SDS (sodium dodecyl sulfate), 1.5ml of 20% acetic 
acid, 1.5ml of 0.8% TBA (thiobarbituric acid) and 600µl distilled water were added and 
vortexed. The reaction mixture was heated at 95°C for 1h in a water bath and cooled.  
Then 1ml sample was added to 5ml of butanol/ pyridine mixture (15:1 v/v) and vortexed. 
After centrifugation at 14000rpm, the absorbance of the organic phase was determined at 
532nm. Calibration curve was prepared using Tetraethoxypropane. The results were 
expressed as TBA-reactive substances (nM/g wet wt.). 
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4.2.5 Morphological characterization 
Morphology of fresh and cryopreserved adipose tissue after long-term storage was 
assessed by confocal laser scanning microscope (CLSM; Leica Microsystem, Germany) in 
both phase contrast and fluorescence mode. For fluorescence staining, PI was used. 
Adipose tissue was incubated with 100ug/ml of PI for 15 min and observed under CLSM 
(Ex-488nm; Em-600-650nm). Furthermore, keeping in view the fluorescence property of 
curcumin, the curcumin-containing freezing solution was explored for staining the adipose 
tissue. 0.1% (w/v) curcumin was dissolved in PBS and subsequently incubated with fresh 
adipose tissue in room temperature for 30min. CLSM with excitation at 458nm and 
emission filter at 500-520nm was set up to image the adipose tissue. Later on, 2.5% 
Me2SO was added along with the curcumin to stain the adipose tissue homogenously. 
Furthermore, to observe dead cell characteristics in the presence of curcumin adipose 
tissue was treated with 0.25% sodium dodecyl sulfate (SDS) and stained with 0.1% (w/v) 
curcumin/ 2.5%Me2SO. 
 
4.2.6 Isolation of hADSCs from cryopreserved adipose tissue 
hADSCs were isolated from cryopreserved adipose tissue and morphological 
characteristics, proliferation kinetics and differentiation ability was assessed by following 
protocols mentioned in the next section. The results were compared with hADSCs isolated 
from fresh adipose tissue. 
 
4.3 CRYOPRESERVATION OF ADIPOSE-DERIVED STEM CELLS  
 
4.3.1 Isolation and culture of hADSCs 
The stem cells were isolated by collagenase digestion method. In brief, 5gm adipose tissue 
was washed with PBS and incubated with 1mg/ml collagenase I at 37°C for 30min. The 
digested adipose tissue was centrifuged to separate out the stromal cells as a pellet. The 
pellet was washed with PBS and suspended in DMEM medium containing 10% FBS. The 
cells were incubated at 37°C with 5% humidified CO2.The non-adherent cells were 
discarded after 24h. The expansion medium was changed twice weekly until 80% 
confluence was achieved and then the cells were trypsinized and passaged further for 
proliferation.  
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4.3.2 Immunophenotypic characterization of hADSCs 
The expression of the specific surface antigen by the cells was evaluated by flow 
cytometry analysis (FACS Calibur, Becton Dickinson and Co, San Jose, CA, USA). The 
cells of third passage were trypsinized and stained with human monoclonal antibodies 
against CD90, CD73, CD105, CD34, CD44 and HLA-DR. In brief, the trypsinized cells 
were washed with PBS and 2% FBS and kept in dark at 4°C for 1h after adding 10µl 
antibodies. The cells were washed with PBS and 2% FBS before being resuspended in 
PBS for flow cytometry analysis.  
4.3.3 Preparation of freezing solution 
Hydrocolloids in PBS were screened in different concentration for selection of the best 
extracellular cryoprotectant. Subsequently, to replace PBS as carrier media, isotonic 
solutions of NaCl, Na2HPO4, KCl and KH2PO4 was combined with the selected 
cryoprotectant and was evaluated for its cryopreservation efficacy. Furthermore, ectoin 
and hydroxyectoin in different concentration as intracellular cryoprotectant were added to 
the above solutions and evaluated. The developed freezing solution containing suitable 
extracellular and intracellular cryoprotectant in the selected carrier media was further 
optimized and improved by adding catalase. For the development of an optimal freezing 
solution, Taguchi’s orthogonal design method was applied. To this end, four factors 
namely NaCl, PVP, ectoin, catalase as freezing media components and three levels of their 
different concentrations were selected (Table 6.1) to prepare the freezing solutions with 
varying composition (Table 6.2). To further improve the efficacy of the developed 
freezing solution 10nM Z-VAD-FMK or 100mM Y-27632 was added to it. hADSCs from 
different passages (P3-P6) were transferred into 1.5ml cryovials with the prepared freezing 
solution at a concentration of 1x106 cells/ml for cryopreservation experiment. 
4.3.4 Cryopreservation experiment 
After equilibrating the hADSCs with freezing solutions for 1h at 4°C, The sealed vials 
containing a freezing solution and hADSCs were placed in Mr. Frosty (Nalgene, New 
York, U.S.A) and kept in -80°C freezer. After 48h, the cells were thawed in a water bath 
and the post-thawed cells were diluted gradually by adding 9ml prewarmed media and 
centrifuged at 3000rpm for 10min. The supernatant was discarded and the pelleted cells 
were resuspended in DMEM and 20% FBS for culture. To optimize the cooling rate and 
seeding temperature, controlled rate freezer was used following the methods used for 
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adipose tissue cryopreservation in the previous section. Furthermore, hADSCs were also 
stored in LN2 for 90 days to evaluate the long-term efficacy of the developed freezing 
solution.   
4.3.5 hADSCs viability assessment 
Trypan blue assay 
Ten µl Trypan blue (0.4 w/v %) was added to 10µl post-thawed cell suspension for cell 
viability assessment. The cell viability was measured by counting cells in a 
hemocytometer and the stained cells were considered dead cells.  
MTT assay 
Cell viability was also measured by the MTT assay. Cells (5 x 104cells /well) were 
incubated at 37°C in a CO2 incubator in a 6-well plate. After 24h, 4µl MTT (500µg/ml) 
per 100µl media was added and incubated for 3h at 37° C. The formazan crystals were 
solubilized with Me2SO and the absorbance of the solution was recorded at 570nm. 
Flow cytometry study 
To assess the viability of hADSCs, the cells were labeled with PI. In brief, the cells were 
incubated with PI (100µg/ml) for 15min and then subjected to flow cytometry analysis by 
using FACS Calibur flow cytometer (Becton Dickinson, San Jose, CA). For each sample, 
10,000 events were acquired from the region defined for MSCs and analyzed by BD 
FACSDiva Software 6.0 (Becton Dickinson, San Jose, CA) for cell viability assessment. 
4.3.6 Cytoskeleton analysis 
For cytoskeleton analysis, 24h cultured hADSCs were fixed with 2% paraformaldehyde in 
PBS at room temperature for 5min. After that, the cells were treated with 2% BSA and 1% 
glycine and were permeabilized with 0.5% Triton X-100 for 15min. For actin staining and 
nuclear staining, samples were incubated with TRITC-Phalloidin/Alexa-fluoro 488-
Phalloidin and DAPI/Hoechst respectively at 37°C for 30min in dark and samples were 
observed under CLSM. 
4.3.7 Differentiation potential assessment 
The fresh and cryopreserved cells were plated in a 6-well plate and cultured using DMEM 
in 20% FBS supplemented with differentiation media. The osteogenic differentiation 
media consists of 10mM β-glycerophosphate, 100nM dexamethasone and 0.2mM L-
ascorbate and adipogenic differentiation media comprises of 50µm indomethacin, 300nM 
insulin, 100nM dexamethasone, and 500µM IBMX. The osteogenic and adipogenic 
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potential was measured by Alizarin red on the 21st day and Oil Red O staining on the 14th 
day. 
4.3.8 Proliferation kinetics 
5×103 cells/well were seeded into 6-well plates with 2ml of growth medium and incubated 
at 37ºC and 5% CO2. After trypsinization, the cell number counted from day 1 to 9 day. 
The number of viable cells was counted using automated cell counter with cells stained 
with 0.4% Trypan blue. 
4.4 Statistical analysis 
The experimental data were analyzed statistically using IBM SPSS Statistics 20.0 
software. The results are expressed as mean ± standard error. The following equation was 
used for the S/N ratio calculation during optimization of hADSCs cryopreservation by 
Taguchi’s method  
𝑆
𝑁
= −10 ∗ log (𝛴 ( 
1
𝑌2
)/𝑛 
Where Y is the measured data and n is the number of data 
In addition to S/N ratio, response table of mean and statistical analysis of variance 
(ANOVA) was employed to determine the effect of parameters on hADSCs viability. 
 
  
39 | P a g e  
 
 
 
 
 
 
 
 
Chapter 5 - 6 
Results &Discussion 
 
 
 
 
 
 
 
 
 
 
 
 
 
40 | P a g e  
 
 
 
 
 
 
 
 
Chapter 5 
Cryopreservation of adipose tissue 
 
 
 
 
 
 
 
 
 
 
 
 
 
41 | P a g e  
 
5.1 Screening of potential cryoprotectants and carrier media towards the 
formulation of freezing solution for cryopreservation of adipose tissue 
Autologous fat tissue usually harvested by liposuction is used in reconstructive and 
aesthetic surgery due to its abundant availability, relatively easy harvesting and 
biocompatibility of fat tissue [106]. However, the implanted fat tissue is not persistent due 
to its high absorption rate that results in frequent graft failure clinically, thereby, demands 
additional grafts leading to repeated harvesting of fat or adipose tissue, which increases 
cost and patient morbidity [107-110]. Preserving additional tissue at sub-zero temperature, 
keeping in view of its supply as additional grafts is an effective technique to avoid 
repeated harvesting. Besides tissue graft, there is a growing demand of hADSCs that can 
be obtained from adipose tissue as a potential source for the tissue engineering and 
therapeutic applications [111-117]. 
Successful cryopreservation strategy requires a suitable freezing solution comprising of 
CPAs and carrier media. The use of conventional cryoprotectant such as Me2SO is 
harmful due to its toxic effects [118, 119]. Although there are reports of using 
extracellular CPAs, the efficacy of non-toxic intracellular CPAs in cryopreservation of 
adipose tissue has not been reported till date. Furthermore, evaluation of organic 
osmolytes such as ectoin and hydroxyectoin as intracellular CPAs can be of much 
interesting [120]. 
Keeping the above in view, the present study focuses on the evaluation of a number of 
extracellular and intracellular CPAs as well as ionic compounds as possible carrier media 
towards the development of a freezing solution for preservation of adipose tissue. 
Furthermore, an attempt was also given to formulate an optimized freezing solution 
cocktail from the combination of the potential non-toxic extracellular and intracellular 
CPAs in the selected carrier medium. The preliminary screening of CPAs and carrier 
media was assessed based on oil ratio analysis, and the potential components were finally 
selected through the further assessment such as XTT, G3PDH and TBARS assays. The 
result and discussion on the various experimental results generated from the above study 
are presented in this chapter.  
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5.1.1 Screening of extracellular CPAs 
Oil ratio 
The efficiency of the various extracellular CPAs such as sucrose, trehalose as sugars and 
PVP, dextran and HES as hydrocolloids, in PBS carrier medium was evaluated by 
measuring oil ratio as an indicator of damaged or degenerated adipocytes. The experiment 
was also performed with different concentration of CPA solutions in the range of 30-
150mM with the aim of finding optimal concentration of CPAs for cryopreservation of 
adipose tissue. 
 
The oil ratio in Fig 5.1 indicates that among the extracellular CPAs, trehalose shows 
higher viability by providing the least damaged adipocytes in cryopreserved tissue than 
other CPAs used in the study. Besides the type of CPAs, variation in the viability of 
frozen adipose tissue was also observed with varied concentration of CPAs. Though not 
much statistically significant change in viability was shown with varied concentration, 
trehalose at 90mM concentration showed least oil ratio (0.047 ± 0.002) indicating the 
highest viability at this concentration, followed by sucrose (30mM, 0.069 ± 0.010) and 
mannitol (30mM, 0.077 ± 0.015).  
The superior performance of trehalose may be due its excellent membrane stabilizing 
property and trehalose also retains hydrophilic shell around proteins and nucleic acids, 
thereby prevents cryoinjury mediated cell damage [121-123]. the protective role of 
trehalose in adipose tissue cryopreservation was also reported by Pu LLQ et al, though a 
higher concentration (300mM) of trehalose was demonstrated as the optimal concentration 
for cryopreservation of adipose tissue [124].  
Among the hydrocolloids, PVP and dextran, which are established cryoprotectants for 
mesenchymal and hematopoietic stem cells, provided less cell viability as shown by 
higher oil ratio [81, 125, 126]. Similarly, HES, which was reported as an efficient CPA for 
RBCs, was not favorable to adipose tissue preservation [127-130]. The similar finding 
with HES was also reported elsewhere [66].  The raffinose families of oligosaccharides 
(RFOs) such as raffinose and stachyose, which are alpha-galactosyl derivatives of sucrose, 
has shown good cryoprotectant ability for mouse sperms, but these were found to be 
inefficient in the present study [131]. Although arabitol has shown promise in 
cryopreservation of rat embryo, the tissue viability obtained with arabitol was lower to the 
viability obtained with trehalose and sucrose [132]. 
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Therefore, trehalose and sucrose were selected for further study by XTT, G3PDH and 
TBARS assay.  
 
 
Figure 5.1: Oil release indicating the efficiency of  extracellular cryoprotectants in 
maintaining viability of the  cryopreserved adipose tissue. Among the CPAs, trehalose is the 
most efficient achieving maximum cell vitality as shown by the least oil release. A substantial 
viability is also shown by sucrose. PBS was used as carrier media.  
 
XTT Assay 
XTT assay used as functional assay has an advantage over commonly used MTT assay 
due to the solubility of XTT cleavage products in water [133]. The absorbance of cleavage 
products in XTT assay correlates well with the metabolic activity of adipose tissues with 
higher absorbance that represents higher metabolic activity and thus higher viability of 
adipose tissue. 
As observed from XTT results (Fig 5.2), trehalose has shown superior metabolic activity 
achieving higher adipose tissue viability to sucrose as CPA irrespective of level of 
concentrations. Compared with respect to the tested CPA concentration, XTT cleavage 
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product was increasing with increase in concentration up to 90mM and then a declining 
trend was observed with trehalose though the variation was not statistically significant 
between 30mM to 120mM. Whereas metabolic activity was noticed more or less same, 
when adipose tissue was cryopreserved using sucrose as CPA. Among different 
concentrations of sucrose, 60mM sucrose (69.4 ± 5.8%) achieved slightly higher viability 
than other concentrations of sucrose. However, the difference between 30mM and 60mM 
sucrose is not significant (p<0.05) as also revealed by oil ratio analysis. Therefore, 
trehalose with 90mM concentration has been proven to be superior CPA than sucrose. 
 
Figure 5.2: Metabolic activity of the cryopreserved adipose tissue treated with 
trehalose and sucrose in varying concentrations measured by XTT assay. Trehalose 
has shown superior metabolic activity achieving higher adipose tissue viability than 
sucrose at all concentration levels. However, among the concentration range, 
trehalose performed the best at 90mM concentration 
 
G3PDH assay  
G3PDH assay involving adipose specific enzyme is a relatively simple method chosen in 
this study to assess the cellular function of the frozen adipose tissue. The cell membrane 
integrity is detected by this assay through the marking of diffusion of intracellular 
elements through the damaged adipose tissue membrane. The extracellular G3PDH level 
was measured and a higher G3PDH level represents lower tissue viability [134]. 
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The analysis of G3PDH (Fig 5.3) level measured in the washing solution of cryopreserved 
adipose tissue shows that a higher level of enzyme activity was observed when sucrose 
was used as CPA at all concentrations than the level of enzyme activity shown by 
trehalose. Furthermore, among the different concentration of trehalose level tested, 
trehalose at 90mM was found to be more effective than either lower or higher 
concentration providing higher membrane integrity and thus higher cellular function (2.25 
± 0.10 U/ml) of cryopreserved adipose tissue. Whereas a gradual increase in G3PDH 
enzyme level with an increase in CPA concentration was depicted by sucrose when used 
as CPA, though the difference in enzyme activity is not statistically significant. Unlike 
trehalose, the enzyme level representing the adipose tissue viability obtained with sucrose 
at 30mM concentration (2.57 ± 0.26 U/ml) is found to be best among other concentrations. 
 
Figure 5.3: Evaluation of the efficiency of trehalose and sucrose as CPAs for the 
cryopreservation of adipose tissue by measuring the extracellular activity of glycerol-
3-phosphate-dehydrogeage (G3PDH) enzyme. A comparatively lower enzyme 
activity representing the higher tissue viability was shown by trehalose than sucrose. 
90mM was shown to be the most favorable concentration for trehalose giving 
maximum adipose tissue viability  
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TBARS assay   
TBARS assay is one of the most commonly used tests for assessing the lipid peroxidation 
of cells and tissues [135]. Free radical mediated cryo-injury is one of the well-established 
models of cells and tissue damage in cryopreservation [136]. Free radicals formed in this 
process participate in a cascade of reaction with lipid of the cells and tissues and 
peroxidize them to form lipid peroxidation products or malondialdehyde. Therefore, it was 
hypothesized that TBARS assay might be a useful test to quantify malondialdehyde in 
post-thawed tissue, thereby would provide an indirect indication of the viability of the 
adipose tissue.  
The malondialdehyde level measured by TBARS assay (Fig 5.4) was also observed to be 
least with 90mM trehalose (321 ± 7 nM/g wet wt) representing the superiority of the CPA 
over other CPAs. Although, in the concentration range of 30mM to 150mM, the difference 
between malondialdehyde production in trehalose and sucrose cryopreserved adipose 
tissue is statistically insignificant (p<0.05), similar to G3PDH assay the trend suggests 
trehalose is a superior cryoprotectant for adipose tissue cryopreservation than sucrose. 
Among the various concentrations of sucrose, 30mM sucrose gave least TBARS 
production (345 ± 15 nM/g wet wt) indicating the superiority of 30mM sucrose over other 
concentrations of it. The malondialdehyde level of fresh adipose tissue was found to be 
142 ± 11 nM/g wet wt. of the tissue.Thus,there was also significant increase in the level of 
malondialdehyde in the cryopreserved tissues than the fresh tissues indicating the 
significanceof free radical mediated damage in cryopreserved tissues. 
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Figure 5.4: Cellular viability in terms of malondialdehyde production of 
cryopreserved adipose tissues using trehalose and sucrose as CPAs was assessed by 
TBARS assay. The results indicate that 90mM trehalose is superior to sucrose for 
cryopreservation of adipose tissue.  
Overall, all the results taken together suggest that trehalose is a better cryoprotectant than 
sucrose for adipose tissue cryopreservation with 90mM trehalose as the best concentration 
level achieving the highest viability. In the case of sucrose, we could not get uniform 
results in all the assays; however, the trends suggest a lower concentration of sucrose,i.e., 
30mM is better than its higher concentrations. Thus, 90mM trehalose was selected as 
extracellular CPA for the preparation of freezing solution cocktail for adipose 
cryopreservation.  
5.1.2 Screening of intracellular CPAs 
Organic osmolytes such as betaine, ectoin and hydroxyectoin are known to protect cells 
and tissues from osmotic and thermal stresses [137]. Ectoin has also reported being an 
excellent intracellular cryoprotectant for embryo and others [138]. Thus, like extracellular 
CPAs, organic osmolytes in PBS solution was also evaluated as intracellular CPAs for 
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their efficacy in cryopreservation of adipose tissue through the analysis of oil ratio, XTT, 
G3PDH and TBARS assays, which are described below. 
Oil ratio  
The analysis of the results of oil ratios (Fig 5.5) indicate betaine showed a higher oil ratio 
than the other intracellular CPAs representing the lower viability of adipose tissue when 
cryopreserved in betaine. The overall viability trend follows 
ectoin>hydroxyectoin>betaine. The higher efficiency of ectoin has also been reported 
earlier when other tissues cryopreserved in freezing solution containing ectoin [139-143]. 
A substantial tissue viability was also obtained using hydroxyectoin as CPA. Furthermore, 
no significant statistical change in oil ratio value was observed between the concentration 
levels of both ectoin and hydroxyectoin in the range of 90mM to 150mM. Therefore, 
90mM was selected as the most favorable concentration of ectoin and hydroxyectoin. 
However, there was a statistically significant difference in tissue damage between the 
organo-osmolites and the conventional 10% Me2SO as CPA, which is evident from 
decreased oil ratio value (0.042 ± 0.006) measured with the later. Therefore, ectoin and 
hydroxyectoin were selected as the potential organo-osmolites for further study and 10% 
Me2SO as a control. 
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Figure 5.5: Screening of intracellular cryoprotectants based on oil ratio analysis. The 
higher efficiency of ectoin is evident from its lower oil release than other CPAs. The 
overall viability trend follows ectoin>hydroxyectoin>betaine. No statistically 
significant change in oil ratio was observed between the concentration levels for both 
ectoin and hydroxyectoin the range of 90-150mM. Therefore, 90mM was selected as 
the most favorable concentration of ectoin and hydroxyectoin. The viability was 
lower than 10% Me2SO used as a control. 
 
XTT assay 
The results in Fig 5.6 indicate that the control 10% Me2SO (80.2 ± 3.2%) gave higher 
viability than organic osmolytes (p<0.05). However, with an increase in the concentrations 
of organic osmolytes, the viability of the post-thawed adipose tissues increased. In the 
concentration range of 90mM-150mM, 150mM ectoin (69.8 ± 3%) achieved the highest 
viability of tissues, which is slightly higher than 150mM hydroxyectoin (66.7 ± 4.2%). 
However, the difference between the adipose tissues cryopreserved using ectoin and 
hydroxyectoin is statistically insignificant (p<0.05). Similar to oil ratio, XTT assay 
depicted the superiority of the conventional but harmful 10% Me2SO over the organic 
osmolytes. 
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Figure 5.6:  Evaluation of organic osmolytes in various concentrations for 
cryopreservation of adipose tissue by XTT assay. 10% Me2SO was used as a control. 
 
G3PDH assay 
The assessment of cell membrane integrity via the measurement of G3PDH level (Fig 5.7) 
shows a slightly lower enzyme activity thereby a higher tissue viability was obtained with 
ectoin than hydroxyectoin. Thus, it indicates that the cryopreservation of adipose tissue 
was superior using ectoin than hydroxyectoin, though a substantial tissue preservation was 
also shown by later. In comparison, the viability results are slightly lower than those 
obtained with conventional 10% Me2SO. The corresponding G3PDH values are 2.68 ± 
0.15 U/ml (150mM ectoin), 2.96 ± 0.12 U/ml (150mM hydroxyectoin) and 2.28 ± 0.07 
U/ml (10% Me2SO). Furthermore, it was also analyzed that the protective efficacy 
increased with increase in the concentration of organic osmolytes and overall, 150mM 
ectoin gave significantly (p<0.05) higher viability than 150mM hydroxyectoin.  
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Figure 5.7: Effect of ectoin and hydroxyectoin as intracellular CPAs on the 
cryopreservation of adipose tissue by the assessment of G3PDH enzyme activity. 
Ectoin than hydroxyectoin showed a slightly higher viability. Both CPAs show lower 
efficiency 10% Me2SO. 
TBARS assay 
Fig 5.8 depicts the TBARS analysis data, which reveals that that 150mM ectoin (361 ± 11 
nM/g wet wt) gave significantly lower lipid peroxidation products than 150mM 
hydroxyectoin (397 ± 5 nM/g wet wt) indicating the higher viability achieved with ectoin 
than hydroxyectoin. However, the lipid peroxidation with ectoin and hydroxyectoin were 
significantly higher than Me2SO (285 ± 19 nM/g wet wt). This represents the lower 
efficacy of the organic osmolytes than 10% Me2SO. 
The results can be explained by the fact that ectoin possess less number of hydroxyl 
groups and thus is lesser water-soluble than hydroxyectoin; hence, the distribution of 
ectoin within the lipid-filled adipocytes may be much higher than hydroxyectoin [144]. 
Thus, 150mM ectoin and 10% Me2SO were selected as intracellular CPAs for formulating 
the freezing solution cocktail for the freezing solution cocktail. 
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Figure 5.8: Viability assessment of post-thaw adipose tissues using ectoin and 
hydroxyectoin as CPAs by TBARS assay. The viability obtained with ectoin is 
slightly higher than hydroxyectoin and 150mM is the most favorable concentration 
at which ectoin performed better. However, unlike extracellular CPAs, the 
conventional 10% Me2SO (control) is superior to organic osmolytes.  
 
5.1.3 Screening of ionic compounds 
Not enough studies were conducted to understand the role of carrier medium in 
cryopreservation of cells and tissues. However, the significance of ionic carrier medium is 
evident from the literature related to cryopreservation of sperms where extenders 
comprised of various ions such NaCl, KCl, NaHCO3,MgCl2 etc. are usually used to 
preserve the functionality of cryopreserved sperm [145] . Evidence proving the 
significance of ionic solutes in preservation of organs and tissues is apparent from the 
literature of low temperature storage of organs for organ transplantation [146, 147].  
Earlier developed Euro-Collins and University of Wisconsin preservation solutions are 
intracellular type solution having higher potassium ions than sodium ions. Both these 
solutions were observed to offer better transplantation outcome when used for 
preservation of kidney and liver. However, relatively newer developed solutions like 
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Celsor, IGL-1 (Institute Georges Lopez) and ET-K (Kyoto University solution) that have 
higher sodium concentration than potassium were observed to give better protection to 
most of the organs including hearts, vessels and pancreas. Therefore, the effect of various 
types of ionic compounds such as NaCl, Na2HPO4, KCl, KH2PO4, MgSO4 and MgCl2 
towards the cryopreservation of adipose tissue in varying concentration was investigated 
in the range of 80mM-240mM concentration. PBS was used as a control. The evaluation 
results are described here. 
 
Oil ratio 
As described earlier, the damaged adipocytes in adipose tissue cryopreserved in different 
ionic components measured by oil ratio is depicted in Fig 5.9. The extent of oil release 
thereby representing the level of damaged tissue was different with different ionic 
compounds and the trend was observed as NaCl<Na2HPO4<KCl<KH2PO4<MgCl2≈ 
MgSO4, though there is not much change in viability between NaCl and Na2HPO4. The oil 
release was also found to change with a change in concentration of carrier media. The oil 
release was increased with increase in concentration from 80mM-120mM and then 
decreased with further increase in the concentration of both NaCl and Na2HPO4. However, 
the minimum oil release means the maximum viability of adipose tissue was obtained at 
160mM. Whereas in the case of KCl,  a continual decrease in oil release with an increase 
in concentration was observed. Overall, among the ionic compounds used, 160mM NaCl 
(0.038 ± 0.002) showed the highest viability of cryopreserved tissue whereas MgSO4 and 
MgCl2 showed the lowest tissue viability. Except at 240mM concentration of ionic 
compounds,  the trend of viability follows NaCl>Na2HPO4>KCl in all concentrations. 
Thus, it has been demonstrated that the type of ionic compounds and their concentration 
significantly influence the adipose tissue viability. 160mM NaCl and 160mM Na2HPO4 
showed superior viability than other ionic solution and hence these compounds were 
selected for further study. 
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Figure 5.9: Screening of ionic compounds for cryopreservation of adipose tissue by 
oil ratio analysis. The trend of oil release was observed as 
NaCl<Na2HPO4<KCl<KH2PO4<MgCl2≈ MgSO4, indicating the superiority of NaCl 
over other carrier media.  
 
XTT assay 
The trends of XTT assay (Fig 5.10) showed that the maximum metabolic activity was 
observed with 160mM NaCl (84.1 ± 5.2 %) followed by 160mM Na2HPO4 (78.8 ± 3.7%). 
Moreover, the metabolic activity of adipose tissue cryopreserved in 160mM NaCl and 
160mM Na2HPO4 is significantly higher than the PBS (65.4 ± 4.1%) used as a control. 
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Figure 5.10: Evaluation of selected ionic compounds for cryopreservation of adipose 
tissue by XTT assay. The maximum metabolic activity was observed with NaCl 
followed by  Na2HPO4 at 160mM concentration. Moreover, the metabolic activity of 
adipose tissue cryopreserved in NaCl and Na2HPO4  at 160mM concentration is 
significantly higher than the PBS used as a control. 
 
G3PDH assay 
The results of extracellular G3PDH activity assay (Fig 5.11) of adipose tissue viability 
revealed similar trend as assessed by oil ratio and XTT assay. A lower level of enzyme 
activity representing a better cellular function of adipose tissue was revealed when 
cryopreserved in 160mM NaCl (1.85 ± 0.06 U/ml) than that obtained using 160mM 
Na2HPO4 showing the G3PDH activity of 2.01 ± 0.17 U/ml. Although, the difference in 
extracellular G3PDH level between NaCl and Na2HPO4 is insignificant (p<0.5), the 
difference between the individual ionic compounds and PBS (3.07 ± 0.15 U/ml) is very 
much significant (p<0.05) indicating higher protective ability of individual ionic 
compounds than PBS.  
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Figure 5.11: Evaluation of selected ionic compounds for cryopreservation of adipose 
tissue by the extracellular G3PDH activity assay. A lower level of enzyme activity 
representing a better cellular function of frozen adipose tissue was depicted when 
cryopreserved in 160mM NaCl than the viability obtained using 160mM Na2HPO4 
and 240mM KCl. Furthermore, the individual ionic compounds have shown higher 
protective ability than PBS.  
 
TBARS assay 
The lipid peroxidation products released from adipose tissue by free radical mediated 
cryoinjury was measured by TBARS assay (Fig 5.12). The presence of 160mM NaCl and 
160mM Na2HPO4 lead to significantly (p<0.05) lesser malondialdehyde production in 
cryopreserved adipose tissue than PBS (414 ± 13 nM/g wet wt) indicating its higher 
protective efficacy for cryopreserved adipose tissue than PBS. The trend suggests that in 
the presence of 160mM NaCl (271 ± 7 nM/g wet wt), the lipid peroxidation is least 
followed by 160mM Na2HPO4 (320 ± 48 nM/g wet wt). Although, the variation between 
the quantities of lipid peroxidation products of cryopreserved adipose tissue with ionic 
compounds is insignificant (p<0.05), there is a significant difference between 160mM 
NaCl and PBS.   
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Figure 5.12: Viability of cryopreserved adipose tissue in the presence of different 
ionic compounds in freezing solution as carrier media was measured by TBARS 
assay. The results indicate 160mM NaCl as the superior carrier medium. 
Considering all the assay results taken together, NaCl at 160mM concentration gave 
higher viability of cryopreserved adipose tissue than other ionic components. A 
comparable but slightly lower viability was also achieved when adipose tissue 
cryopreserved in Na2HPO4 solution.  It is interesting to note that at near isotonic 
concentration, NaCl performed better whereas Na2HPO4 and KCl performed well at 
hyperosmotic concentration. This result may be due to the altered distribution of ions in 
adipocytes during cryopreservation of adipose tissue when NaKATPase pumps cease to 
function and solute concentration effect becomes prominent [148, 149]. At this time, 
sodium and chloride ions might have a predominant role in the viability of cryopreserved 
adipose tissue than potassium and phosphate ions. Moreover, sodium and chloride, the 
most common extracellular cation and anion, may provide better protection to cells at 
isotonic concentration whereas potassium and phosphate, which are the most common 
intracellular cation and anion, offer better protection at hyperosmolar concentration. 
However, KH2PO4, which constitutes of only intracellular type ions, showed poor results 
in all concentrations indicating the presence of either sodium or chloride as extracellular 
ions are necessary to have satisfactory viability even at hyperosmolar concentration. The 
prominence of ionic carrier media in maintaining the viability of cryopreserved adipose 
tissue may be because of the unique features of adipocytes compared to other cells of our 
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body. During cryopreservation, ice-mediated and osmotic imbalance mediated injuries are 
the two major factors, which govern the fate of cryopreserved cells and tissues. While 
though ice-mediated injury plays dominant mode of cryoinjury for cells filled with mainly 
colloidal water, adipocytes, which mainly contain lipids, may be influenced by the 
osmotic factor more dominantly than ice factor during cryopreservation [150]. However, 
further investigation on the detailed mechanism is necessary to understand much complex 
cryopreservation phenomenon.  
Therefore, to formulate ultimate freezing solution cocktail, 160mM NaCl was selected as 
the potential carrier medium. 
5.1.4 Formulation and evaluation of freezing solution for adipose tissue 
cryopreservation 
 
The selected extracellular and intracellular CPAs in 160mM NaCl carrier medium was 
evaluated individually as well as in combination to formulate an optimized freezing 
solution for adipose tissue cryopreservation. To this end, different batches of freezing 
solutions such as 160mM NaCl/90mM trehalose, 160mM NaCl/150mM ectoin, 160mM 
NaCl/90mM trehalose/150mM ectoin and 160mM NaCl/10% Me2SO were formulated to 
evaluate their efficiency towards adipose tissue cryopreservation. 
Oil ratio 
The results of oil analysis (Fig 5.13) indicate that among the prepared freezing solutions, 
160mM NaCl/10% Me2SO has shown the most effective providing maximum viability of 
0.032±0.004 followed by 160mM NaCl/90mM trehalose (0.035 ± 0.002) indicating both 
Me2SO and trehalose containing freezing solution are efficient for the preservation of 
adipose tissue. Though a slightly higher tissue viability was obtained with 10% Me2SO in 
NaCl carrier media than viability achieved with 160mM NaCl/90mM trehalose, the 
difference in viability is statistically insignificant. Nevertheless, both these freezing 
solutions showed higher viability when compared with viability obtained with 160mM 
NaCl, 160mM NaCl /150mM ectoin and 160mM NaCl/90mM trehalose/150mM ectoin. 
Interestingly, the presence of ectoin in the formulated freezing solution did not offer any 
additional advantage in cryopreservation of adipose tissue. 
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Figure 5.13: Post-thaw viability of cryopreserved adipose tissue in freezing solutions 
formulated from trehalose and ectoin in NaCl as carrier media by oil ratio analysis 
(D, Me2SO; T, Trehalose; E, Ectoin). The freezing solution comprising of 160mM 
NaCl/10% Me2SO has shown the most effective providing maximum viability 
followed by 160mM NaCl/90mM trehalose indicating freezing solution containing 
either Me2SO or trehalose are efficient for the preservation of adipose tissue. 
 
XTT assay 
Unlike oil ratio results, all the formulated freezing solutions have shown more or less 
similar XTT values (Fig 5.14) representing the comparable level of adipose tissue 
viability. Overall, 160mM NaCl/90mM trehalose achieved a slightly higher viability (84.8 
± 4.3%)  than other freezing solutions prepared from ectoin and thus proven to be the most 
potential. When compared the viability was also comparable to the viability obtained 
using 10% Me2SO in NaCl (85.3 ± 3.9%). Thus, 160mM NaCl/90mM trehalose is proven 
to be a potential non-toxic freezing solution for adipose tissue. 
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Figure 5.14: Cellular viability of cryopreserved adipose tissue in freezing solutions 
prepared from trehalose and ectoin in NaCl carrier media by XTT assay (D, Me2SO; 
T, Trehalose; E, Ectoin). Overall, the formulated 160mMNaCl/90mM trehalose 
achieved a slightly higher viability (84.8 ± 4.9%) than other freezing solutions and 
thus proven to be the most efficient freezing solution. The viability was also 
comparable to the viability obtained using 10% Me2SO. 
 
G3PDH assay 
The cell membrane integrity of adipose tissue was assessed by G3PDH activity and the 
experimental data is shown in Fig 5.15. The enzyme activity was shown by freezing 
solution containing ectoin (2.008 ± 0.147 U/ml) as CPA is higher that represents higher 
adipocyte damage than the trehalose-containing freezing solution (1.751 ±0.121 U/ml). 
The freezing solution containing trehalose has also shown similar viability outcome with 
cryopreserved adipose tissue.  
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Figure 5.15: Viability of cryopreserved adipose tissue in freezing solutions prepared 
from trehalose and ectoin in NaCl carrier media assessed by G3PDH activity (D, 
Me2SO; T, Trehalose; E, Ectoin). A higher adipocyte damage in cryopreserved 
adipose tissue was shown by freezing solution containing ectoin as CPA than 
trehalose, representing the higher tissue viability achieved with trehalose. 
 
TBARS assay 
Fig 5.16 shows the TBARS assay results obtained with adipose tissue cryopreservation in 
the formulated freezing solution as 160mM NaCl/10% Me2SO ≈ 160mM NaCl/90mM 
trehalose > 160mM NaCl/150 ectoin and 160mM NaCl/90mM trehalose/150M ectoin. The 
results follow the trend of viability is comparable to the values obtained with other assays. 
Thus, 160mM NaCl/10% Me2SO showing TBARS value of 253 ± 15 nM/g wet wt and 
160mM NaCl/90mM trehalose showing TBARS value of 256 ± 16 nM/g wet wt) are 
comparable and the solutions provided superior efficacy than other freezing solution for 
adipose tissue cryopreservation. Interestingly, similar to other assays, ectoin did not show 
any impact as an intracellular cryoprotectant on cryopreservation outcome. 
62 | P a g e  
 
 
Figure 5.16: Viability of cryopreserved adipose tissue in freezing solutions prepared 
from trehalose and ectoin in NaCl carrier media measured by TBARS assay. The 
results indicate 160mM NaCl/10%Me2SO and 160mM NaCl/90mM trehalose 
achieved superior viability than other freezing solutions. (D, Me2SO; T, Trehalose; E, 
Ectoin) 
Overall, the present study demonstrated that 160mM NaCl/90mM trehalose and 160mM 
NaCl/ 10% Me2SO offer better viability of cryopreserved adipose tissue compared to 
160mM NaCl alone. However, 160mM NaCl alone offers significantly higher viability 
compared to other ionic compounds and cryoprotectants representing the prominent role 
of osmolarity and carrier media in the cryopreservation of adipose tissue. The higher 
viability obtained with ectoin in PBS than PBS alone was not reflected in the viability 
outcome using ectoin in NaCl, indicating the limited role of ectoin in the cryopreservation 
of adipose tissue. Further study on enhancement of the protective role of the developed 
freezing solution in adipose tissue cryopreservation is important to ensure its higher 
viability on long-term storage. 
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5.2 Improvement of adipose tissue viability by the addition of anti-oxidants in 
freezing solution 
 
The oxidative stress mediated damage has been reported to be more pronounced in 
cryopreservation of adipose tissue than other tissue types as adipose tissue is usually 
harvested from obese patient and adipocytes in obese are known to have a higher 
concentration of free radicals compared to other body tissues [151, 152]. Furthermore, 
mechanical manipulation of adipose tissue during liposuction and further downstream 
processes, increase the susceptibility of the tissue towards free radical generation. Besides 
ice related injury, the role of free radical mediated cryoinjury due to ROS generation is 
also a critical factor that causes cell death during cryopreservation.  
The addition of antioxidant as a supplement in freezing solution is reported to be a 
promising strategy to overcome cryoinjury during cryopreservation of cells and tissues. 
Curcumin, a phytochemical having antioxidative property increased the various cells and 
tissue viability as reported earlier [153]. Besides curcumin, other antioxidants such as 
carnitine and Vit E decreased cytoplasmic lipid content and increased the cytotolerance of 
oocytes during vitrification [154].  L-carnitine also significantly improved epididymal 
sperm motility after cryopreservation as reported elsewhere [155]. 
Keeping the above in view, we hypothesized that supplementation of antioxidants in 
160mM NaCl/90mM trehalose freezing solution may improve the cryopreservation 
outcome of adipose tissue. Therefore, the present study focusses on exploring potential 
antioxidants for achieving improved viability of cryopreserved adipose tissue and 
investigates their influence on the cryopreservation efficiency of the previously formulated 
freezing solution for adipose tissue preservation. In this study, curcumin, carnitine, lipoic 
acid, Vit E, gallic acid, ellagic acid and quercetin were chosen as antioxidants based on the 
literature. Similar to the earlier section, oil ratio, XTT, G3PDH and TBARS have been 
measured to assess the viability of post-thawed adipose tissue. 
5.2.1 Screening of antioxidants 
Oil ratio 
As in the case of CPAs, the screening of potential antioxidants was done by measuring oil 
release during cryopreservation (Fig 5.17). As indicated, a varying oil ratio representing 
the varying level of tissue damage was found with different types of antioxidants. Among 
the various antioxidants, curcumin and carnitine achieved higher tissue viability than other 
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antioxidants. The tissue viability was also observed to be concentration dependent though 
curcumin and carnitine showed the superior antioxidant property providing less oil release. 
The viability of cryopreserved adipose tissue decreased with increase in the concentration 
of antioxidants except Vit E, which showed a reversed trend of oil release. As compared, 
1mg/ml curcumin (0.040 ± 0.004) achieved least oil ratio followed by 3mg/ml of carnitine 
(0.041 ± 0.002). The lower oil ratio shown by 1mg/ml curcumin represents its superiority 
in achieving higher tissue viability than carnitine and other antioxidants used under study. 
A comparable oil ratio was also achieved with curcumin and carnitine. Both curcumin and 
carnitine were studied further to compare and confirm their superiority over each other. 
 
Figure 5.17: Screening of antioxidants for cryopreservation of adipose tissue 
measured by oil ratio. Measured oil ratio was varied representing the varying level of 
tissue damage with varying types of antioxidants. Among the various antioxidants, 
curcumin and carnitine achieved higher tissue viability than others. Overall, 1mg/ml 
curcumin (0.040 ± 0.004) achieved least oil ratio followed by 3mg/ml of carnitine 
(0.041 ± 0.002) 
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XTT assay 
XTT assay data as shown in Fig 5.18 reveals the higher metabolic activity (84.9 ± 2.9%) 
of adipose tissue was shown with curcumin and 1mg/ml is the most favorable 
concentration of curcumin. The increase in concentration beyond 1mg/ml did not show 
any benefit in the preservation of adipose tissue and no change in viability between 
3mg/ml and 5mg/ml of curcumin. Whereas a typical trend of viability was observed when 
cryopreservation of adipose tissue was performed using carnitine. The viability of adipose 
tissue increased with increase in the concentration of carnitine from 1mg/ml to 3mg/ml 
(82.78 ± 3.65%) and then decreased with further increase in concentration. In comparison 
between curcumin and carnitine, an equivalent level of adipose tissue viability was 
achieved at 1mg/ml and 3mg/ml respectively. Thus, the study has demonstrated the 
superior efficiency of curcumin using comparatively lesser amount than carnitine. 
 
 
Figure 5.18: Evaluation of curcumin and carnitine for cryopreservation of adipose 
tissue measured by XTT assay. An equivalent level of adipose tissue viability was 
achieved at 1mg/ml and 3mg/ml respectively. 
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G3PDH assay 
The measurement of the extracellular G3PDH enzymes released by lysed adipocytes 
indicates the lower viability of cryopreserved adipose tissues with a higher concentration 
of curcumin (Fig 5.19). The results show that quantity of extracellular G3PDH was lowest 
with 1mg/ml curcumin (1.91 ± 0.10 U/ml) representing its superior antioxidant efficiency 
in reducing ROS generated tissue damage. Furthermore, similar to XTT assay, a non-
linear tissue damage and hence tissue viability of cryopreserved adipose tissue was 
observed when carnitine was used as an antioxidant. The viability of cryopreserved tissues 
in 3mg/ml carnitine was the maximum, which was also comparable to the viability 
achieved with 3mg/ml curcumin. Furthermore, the viability difference between carnitine 
and curcumin at 5mg/ml is not statistically significant. 
 
Figure 5.19: Performance evaluation of curcumin and carnitine for cryopreservation 
of adipose tissue measured by G3PDH assay and confirm the superior antioxidant 
activity shown by curcumin providing higher tissue viability at comparatively lower 
concentration than carnitine.   
 
TBARS assay 
The quantity of malondialdehyde production during cryopreservation of adipose tissue 
measured by TBARS assay corroborated with the findings of both XTT and G3PDH assay 
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(Fig 5.20). The adipose tissue cryopreserved with 1mg/ml curcumin (270 ± 24 nM/g wet 
wt) showed lesser lipid peroxidation than tissues cryopreserved with other concentrations 
of curcumin and carnitine. However, the difference in the level of protection achieved 
with 3mg/ml carnitine (302 ± 15 nM/g wet wt) and 1mg/ml curcumin is statistically 
insignificant (p<0.05) that signifies the concentration level at which individual 
antioxidants functions well in preventing tissue damage. Therefore, all the assays taken 
together curcumin was proven to be the best antioxidants and 1mg/ml is the most effective 
concentration. 
 
Figure 5.20: Evaluation of curcumin and carnitine for cryopreservation of adipose 
tissue measured by TBARS assay. The assay result corroborated with the findings of 
both XTT and G3PDH assay revealing the higher efficiency of curcumin. 
The results revealed that curcumin and carnitine were effective and ellagic acid, gallic acid 
and quercetin were found to be ineffective in maintaining the viability of cryopreserved 
adipose tissue. The result may be explained by the fact that antioxidants when used in 
inappropriate concentration may also act as free radical or ROS generator imparting 
additional damage to the tissues [156-158]. Furthermore, compared to only water (polar) 
soluble antioxidants such as ellagic acid, gallic acid and quercetin, antioxidants that are 
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soluble in only non-polar solvents (curcumin and Vit E) as well as both polar and non-
polar solvents (carnitine and lipoic acid) performed better for cryopreservation of adipose 
tissue [159]. The result may be explained by the fact that adipocytes are filled mostly with 
triglycerides, a nonpolar molecule and thus, permeation and distributions of non-polar 
antioxidants within the cells performed better compared to polar antioxidants [160]. 
Therefore, 1mg/ml curcumin and 3mg/ml carnitine were selected for further study to 
investigate their effectiveness in improving the cryopreservation of adipose tissue by 
supplementing with the most efficient 160mM NaCl/90mM trehalose freezing solution. 
5.2.2 Improvement of 160mM NaCl/90mM trehalose freezing solution supplemented 
with antioxidants 
 
As it has already been mentioned that antioxidants have an important role in overcoming 
free radical mediated cryoinjury during cryopreservation of cells and tissues. In our 
previous work, carnitine and curcumin were found to be efficient antioxidants performing 
well towards cryopreservation of adipose tissue in PBS solution. Therefore, it was 
hypothesized that the addition of these antioxidants may improve the cryopreservation 
outcome of the 160mM NaCl and the formulated 160mM NaCl/90mM trehalose freezing 
solution for adipose tissue cryopreservation. Therefore, in this phase of dissertation work, 
cryopreservation experiments were carried out with these freezing solutions with the 
addition of carnitine and curcumin to investigate their effect on the cryopreserved tissue 
viability.  
Oil ratio  
Oil ratio data (Fig 5.21) indicates that the supplementation of antioxidants with 160mM 
NaCl and 160mM NaCl/90mM trehalose freezing solutions significantly improved the 
viability of cryopreserved adipose tissue. Although there was no significant difference 
(p<0.05) among oil ratios of 160mM NaCl/1mg/ml  curcumin (0.032 ± 0.004), 160mM 
NaCl/3mg/ml carnitine (0.033 ± 0.002) and 160mM NaCl/90mM trehalose (0.035 ± 
0.002), there was significant difference between the oil ratios obtained with 160mM 
NaCl/90mM trehalose/1mg/ml curcumin (0.02 ± 0) and 160mM NaCl/90mM 
trehalose/3mg/ml carnitine (0.025 ± 0.002). Overall, freezing solutions containing 
curcumin achieved higher viability than carnitine supplemented freezing solutions and the 
highest viability was shown by 160mM NaCl/90mM trehalose/1mg/ml curcumin 
representing its superior performance than other freezing solution.  
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Figure 5.21: Oil ratio analyses indicate the viability of cryopreserved adipose tissue 
using curcumin and carnitine in freezing solution. 160mM NaCl was used as carrier 
media. The viability obtained with 160mM NaCl/90mM trehalose/1mg/ml 
curcumin(0.02 ± 0.00) and 160mM NaCl/90mM trehalose/3mg/ml carnitine (0.025 ± 
0.002) freezing solutions was higher than the viability obtained with 160mM 
NaCl/10% Me2SO (0.032 ± 0.004). 
 
XTT assay 
The XTT results (Fig 5.22) shows that the difference in metabolic activity achieved with 
the cryopreserved adipose tissues in different freezing solutions was not found to be 
statistically significant. However, adipose tissue cryopreserved in 160mM NaCl/90mM 
trehalose/1mg/ml curcumin freezing solution achieved the highest metabolic activity 
(89.7± 4.4%).  
Interestingly, as also observed in oil ratio analysis, 160mM NaCl/1mg/ml curcumin (86.2 
± 3.4%) freezing solution gave better viability than 160mM NaCl/90mM trehalose (84.8 ± 
4.3%) indicating a dominant role of redox state in adipocytes in determining the viability 
of cryopreserved adipose tissue. However, combined effect of trehalose and 160mM 
NaCl/1mg/ml curcumin improved the viability revealing the independent and additive 
cryoprotective mechanisms of curcumin and trehalose. Freezing solutions supplemented 
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with carnitine provided comparable results to that obtained with 160mM NaCl/90mM 
trehalose freezing solution as assessed by both oil ratio and XTT assay indicating a similar 
level of efficacy of carnitine and trehalose. However, similar to curcumin-supplemented 
solutions, the addition of trehalose to carnitine supplemented freezing solution further 
improved the viability of cryopreserved adipose tissue. 
 
Figure 5.22: The viability assessment of cryopreserved adipose tissue using curcumin 
and carnitine as antioxidants in freezing solution. 160mM NaCl was used as carrier 
media. adipose tissue cryopreserved in 160mM NaCl/90mM trehalose/1mg/ml 
curcumin freezing solution achieved the highest metabolic activity (89.7 ± 4.4%). 
 
G3PDH assay 
As indicated in Fig 5.23 the extracellular G3PDH concentration was the least with the 
cryopreserved adipose tissue when cryopreserved in 160mM NaCl/90mM 
trehalose/1mg/ml curcumin (1.62 ± 0.07 U/ml) freezing solution. However, the result was 
not statistically significantly different (p<0.05) from other freezing solution except when 
the adipose tissue cryopreserved in 160mM NaCl/3mg/ml carnitine.  
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Figure 5.23: G3PDH assay indicate the viability of cryopreserved adipose tissue 
using curcumin and carnitine in freezing solution. 160mM NaCl was used as carrier 
media. The extracellular G3PDH concentration was the least and hence the 
maximum viability of post-thawed adipose tissue when cryopreserved in 160mM 
NaCl/90mM trehalose/1mg/ml curcumin freezing solution. 
 
TBARS assay 
The trend in malondialdehyde production and thus the adipocyte viability in cryopreserved 
adipose tissue (Fig 5.24) were similar to the viability results obtained with oil ratio, XTT 
and G3PDH assay results proving the addition of antioxidants improved the viability of 
cryopreserved adipose tissue. The tissue preserved in 160mM NaCl/90mM 
trehalose/1mg/ml curcumin freezing solution undergoes lipid peroxidation (204 ± 11 nM/g 
wet wt), which is significantly lower than the conventional 10% Me2SO freezing solution 
(253 ± 15 nM/g wet wt). Although, freezing solution comprising of 160mM NaCl/90mM 
trehalose/3mg/ml carnitine (219 ± 15 nM/g wet wt) performed significantly higher than 
160mM NaCl/10% Me2SO, the adipose tissue viability obtained with 160mM 
NaCl/3mg/ml carnitine were comparable to the viability obtained with 160mM NaCl/10% 
Me2SO freezing solution. The difference between the concentration of lipid peroxidation 
products with 160mM NaCl/90mM trehalose/3mg/ml carnitine and 160mM NaCl/90mM 
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trehalose/1mg/ml curcumin freezing solutions was not statistically significant (p<0.05) as 
also revealed by XTT and G3PDH assay. 
 
Figure 5.24: TBARS assay indicate the viability of cryopreserved adipose tissue using 
curcumin and carnitine in freezing solution. Among the freezing solutions, 160mM 
NaCl/90mM trehalose/1mg/ml curcumin underwent significantly lower lipid 
peroxidation (204 ± 11 nM/g wet wt) than the freezing solution containing 
conventional 10% Me2SO. A comparable tissue viability using 160mM NaCl/90mM 
trehalose containing carnitine at a comparatively higher concentration (3mg/ml) was 
obtained. 
Overall, considering the results of all assays taken into account, it was observed that 
160mM NaCl/90mM trehalose/1mg/ml curcumin freezing solution performed better than 
other freezing solution including Me2SO containing freezing solution. Thus, the study 
provides a Me2SO free, non-toxic freezing solution that has the ability to cryopreserve 
adipose tissue with maintained tissue viability. Furthermore, the presence of curcumin in 
the post-thawed adipose tissue may offer the additional advantage of better wound healing 
and aesthetic outcome after lipofilling operation. Besides antioxidant property, curcumin 
is known to exhibit anti-inflammatory and anti-infective properties, which make it a 
unique molecule for wound healing applications [161]. Curcumin treatment resulted in 
increased formation of granulation tissue, neovascularization and enhanced biosynthesis of 
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extracellular matrix proteins such as collagen [162]. Curcumin treated cutaneous wound 
showed decreased levels of lipid peroxides (LPs) and cross-linking of collagen. Therefore, 
all these factors may provide additional benefit in achieving better wound healing in the 
lipofilling operation and tissue regeneration by the use of cryopreserved adipose tissue 
through tissue engineering technique. Moreover, in the case of autologous fat grafting 
needs to be performed at the tumor resected site, curcumin may kill the residual tumor 
cells because of its anticancer property [163, 164]. Thus, the presence of curcumin at graft 
site may lead to less resorption of grafts, maintaining the contour of the surgical site and 
improve aesthetic outcome of the surgery. The hypothesis is supported by the fact that 
antioxidants N-acetylcysteine and Coenzyme Q10, treatment resulted in improved graft 
retention [165, 166]. 
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5.3 Effect of signaling pathway inhibitors  
Cryoinjury during cryopreservation accentuates the apoptosis mediated death of 
adipocytes in adipose tissue [167]. The initiation of apoptosis is possible by many 
mechanisms and pathways such as intrinsic and extrinsic pathways. The intrinsic pathway 
contains proteins such as second mitochondria-derived activator of caspase (SMAC) or 
cytochrome c, while the extrinsic pathway starts with special TNF-receptors, also called 
‘death receptors.' All pathways result in the activation of substrate specific cysteine 
proteases, also called caspases that are the effectors of apoptosis [168]. Molecules that 
inhibit caspases are known to inhibit apoptosis-mediated cell death [169]. Z-VAD-FMK is 
a cell permeable, pan-caspase inhibitor, which prevents apoptosis-mediated cell death 
during cryopreservation of cells and tissues thereby, increases the post-thaw viability 
[170]. 
Similar to caspases, Rho/ROC kinase also plays a negative role in maintaining the 
viability of adipose tissue [171]. Increased Rho/ROC kinase activity was observed in 
adipose tissue of obese and has linkage to adipose hypertrophy, metabolic dysregulation 
and adipose tissue inflammation. Furthermore, Rho/ROCK inhibits the cytoskeletal 
reorganization and interferes with insulin pathway necessary for adipogenesis of hADSCs. 
Rho/ROCK inhibitor such as Y-27632 reverses the negative effects thereby maintains a 
healthy state of adipose tissue [172]. The ROCK inhibitor Y-27632 increased the viability 
of various cryopreserved cells and tissue [173]. 
Although the role of caspase and ROCK inhibitors in increasing the viability of 
cryopreserved cells and tissues are widely recognized, the molecules have not been 
evaluated so far for their efficacy in cryopreservation of adipose tissue. Therefore, it was 
hypothesized that the addition of Z-VAD-FMK and Y-27632 in the developed freezing 
solution might improve the viability of post-thawed adipose tissue. Thus, an effort was 
given to investigate the impact of Z-VAD-FMK and Y-27632 after supplementing them 
with the developed freezing solution. Similar to the previous methodology, the viability of 
post-thaw adipose tissue was evaluated by oil ratio, XTT, G3PDH and TBARS assays. 
Oil ratio 
The oil release due to damage of adipocyte present in adipose tissue was assessed by 
performing cryopreservation experiment using the most effective freezing solution 
160mM NaCl/90mM trehalose/1mg/ml curcumin formulated in the previous chapter 
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supplementing with 10nM Z-VAD-FMK and 100mM Y-27632. The concentrations of 
inhibitors were based on literature [174, 175]. The results in Fig 5.25  reveal that there is 
no significant difference in oil released from post-thawed adipose tissue cryopreserved 
with the most efficient 160mM NaCl/90mM trehalose/1mg/ml curcumin freezing solution 
(0.0213 ± 0.0023) with and without inhibitors, though a slightly lower viability was shown 
by Y-27632 (0.0227 ± 0.0023). This represents that the addition of inhibitors has 
negligible influence on the tissue viability. 
 
Figure 5.25: Effect of Rho kinase and caspases inhibitors supplemented with the 
most effective  160mM NaCl/90mM trehalose/1mg/ml curcumin freezing solution on 
the viability of cryopreserved adipose tissue by oil ratio. It is indicated that the 
addition of inhibitors has no significant influence on the tissue viability. 
 
XTT assay 
XTT results (Fig 5.26) shows a marginal increment of adipose tissue viability by adding 
inhibitors and the viability showed by both inhibitors is comparable. The corresponding 
viability values were found to be 89.6 ± 3.6% and 89.4 ± 3.4% with Z-VAD-FMK and Y-
27632. Though a slightly higher adipose tissue viability obtained with the freezing 
solution supplemented with inhibitors but the difference between the viability results with 
and without inhibitors are statistically insignificant (p<0.05) thereby demonstrating that 
the inhibitors do not play any significant role in maintaining the viability of cryopreserved 
adipose tissue. 
76 | P a g e  
 
 
Figure 5.26: XTT assay indicates the viability of cryopreserved adipose tissue using 
Rho kinase and caspase inhibitors supplemented with the formulated freezing 
solution. Results indicate a slightly higher adipose tissue viability obtained by adding 
inhibitors, but the difference between the viability results with and without inhibitors 
are statistically insignificant (p<0.05) which signifies that the inhibitors do not play 
any significant role in maintaining the viability of cryopreserved adipose tissue. 
 
G3PDH assay 
Similar to the findings of oil ratio and XTT assays, the results of G3PDH assay (Fig 5.27) 
also indicate that there is no significant difference in enzyme activity during 
cryopreservation of adipose tissue using formulated 160mM NaCl/90mM 
trehalose/1mg/ml curcumin with and without inhibitors. The enzyme activities of 1.67 ± 
0.10 U/ml and 1.61 ± 0.07 U/ml were shown with the addition of Z-VAD-FMK and Y-
27632 to the freezing solution (1.62±0.07 U/ml) respectively. Thus, the results represent 
the limited role of Z-VAD-FMK and Y-27632 compounds in the protection of 
cryopreserved adipose tissue. However, similar to oil ratio analysis results, the freezing 
solution containing Y-27632 gave slightly better performance than Z-VAD-FMK. 
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Figure 5.27: G3PDH assay indicates the viability of cryopreserved adipose tissue 
using Rho kinase and caspases inhibitors supplemented with the freezing solution. 
 
TBARS assay 
TBARS assay (Fig 5.28) also showed that there was no beneficial effect of Z-VAD-FMK 
and Y-27632 when added to 160mM NaCl/90mM trehalose/1mg/ml curcumin freezing 
solution. However, 160mM NaCl/90mM trehalose/1mg/ml curcumin/10nM Z-VAD-FMK 
(215 ±15 nM/g wet wt) performed slightly higher than 160mM NaCl/90mM 
trehalose/1mg/ml curcumin /100mM Y-27632 (217 ±13 nM/g wet wt). 
 
Figure 5.28: TBARS assay indicates the effect of Rho kinase and caspases inhibitors 
on the viability of cryopreserved adipose tissue using 
160mMNaCl/90mMtrehalose/1mg/ml curcumin freezing solution. Though there is no 
significant improvement in viability was observed using inhibitor, Z-VAD-FMK 
inhibitor shows slightly better performance than Y-27632. 
Overall, the results proved that addition of Z-VAD-FMK and Y-27632 did not improve 
the viability of post-thaw adipose tissue.  
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5.4 Control rate freezing of adipose tissue using formulated freezing solution 
Cooling rate during cryopreservation has a profound effect on the viability of 
cryopreserved cells and tissues. Slow cooling leads to extracellular ice formation and 
hence the dominant mechanism of cryoinjury is solute concentration effect [176]. 
Whereas, rapid cooling leads to intracellular ice formation and thus ice-mediated injury 
becomes dominant cause of cell death [177]. Therefore, to achieve maximum cell 
viability, the optimal cooling rate is essential.  
In the present research, initially the adipose tissue was cryopreserved in -80°C freezer in 
isopropanol containing bath so as to maintain 1-2°C/min cooling rate [178]. Keeping this 
in view, adipose tissue was subjected to control rate freezing in a controlled rate freezer 
(CRF) to achieve more accurate and precise temperature control using the most effective 
160mM NaCl/90mM trehalose/1mg/ml curcumin freezing solution [38].  
5.4.1 Effect of cooling rate 
The effect of cooling rate on the cryopreservation of adipose tissue was studied at varying 
cooling rate such as 0.5°C/min, 1°C/min, 2.5°C/min, 5°C/min in CRF from 4°C to -120°C 
followed by preservation in LN2  After 48h, the cryopreserved tissues were thawed rapidly 
in a 37°C water bath. Rapid thawing method was selected based on the reported literature 
that suggests that rapid thawing is superior to slow thawing method. The viability of post-
thawed adipose tissue was assessed as usual by oil ratio, XTT, G3PDH and TBARS 
assays.  
Oil ratio 
The experimental results on oil release from cryopreserved adipose tissue at varying 
cooling rate are shown in Fig 5.29. The viability results indicate that the adipose tissue 
cryopreserved at -1°C/min cooling rate released less oil from the damaged adipose tissue 
than either below or above -1°C/min and thus retained more viability. The trend of oil 
release at different cooling rate is as follows- -1°C/min (0.019 ± 0.002) <0.5°C/min (0.021 
± 0.002) <2.5°C/min (0.023 ±0.002) < 5°C/min (0.029 ± 0.002). Although, mean oil ratio 
at -1°C/min cooling rate is higher than 0.5°C/min, the difference between them is 
insignificant (p<0.05). Thus, with increasing cooling rate, the viability of the post-thawed 
adipose tissues decreased rapidly. In comparison, oil ratios between adipose tissue 
preserved using isopropanol filled container in -80°C freezer (0.021 ± 0.002) and 
controlled rate freezer at -1°C/min cooling rate and storage at LN2, is comparable though a 
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slightly lower oil ratio representing superior tissue viability was achieved with the later 
condition.  
 
Figure 5.29: Oil ratio analyses indicate the effect of cooling rate on the 
cryopreservation of adipose tissue using 160mM NaCl/90mM trehalose/1mg/ml 
curcumin freezing solution. The trend of oil release at different cooling rate is as 
follows- -1°C/min (0.019 ± 0.002) <0.5°C/min (0.021 ± 0.002) <2.5°C/min (0.023 ± 
0.002) <5°C/min (0.029 ± 0.002) indicating  -1°C/min is the best cooling rate 
providing maximum adipose tissue viability.  
 
XTT assay 
As indicated in Fig 5.30, -1°C/min cooling rate showed the maximum metabolic activity 
(93.1± 2.2%) followed by adipose tissues cryopreserved at -0.5°C/min (89.7 ± 2.9%), -
2.5°C/min (84.1 ± 3.5%) and -5°C/min (83.9 ± 3.8%). As also observed with oil ratio 
measurement, the difference in metabolic activity between adipose tissue preserved in 
isopropanol filled container and -1°C/min controlled rate freezing is statistically 
insignificant (p<0.05). However, the mean metabolic activity of controlled rate frozen 
samples was higher than samples frozen using Mr. Frosty. This indicates the superiority of 
the control rate freezing in the maintenance of adipose tissue viability. 
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Figure 5.30: XTT assay showing the effect of cooling rate on the viability pattern of 
cryopreserved adipose tissue using 160mM NaCl/90mM trehalose/1mg/ml curcumin 
freezing solution. The maximum viability was obtained at -1°C/min. 
 
G3PDH assay 
The viability in terms of cell membrane integrity evaluated by G3PDH assay (Fig 5.31) 
indicated the similar trend of tissue damage and reconfirmed -1°C/min cooling rate is the 
most effective cooling rate providing maximum tissue viability. The tissue damage in 
terms of enzyme activity level observed at different cooling rate follows the following 
trends -1°C/min (1.57 ± 0.10 U/ml) <  -0.5°C/min (1.72 ± 0.07 U/ml) <  -2.5°C/min 
(1.77±0.03 U/ml) < -5°C/min (1.86 ± 0.12 U/ml) representing the decrease in viability 
with rapid cooling rate above -1°C/min as well as below -1°C/min as slow cooling. 
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Figure 5.31: G3PDH assay indicates the effect of cooling rate on the cryopreservation 
of adipose tissue using 160mM NaCl/90mM trehalose/1mg/ml curcumin freezing 
solution. -1°C/min is observed to provide the maximum post-thaw viability by 
showing least extracellular G3PDH enzyme activity. 
 
TBARS assay 
The results of TBARS assay (Fig 5.32) corroborate with the findings of other assays, 
which suggested slow cooling particularly the cooling rate of -1°C/min is superior to other 
cooling rates for cryopreservation of adipose tissue. The lipid peroxidation products in 
post-thawed adipose tissue cryopreserved with -1°C/min cooling rate (200 ± 13 nM/g wet 
wt) is significantly lower than the adipose tissue cryopreserved with other cooling rates. 
Furthermore, the slow cooling rate below -1°C/min did not favor the adipose tissue 
viability cryopreserved in 160mM NaCl/90mM trehalose/1mg/ml curcumin freezing 
solution. 
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Figure 5.32: Effect of cooling rates on the post-thaw viability adipose tissue 
cryopreserved in  160mM NaCl/90mM trehalose/1mg/ml curcumin freezing solution 
assessed by TBARS assay. The viability shows a similar trend that evaluated by XTT 
and G3PDH assays. 
The study on the cooling rate established that the formulated 160mM NaCl/90mM 
trehalose/1mg/ml curcumin freezing solution is the most effective at -1°C/min cooling rate 
achieving most tissue viability than other cooling rate and -80°C freezer. Therefore, -
1°C/min cooling rate was selected for the subsequent controlled rate freezing of adipose 
tissue. 
 
5.4.2 Effect of Seeding 
Nucleation of ice is one of the most significant uncontrolled variables in conventional 
cryopreservation leading to sample-to-sample variation in cell recovery, viability and 
function [179]. Predictable nucleation of ice allows a way of increasing viability of cells 
and reducing variability between samples. Therefore, nucleation of ice should be 
controlled to allow standardization of cryopreservation protocols of cells and tissues for 
biobanking [180].  
Seeding or introduction of small ice crystals into the undercooled sample is a way of 
controlled nucleation of ice [181, 182]. The seeding is performed manually by generating 
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a cold spot on the outside of a closed cryovials using a stainless steel electrode. To find 
out the effect of seeding temperature on the viability of cryopreserved adipose tissue, the 
adipose tissue was seeded at -5°C, -7°C, and -9°C while cooling from 4°C to -120°C at -
1°C/min. The freezing solution used was 160mM NaCl/90mM trehalose/1mg/ml 
curcumin. The samples were stored at LN2 for 48 h before being thawed rapidly and 
assessed for viability. 
Oil ratio 
The oil release from cryopreserved adipose tissue was found to depend on the seeding 
temperature. The viability (Fig 5.33) was initially increased with decreased in seeding 
temperature from -5°C to -7°C and the viability remained constant afterward. Therefore, -
7°C is the most effective seeding temperature that provided maximum tissue viability with 
minimum oil release. The corresponding oil ratios achieved were 0.021 ± 0.002 (-7°C), 
0.024 ± 0.004 (-5°C), 0.021 ± 0.002 (9°C). However, the difference in results between 
them is insignificant (p<0.05). Interestingly, when compared to samples frozen with -
1°C/min cooling rate without seeding, seeding decreased the viability of cryopreserved 
adipose tissue, albeit insignificantly (p<0.05). 
 
Figure 5.33: Measured oil ratio showing the effect of seeding temperature on the 
cryopreservation of adipose tissue using 160mM NaCl/90mM trehalose/1mg/ml 
curcumin freezing solution. As observed, -7°C is the most effective seeding 
temperature that provided maximum tissue viability with minimum oil release from 
adipose tissue. 
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XTT assay 
As in the previous assay, the metabolic activity (Fig 5.34) of cryopreserved adipose tissue 
indicates that there is no significant change in post-thaw viability (92.1 ± 2.4%). 
Furthermore, seeding also decreased the metabolic activity of post-thawed adipose tissue 
indicating lesser viability than non-seeded samples.  
 
Figure 5.34: Effect of seeding temperature on the cryopreservation of adipose tissue 
using 160mM NaCl/90mM trehalose/1mg/ml curcumin freezing solution evaluated by 
XTT measurement. The trend shows the similar viability pattern observed with all 
the seeding temperature.   
 
G3PDH assay 
The results in Fig 5.35 indicate that the G3PDH activity at different seeding temperature 
follows a similar trend as that of the oil ratio. Seeding at -7°C showed the least 
extracellular concentration of G3PDH (1.61 ± 0.07 U/ml) in the cryopreserved samples 
than other seeded and non-seeded samples. However, the difference is not statistically 
significant (p<0.05) between them. 
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Figure 5.35: G3PDH assay showing the effect of seeding temperature on the post-
thaw viability of adipose tissue cryopreserved in 160mMNaCl/90mM 
trehalose/1mg/ml curcumin freezing solution. The assay result confirms that seeding 
at -7°C is favorable for the maintenance of adipose tissue by offering minimum oil 
release.  
 
TBARS assay 
The results of TBARS assay (Fig 5.36) also indicate similar finding to oil ratio, XTT and 
TBARS assay. Samples preserved at -7°C showed least generation of lipid peroxidation 
products (202 ± 10 nM/g wet wt) than others. However, similar to other assays, TBARS 
assay also proved the deteriorating effect of seeding on the cryopreservation of adipose 
tissue. 
 
Figure 5.36: The viability pattern for post-thaw adipose tissue evaluated by TBARS 
assay indicating -7°C as the seeding temperature that provided maximum tissue 
viability with producing minimum lipid peroxidation products. 
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 Overall, the results show that the seeding temperature does not have any significant 
influence on the cryopreservation of adipose tissue. As also observed in the previous 
results, maintaining osmotic balance and preventing oxidative stress is more significant in 
the case of adipose tissue cryopreservation than preventing ice related cryoinjury.  
A comparison of the viability of adipose tissue cryopreserved in different freezing solution 
is shown in Table 5.1. As indicated, the maximum tissue viability was achieved using  
160mM NaCl /90mM trehalose/1mg/ml curcumin freezing solution with control rate 
freezing  at -1°C/min cooling rate  followed by storage in LN2 
Table 5.1 Comparison of viability using different freezing solution  
Freezing solution Oil ratio XTT assay 
(%) 
G3PDH 
assay (U/ml) 
TBARS assay 
(nM/g wet wt) 
PBS 0.083±0.005 65.39±4.13 3.069±0.147 414±13 
90mM trehalose/PBS 0.047±0.002 82.55±2.97 2.249±0.100 321±7 
150mM ectoin/PBS 0.077±0.002 69.79±3.45 2.683±0.154 361±11 
160mM NaCl 0.039±0.002 84.14±5.22 1.848±0.056 271±7 
90mM trehalose/160mM 
NaCl 
0.035±0.002 84.76±4.28 1.751±0.121 256±16 
10% Me2SO/PBS 0.043±0.006 80.20±3.21 2.281±0.074 285±19 
10% Me2SO/160mM NaCl 0.032±0.004 85.35±3.88 1.719±0.169 253±15 
160mM NaCl /90mM 
trehalose 
0.035±0.002 84.76±4.28 1.751±0.121 256±16 
160mM NaCl /90mM 
trehalose/1mg/ml curcumin 
(-80°C) 
0.02±0 89.72±4.41 1.622±0.074 204±10 
160mM NaCl /90mM 
trehalose/1mg/ml curcumin 
(-1°C /min cooling rate 
followed by storage in LN2) 
0.019±0.002 93.13±2.21 1.574±0.100 200±13 
160mM NaCl /90mM 
trehalose/1mg/ml curcumin 
(-1°C/min cooling rate, 
seeding at -7°C followed by 
storage in LN2) 
0.021±0.002 92.09±2.38 1.607±0.074 202±10 
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5.5 Long-term viability of adipose tissue by controlled rate freezing using formulated 
freezing solution 
 
The maintenance of viability with long shelve-life is of prime importance. Long-term 
preservation is required to hold the potential therapeutic modality of adipose tissue in 
reserve for use at a future date. Given increasing application of adipose tissue in a 
cosmetic and aesthetic surgery, the significance of long-term preservation of adipose 
tissue is increasing. Although the viability of cryopreserved cells and tissues is known to 
decrease over time because of free radicle formation and other events, the incidence of 
adverse events on the long-term viability of cryopreserved adipose tissue is unclear, often 
with conflicting conclusion [183]. Therefore, after achieving a successful result on a short-
term basis, the developed freezing solution having composition 160mM NaCl/90mM 
trehalose/1mg/ml curcumin was evaluated for its efficacy towards the maintenance of 
tissue viability on a long-term perspective. The adipose tissue was cryopreserved by 
control rate freezing using the developed freezing solution and the tissue viability was 
assessed in an interval of 7, 15, 30, 60 and 90 days of storage in liquid nitrogen. The 
controlled rate freezing was performed at -1°C/min cooling rate from 4°C to -120°C after 
equilibrating with the freezing solution for 1h at 4°C. 
Oil ratio 
The results depicted in Fig 5.37 revealed that the oil release and hence adipocyte damage 
of cryopreserved adipose tissue was increased gradually over storage time that represents 
the gradual loss in tissue viability with time. However, the viability of adipose tissue after 
90 days of storage (0.027 ± 0.002) was not significantly different from viability even after 
7 days (0.024 ± 0.004) in terms of oil ratio indicating that the developed freezing solution 
is efficient in maintaining adipose tissue viability for a longer period of storage.  
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Figure 5.37:Measured oil ratio showing the effect of 160mMNaCl/90mM trehalose/ 
1mg/ml curcumin freezing solution on the long-term viability of cryopreserved 
adipose tissue, which demonstrates that the developed freezing solution is efficient in 
maintaining adipose tissue viability during 90 days period of storage.  
 
XTT assay 
The results of XTT assay, as shown in Fig 5.38, corroborate with the finding of oil ratio 
analysis. The metabolic activity and hence the viability was gradually decreased with 
storage period. However, the difference in viability loss was not statistically significant. 
As for example, the viability of 89.7 ± 3.1% after 7 days of storage was decreased only to 
88.00 ± 3.6% after 90 days indicating that the maximum viability loss was only 2% during 
the 90 days of storage of adipose tissue. 
 
Figure 5.38: Assessment of the long-term viability of cryopreserved adipose tissue 
measured by XTT assay. The result indicates the efficacy of the developed 160mM 
NaCl/90mM trehalose/1mg/ml curcumin freezing solution towards preserving 
adipose tissue during the 90 days storage. 
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G3PDH assay 
Fig 5.39 depicted an increase in the concentration of extracellular G3PDH over time. The 
activity of the enzyme was shown to be 1.65 ± 0.1 U/ml after 7 days and the activity was 
increased to 1.80±0.07 U/ml after 90 days. The nominal change in G3PDH concentration 
indicates less damage of cryopreserved adipose tissue even after 90 days of storage. 
Therefore, the developed freezing solution is proven to be efficient in preserving adipose 
tissue with long shelve life. 
 
Figure 5.39: G3PDH assay shows the efficiency of 160mM NaCl/90mM 
trehalose/1mg/ml curcumin freezing solution on the long-term viability of 
cryopreserved adipose tissue. The cryopreserved adipose tissue was maintained well 
during the 3months period of storage.   
 
TBARS assay 
The assay measures the formation of lipid peroxidation products after 7 days, 15 days, 30 
days, 60 days and 90 days. As indicated from Fig 5.40, the malondialdehyde concentration 
increases as the cryopreserved adipose tissues undergo lipid peroxidation over time. The 
malondialdehyde level 209 ± 6 on first week changed to 234 ± 15 nM/g wet wt. of adipose 
tissue at the end of 3rd month. The results reveal an increase in the concentration of 
malondialdehyde over time further indicating a decrease in viability or continuation of 
malondialdehyde formation. However, the reduction in viability is not statistically 
significant representing the efficiency of freezing solution for cryopreservation of adipose 
tissue. 
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Figure 5.40: TBARS assay shows the viability pattern of adipose tissue 
cryopreserved in the developed 160mM NaCl/90mM trehalose/1mg/ml curcumin 
freezing solution during the 90 days period of storage.  
 
5.5.1 Morphological assessment of cryopreserved adipose tissue using CLSM 
To assess the structural and functional integrity of adipose tissue cryopreserved for 90 
days, phase contrast microscopy, fluorescent imaging with PI were performed. 
Furthermore, inherent fluorescence of the developed freezing solution, because of the 
presence of curcumin was also evaluated and used to assess the morphology of 
cryopreserved adipose tissue.  The results were also compared with fresh adipose tissue. 
Phase contrast images (Fig 5.41) has revealed the distinct morphology of adipocytes in 
fresh and cryopreserved adipose tissue. 
 
Figure 5.41: CLSM images of fresh and post-thaw cryopreserved (90 days) adipose 
tissue.  The images reveal the distinct morphology of adipocytes in fresh and 
cryopreserved adipose tissue.  
Viability of adipocytes in cryopreserved adipose tissue by PI 
The structural integrity of cryopreserved adipose tissue was based mostly on H&E 
staining. However, judging adipocyte health by shape or nuclear appearance can be 
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misleading, and histologic sections are too thin to show most nuclei of healthy adipocytes. 
Therefore, fluorescent staining with PI was used to assess the status of both fresh and 
cryopreserved tissues. PI is impermeable to cell membrane until there is a breach in the 
cell membrane. Once inside the cells, PI bind with nucleic acids and then fluoresce 
revealing the dead cells.  
 
Figure 5.42: CLSM images are showing the structural integrity of fresh (a) and 
cryopreserved adipose tissue of 90 days storage (b) using PI as fluorescence dye. The 
discrete distribution of red stains mainly represents stained nuclei of dead adipocytes 
and the arrays of red stains cells mainly represent dead endothelial cells of the 
vessels. 
Fig 5.42 has revealed the structural integrity of fresh and cryopreserved adipose tissue 
after staining with PI. As revealed, there was not much difference in viability between 
fresh and cryopreserved tissues. Both fresh and cryopreserved adipose tissue mainly 
constituted of non-stained viable adipocytes.  
Vessels made up of endothelial cells provide sufficient nutrient and oxygen support for 
active metabolism and survival of the tissue. As can also be seen in Fig 5.43, the 
adipocytes are mostly viable; however, the most cells of vasculatures are dead in both 
fresh and cryopreserved adipose tissue supporting the recently reported literature on the 
importance of diffusion and neovascularization on long-term fat grafts survival [184]. The 
finding also supports the existing theory of fat grafts, which states that long-term graft 
volume consists primarily of grafted adipocytes that have survived the entire procedure 
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and grafted fats initially lack vascular support and the oxygen; nutrient supply to grafts 
occurs primarily through diffusion and neovascularization from surrounding tissue [185].  
 
Figure 5.43: CLSM of fresh (a) and cryopreserved (90 days) adipose tissue (b) using 
PI indicating dead endothelial cells.   
 
Assessment of structural integrity of adipocytes using the developed freezing solution  
Curcumin is a well-known fluorescence molecule with an excitation wavelength in the 
range of 420-480nm and emission band of 490-520nm [186-189]. As the developed 
freezing solution contains curcumin, the inherent fluorescence property of the freezing 
solution was used to assess the status of the cryopreserved adipose tissue. Fresh adipose 
after staining with curcumin acted as a control. As seen in the Fig 5.44a, curcumin was 
insoluble in PBS and appeared as heterogeneously distributed fluorescent particulates over 
the adipose tissue. As revealed in Fig 5.44b, the curcumin forms homogeneous solution 
after incubation with 2.5% Me2SO for 30min and the depth of penetration of curcumin 
increased. Furthermore, the non-permeation of homogenously distributed curcumin inside 
the cells helped in developing the contrast between adipocytes. The less permeability of 
curcumin inside the cell is also resulted in less bioavailability of it because of less 
permeation of curcumin inside cells [190].  
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Figure 5.44:CLSM images of adipose tissue using curcumin in PBS (a) and curcumin 
in 2.5% Me2SO. The heterogeneous distribution of changed to homogenous 
distribution with more depth of penetration after solubilizing curcumin in Me2SO. 
 
To evaluate the potential of curcumin to be able to differentiate between live and dead 
cells, adipose tissue was incubated with 0.25% SDS solution in the presence of 0.1% 
curcumin/2.5%% Me2SO solution for 30min. SDS, a surfactant molecule is supposed to 
compromise the plasma membrane and let the dye permeate inside the cells easily as seen 
in Fig 5.45a. Furthermore, because of fat solubility of curcumin, it stains the lipids of 
adipocytes, differentiating the dead cells from live cells. Therefore, curcumin may be used 
as live/dead differential stains for adipocytes. To evaluate the status of the cryopreserved 
adipose tissue frozen with 160mM NaCl/90mM trehalose/1mg/ml curcumin, the post-
thawed tissue was incubated with 2.5% Me2SO for 30min in the presence of the freezing 
solution containing curcumin. Fig 5.45b, c reveals that most of the adipocytes of 
cryopreserved adipose tissue retained the viability like fresh adipose tissue.  
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Figure 5.45: shows the structural and functional integrity of SDs treated (a), fresh (b) 
and cryopreserved (90 days) adipose tissue (c) using 0.1% curcumin/ 2.5% Me2SO. 
Arrow indicate dead adipocytes 
 
5.5.3 Survival of stem cells in cryopreserved adipose tissue 
The retention of mesenchymal stem cells in the adipose tissue has several advantages. It 
has been reported that supplementation of hADSCs along with adipose tissue for 
reconstructive and aesthetic surgery improved the outcome of the surgery. Furthermore, 
successful isolation of hADSCs from cryopreserved adipose tissue provides an alternative 
cheaper source of hADSCs, supplementing the benefits of hADSCs cryobanks.  Thus, an 
attempt was made to isolate hADSCs from cryopreserved adipose tissue (90 days) and the 
isolated hADSCs were compared with hADSCs isolated from fresh adipose tissue. 
Morphology of isolated hADSCs 
The morphological characteristic of the cultured hADSCs isolated from fresh and 
cryopreserved adipose tissue (90 days) was assessed by observation under phase contrast 
microscope.  
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Figure 5.46: Phase contrast microscopic images shows gradual change of round to 
fibroblastic cell morphology of hADSCs isolated from fresh (a) and cryopreserved 
(90 days) adipose tissue (b) observed upon culture in DMEM containing 10% FBS. 
The cells reached confluency on the 12th day of culture. (Scale bar 100µm). 
Fig 5.46b depicts that the initial round shape like morphology of isolated hADSCs from 
cryopreserved adipose tissue was gradually changed to fibroblast-like appearance over 12 
day culture period. Moreover, the cells were observed to adhere to the culture dish after 8h 
of incubation and fibroblast-like morphology was noticed after 18h. The cultured cells 
reached confluence after 12 days of culture. Similar morphology was also observed with 
fresh hADSCs (Fig 5.46a). 
Proliferation kinetics 
As indicated from Fig 5.47, the hADSCs isolated from cryopreserved cells were 
proliferated normally as the hADSCs isolated from fresh adipose tissue indicating the 
freezing solution has no adverse influence on the proliferation of hADSCs representing its 
ability to maintain cryopreserve adipose tissue. Upon seeding at a concentration of 5x103 
cells/well, the hADSCs from fresh adipose tissue proliferated to 67.33±2.08 x103 
cells/well, whereas hADSCs from cryopreserved adipose tissue proliferated to 68.33±3.05 
x103 cells/well on the 9th day. 
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Figure 5.47: Proliferation kinetics of hADSCs isolated from fresh and cryopreserved 
adipose tissue of 3months storage. Cryopreserved hADSCs were proliferated 
normally as the hADSCs isolated from fresh adipose tissue indicating the freezing 
solution has no adverse effect on the proliferation of hADSCs of adipose tissue and 
thus able to maintain the adipose tissue viability.  
 
Differentiation potential of hADSCs 
Osteogenesis (Fig 5.48) of hADSCs was indicated by staining of deposited calcium with 
alizarin red whereas staining of lipid droplet by Oil Red O indicates adipogenesis of 
hADSCs. Thus, the results showed that the isolated hADSCs from cryopreserved adipose 
tissue differentiated successfully to osteogenic and adipogenic lineages paving its 
application in tissue engineering and regenerative medicine. 
 
Figure 5.48: Assessment of differentiation potential of hADSCs isolated from fresh 
(a, b) and cryopreserved (90 days storage ) adipose tissue(c, d). (a, c) Osteogenic 
(Alizarin red staining) and (b, d) adipogenic lineages (Oil Red O staining). As 
indicated the isolated hADSCs differentiated successfully to osteogenic and 
adipogenic lineages.  
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Overall, though a slightly lower viability of adipose tissue frozen with the developed 
160mM NaCl/90mM trehalose/1mg/ml curcumin freezing solution was observed in 
comparison to fresh tissue, but the developed freezing solution was able to maintain high 
viability even after 3 months of storage in LN2 as evident from Table 5.2. shows the 
comparison of viability between fresh and cryopreserved adipose tissue after 3 months of 
storage. Furthermore, hADSCs were successfully isolated from the cryopreserved adipose 
tissue (90 days) frozen with the developed freezing solution. The isolated hADSCs 
showed adherancy with plastics, regular morphology and proliferation and also retained 
the differential ability to osteogenic and adipogenic lineages. Thus, the developed freezing 
solution has no adverse influence on the mesenchymal stem cells present in the adipose 
tissue. Therefore, adipose tissue frozen with 160mM NaCl/90mM trehalose/1mg/ml 
curcumin freezing solution is not only suitable for reconstructive and aesthetic surgery but 
also  a good source of hADSCs when need arises.  
Table 5.2 Comparison of viability between fresh and cryopreserved (3months)  
                 adipose tissue  
 
Tests Fresh AT Cryopreserved  AT 
Oil ratio 0 0.027±0.002 
XTT (%) 100% 88 ±3.6 
G3PDH assay (U/ml) 1.09±0.05 1.80±0.07 
TBARS assay (nM/g wet wt.) 142.47±11.54 233.62±15.13 
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Chapter 6 
Cryopreservation of Adipose tissue-
derived stem cells 
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6.1Screening of potential cryoprotectants and carrier media towards the formulation 
of freezing solution for cryopreservation of adipose tissue-derived stem cells 
 
Mesenchymal stem cells (MSCs) are potential for tissue regeneration because they are 
multipotent and differentiate into different cell types such as osteoblasts, adipocytes, 
chondrocytes, myoblasts and the like [191]. Adipose tissue is an attractive source of MSCs 
because of its easy availability and accessibility, thereby offers its application in 
producing therapeutic and tissue engineering products [192]. In this context, an effective 
cryopreservation strategy for preservation of hADSCs with long shelve-life is important 
for their clinical application. 
Cryopreservation using conventional freezing solution consisting of Me2SO and FBS has 
several detrimental effects including, the acute and chronic toxicity of patients and 
genotoxicity of preserved cells.  Furthermore, the most commonly used DMEM carrier 
media having multicomponent constituent creates more complex and unpredictable cell 
environment at sub-zero temperature because of ice crystallization. Hence, development of 
a Me2SO and serum-free freezing solution in a suitable carrier media for preserving 
hADSCs is inevitable.  
Therefore, efforts have been made in this phase of the dissertation to investigate the 
potentiality of various hydrocolloids and organic osmolytes as natural CPAs and 
phosphate buffered saline (PBS) and its individual components as carrier media to 
formulate a freezing solution for cryopreservation of hADSCs. The performance of the 
formulated freezing solution was evaluated by a battery of routine as well as advanced 
tests such as immunophenotype (flow cytometric analysis), cell viability and cell 
proliferation (Trypan blue; MTT assay), cytoskeletal analysis (CLSM study) and 
differential potential (alizarin red; Oil Red O assays). The experimental results obtained in 
the above research are discussed in this chapter. 
6.1.1 Morphological and Immunophenotypic characterization of hADSCs 
The morphology of the isolated and cultured hADSCs from fresh adipose tissue was 
assessed microscopically (Fig 6.46a). The initial round cells gradually changed to 
fibroblast-like appearance. The cultured cells have expressed 99% CD90, 89% CD73, 
98% CD105 as positive and 1.2% CD34,2% CD45, and 0.5% HLA-DR  as negative 
surface markers indicating the cells are mesenchymal stem cells type (Fig 6.1). 
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Figure 6.1: Flowcytometric analysis showing the expression of positive CD90 (99%), 
CD73 (89%), and CD105 (98%) markers and negative HLA-DR (0.5%), CD34 
(1.2%) and CD45 (2%) markers representing the cells are of mesenchymal stem cells 
in characteristics. 
 
6.1.2 Evaluation of hydrocolloids  
Hydrocolloids are polysaccharides that prevent ice crystallization, thereby act as 
extracellular cryoprotectants. The importance of hydrocolloids as cryoprotectants (CPA) 
was reported in the literature [193, 194]. Polyvinylpyrrolidone (PVP) and methylcellulose 
(MC) hydrocolloids have shown promise in cryopreservation of hADSCs [92, 93]. 
Furthermore, the hydrocolloids namely gums, CMC, MC and inulin were selected based 
on their use as food additives and various medicinal products without any cytotoxicity 
[195, 196].    
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Figure 6.2: Effect of types of hydrocolloids and their concentrations on the viability 
of cryopreserved hADSCs assessed by Trypan blue assay. Among the hydrocolloids, 
has performed best achieving the maximum viability of 55.7 ± 3.2%. The viability 
trend observed as 10% PVP > 0.3% tragacanth gum (43 ± 4.6%) > 1% (w/v) 
methylcellulose (37% ± 2.1%) > others 
 
Trypan blue assay results (Fig 6.2) shows that 10% (w/v) PVP/ PBS is the most efficient 
cryoprotectant achieving maximum viability (55.7 ± 3.2 %) followed by 0.3% (w/v) 
tragacanth gum (43 ± 4.6%) and 1% (w/v) methylcellulose (37% ± 2.1%). The viability 
obtained with 10% PVP is 12% and 18% higher than tragacanth gum (TG) and 
methylcellulose (MC) respectively. Among natural hydrocolloids, tragacanth gum showed 
higher viability than other polysaccharides, which may be due to its molecular weight and 
neutral characteristics.  The viability obtained with 10%PVP/PBS was also higher than 
10%Me2SO/PBS (control) and viability achieved with 10%Me2SO/PBS supplemented 
with 20%(v/v) FBS was comparable. Inulin, pectin and carrageenan showed the lowest 
viability. The viability trend observed by MTT assay was similar to Trypan blue assay 
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(Fig 6.3).  The results confirm PVP as the superior cryoprotectant to the other 
hydrocolloids used in this study and the 10% Me2SO as the conventional CPA for 
hADSCs. 
 
Figure 6.3: Effect of selected hydrocolloids on the viability of cryopreserved hADSCs 
assessed by MTT assay. The viability data obtained by MTT assay followed similar 
trends as Trypan blue assay. The results confirm PVP as the superior cryoprotectant 
to the other hydrocolloids used in this study as well as 10% Me2SO as the 
conventional CPA for hADSCs preservation. 
 
6.1.3 Evaluation of PVP in combination with PBS components as carrier media 
The most commonly used PBS as carrier media consists of NaCl, Na2HPO4, KCl and 
KH2PO4. It was hypothesized that these components may have a specific role in 
cryopreservation of stem cells, which has not been explored. Hence, these compounds 
were evaluated individually at a buffered isotonic concentration in combination with 
10%PVP.  As indicated in Fig 6.4a, 10%PVP/ 0.9% NaCl shows the highest viability 
(70.3 ± 1.5%) with the lowest viability shown by 10%PVP/ Na2HPO4 (34.3 ±3.1%). The 
viability obtained with 10% PVP in isotonic NaCl is 15% more than the viability obtained 
using other carrier media. The viability (60.7 ± 2.1%) of hADSCs with 10%PVP/KCl is 
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comparable to the viability (55.7 ± 3.2%) obtained using 10%/PVP/PBS.  The results also 
revealed that phosphate containing ionic compounds offer lower viability than chloride-
containing compounds.  The viability data measured by MTT assay (Fig 6.4b) followed 
the similar trend as viability assessed by Trypan blue method thereby confirming 
10%PVP/ 0.9% NaCl as a superior freezing solution.  
Interestingly, the viability observed with NaCl containing freezing solution in our 
experiment is in good agreement with viability achieved with DMEM containing freezing 
solution. Thus,  the results prove that the effectiveness of DMEM and normal saline on 
cryoprocess is comparable, and normal saline may replace DMEM due to its lower price 
and easy availability. Furthermore, chloride based ionic compounds performed better than 
phosphate based compounds indicating the freezing solution containing extracellular 
anions and cations provide better viability compared to the respective intracellular 
counterpart. The results may be contrary to many other reports stating that the intracellular 
type freezing medium offers better viability [5]. The concept of intracellular preservation 
media is mainly for the hypothermic preservation of organs and tissues, and the same 
concept may not be appropriate for the cryopreservation of mesenchymal stem cells. 
 
Figure 6.4: Effect of PBS and its individual ionic components as carrier media on the 
viability of cryopreserved hADSCs in 10% PVP assessed by Trypan blue assay (a) 
and MTT assay (b). 0.9% NaCl is found to be the best among the carrier media. The 
results also revealed that phosphate containing ionic compounds performed better 
than chloride-containing compounds thus signifies that the freezing solution 
containing extracellular anions and cations provide better viability compared to the 
respective intracellular counterpart. 
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6.1.4 Improvement of the developed freezing solution by the addition of organic 
osmolytes 
 
Natural osmolytes are small organic molecules that maintain cell volume and fluid balance 
of cells under stress and act as intracellular cryoprotectants. Organic osmolytes are non-
cytotoxic and used in skin ointments, nasal sprays and eye drop. Although organic 
osmolytes namely ectoin and hydroxyectoin as intracellular CPAs have shown promise in 
cryopreservation of human endothelial cells and murine embryos, have not so far been 
explored for cryopreservation of hADSCs. 
The effect of natural organic osmolytes in combination with the best freezing solution 
(10%PVP /0.9%NaCl was investigated with the aim of achieving improved viability of 
cryopreserved hADSCs.  
Fig 6.5a shows that the supplement of ectoin and hydroxyectoin increased the viability of 
cryopreserved hADSCs although a slightly higher viability was achieved with ectoin. The 
viability was also increased with increase in the concentration of osmolytes in freezing 
solution and the maximum cell viability of 81.7 ± 2.1 %) was obtained using ectoin at 
60mM concentration. Thus, an increase of 11% viability of 10%PVP/0.9%NaCl was 
obtained with the addition of osmolytes.  The cell recovery assessed by MTT also 
followed the similar trends. (Fig 6.5b). Thus, it is demonstrated that 
10%PVP/0.9%NaCl/60mM ectoin was established as the most efficient freezing solution 
that provided the highest cell viability than other freezing solutions.  
Usually, the supplementation of intracellular CPA with extracellular CPA complements 
each other to increase the viability of cryopreserved cells. Therefore, PVP, an extracellular 
CPA was supplemented with intracellular CPA such as ectoin and hydroxyectoin. Ectoin 
was found to be more efficient than hydroxyectoin, as the superior cryopreservation 
outcome was obtained using ectoin. Furthermore, ectoin was also reported to have the 
potential to replace Me2SO as a cryoprotectant in a serum-free cryomedium for MSCs 
[139].  Thus, the viability obtained with developed freezing solution 
10%PVP/0.9%NaCl/60mM ectoin is also comparable to the conventional 
10%Me2SO/DMEM supplemented with FBS (80%). 
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Figure 6.5: Effect of organic osmolytes on the viability of cryopreserved hADSCs. 
The Trypan blue assay (a) and MTT assay (b) results revealed that 
10%PVP/0.9%NaCl freezing supplemented with organic osmolytes improve cell 
viability. Furthermo0re, ectoin is found to be more efficient in maintaining cell 
viability than hydroxyectoin. Overall,   10%PVP/0.9%NaCl/60mM ectoin was 
established as the most efficient freezing solution that provided the highest cell 
viability than other freezing solutions.  
 
6.1.5 Cytoskeletal analysis 
F-actin, one of the major components of the cytoskeletal system has a significant role in 
maintaining cellular integrity and function. At extremely low temperature, the ultra-
structure of F-actin becomes distorted that causes cell damage, which was assessed by 
cytoskeletal analysis [197]. Fig 6.6a (Priyanka Goyal M.Tech thesis, 2015) and 6.6b 
showed the normal cytoskeletal distribution pattern of F-actin, indicating hADSCs 
cryopreserved in 10%PVP/0.9%NaCl/60mM ectoin retain their normal cell morphology 
like fresh hADSCs proving the efficiency of the formulated freezing solution towards their 
maintenance.   
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Figure 6.6: CLSM images of frozen hADSCs in 10%PVP/0.9%NaCl/60mM ectoin 
freezing solution. Nuclear stain (blue) used was DAPI and the cytoskeletal stain was 
TRITC-Phalloidin. The distribution of F-actin is predominantly beneath the cell 
membrane, indicating its normal distribution in cryopreserved hADSCs.(Scale bar 
25µm) 
 
6.1.6 Differentiation Potential 
Freezing solutions have a significant influence on the differentiation ability of 
cryopreserved cells. The impact of the formulated 10%PVP/0.9%NaCl/60mM ectoin on 
the osteogenic and adipogenic differentiation ability of frozen hADSCs was investigated. 
When the post-thaw hADSCs were exposed to the adipogenic medium, the cell 
morphology underwent a transition from elongated fibroblastic to a round or polygonal 
structure. After 14 days of induction, a consistent cell vacuolation was evident in the 
induced cells. On 0.36% Oil Red O staining, the differentiated cells showed the deposition 
of red lipid droplets throughout the cytoplasm (Fig 6.7b) that indicates the adipogenic 
induction of cryopreserved hADSCs. 
The osteogenic differentiation potential of cryopreserved hADSCs was evident from the 
deposition of calcium as an osteogenic differentiation marker during 21 days of culture 
(Fig 6.7a). Thus, the freezing solution can maintain the osteogenic and adipogenic 
differentiation potential of the cryopreserved hADSCs 
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Figure 6.7: Osteogenic and adipogenic differentiation potentiality of hADSCs 
cryopreserved in 10%PVP/0.9%NaCl/60mM ectoin freezing solution (a) and (b). 
Osteogenic potential of hADSCs is represented by the deposition of red calcium on 21 
days cell culture (a) with Alizarin red assay. Oil Red O staining shows the deposition 
of red lipid droplets throughout the cytoplasm on 14 days (b) indicating the 
adipogenesis.  (Scale bar 200µm). 
 
Overall, Me2SO-free, serum free and efficient freezing solution 10%PVP/ 0.9%NaCl/ 
60mM ectoin was formulated, which will be used in subsequent sections for further 
improvement in its efficacy in cryopreservation of hADSCs.   
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6.2 Optimization of freezing solution composition to improve cryopreservation 
outcome of adipose tissue-derived mesenchymal stem cells 
In the previous work, we have screened and evaluated cryoprotectant efficacy of a number 
of hydrocolloids and organic osmolytes for preserving hADSCs. The study has shown 
polyvinylpyrrolidone (PVP) and ectoin as the potential CPA achieving superior hADSCs 
viability upon cryopreservation than other osmolytes as well as conventional Me2SO. 
Besides cryoprotectants, the normal saline solution was found to be an effective carrier 
media that can replace the complex and much expensive DMEM media used traditionally 
in cryopreserved hADSCs. Based on this study, a novel freezing solution was formulated 
from the combination of PVP as extracellular CPA, ectoin as intracellular CPA, and NaCl 
as the carrier media. The freezing solution (0.9% NaCl/10% PVP/60mM ectoin) was 
found to be effective in terms of cell viability, and differentiation ability of cryopreserved 
hADSCs. Therefore, an attempt has been given in the present study to improve further the 
cryopreservation efficacy of the above-formulated freezing solution by optimizing the 
concentration of its individual components following Taguchi orthogonal design method. 
Taguchi’s optimization method is an attractable and widely used technique because of its 
several advantages; it minimizes trials for generating useful information regarding the 
response of interest, reduces the experimental time and robustness of the process [198, 
199]. In addition, catalase, a natural antioxidant was incorporated in the formulation of 
freezing solution because catalase is reported to mitigate free radicals mediated cell 
damage during freezing,  thereby, an improved viability of cryopreserved cells on long-
term storage is expected [200]. 
6.2.1 Formulation of Freezing solution 
For the development of an optimal freezing solution, Taguchi’s orthogonal design method 
was applied. To this end, four factors namely NaCl, PVP, ectoin, catalase as freezing 
media components and three levels of their different concentrations were selected (Table 
6.1) to prepare the freezing solutions with varying composition as shown in Table 6.2. 
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Table 6.1: Four control factors and three levels of concentration 
NaCl  
(Carrier media) 
PVP (Extracellular 
CPAa)  
 Ectoin (Intracellular 
CPAa) 
Catalase 
(Antioxidant) 
80mM  8%  30mM  50µg/ml 
120mM 10%  60mM  100µg/ml 
160mM 12%  90Mm 150 µg/ml 
a) CPA represents cryoprotectant 
Table 6.2: Formulation of freezing solutions based on Taguchi L9 (3(4)) array 
Cryopreservation 
Solution 
NaCl (mM) PVP (%) Ectoin(mM) Catalase (µg/ml) 
Solution-1 80  8 30  50 
Solution-2 80  10 60  100  
Solution-3 80  12 90 150 
Solution-4 120  8 60 150 
Solution-5 120  10 90 50 
Solution-6 120  12  30 100 
Solution-7 160  8 90 100 
Solution-8 160  10 30 150 
Solution-9 160  12 60 50 
 
6.2.2 hADSCs viability assessment by Trypan blue dye exclusion assay 
Trypan blue permeates the compromised cell membrane of dead cells and stains them 
blue, whereas the intact membrane of live cells excludes the Trypan blue. This property of 
the dye distinguishes the stained dead cells from live cells easily under an optical 
microscope. The viability of the post-thawed hADSCs evaluated by the Trypan blue dye 
assay was also compared with the viability obtained with 10% Me2SO used as a control. 
Experimental results (Table 6.3) revealed that the freezing solution consists of 160mM 
NaCl/10% PVP/ 30mM ectoin/150 µg/ml catalase (solution 8) provides the highest 
viability followed by the freezing solution comprising of 120mM NaCl/10% PVP/90mM 
ectoin/50µg/ml catalase (solution 5). The corresponding viability values are measured to 
be 81% and 80% respectively.  In addition to these solutions, solution 2 (80mM 
NaCl/10% PVP/60mM ectoin/100 µg/ml catalase) and solution 7 (160mM NaCl/8% 
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PVP/90mM ectoin/100 µg/ml catalase) also showed good viability of 78%. The viability 
of all other freezing solutions was less than 70%. Interestingly, no statistically significant 
difference was observed in the viability of solution 8 and solution 5. When compared with 
viability results obtained with control (10% Me2SO in PBS), all the freezing solutions 
except solution 1(80mM NaCl/8% PVP/30mM ectoin/50 µg/ml catalase), showed 
significantly higher viability. An increase of 30% viability was obtained with solution 8 in 
comparison to control. The freezing solution 8 has also shown superior cryopreservation 
outcome than 0.9% NaCl/10% PVP/60mM ectoin (81%) representing the significant role 
of catalase as antioxidant. 
Table 6.3: Trypan blue dye exclusion assay of post-thawed hADSCs 
Sample Repetition-1 Repetition-2 Repetition-3 Mean 
Viability 
SDa) S/N 
ratiob) 
Solution-1 56 55 54 55.00 1.00 34.80 
Solution-2 78 79 77 78.00 1.00 37.84 
Solution-3 71 65 69 68.33 3.05 36.67 
Solution-4 67 64 63 64.66 2.08 36.20 
Solution-5 82 80 80 80.66 1.15 38.13 
Solution-6 69 67 68 68.00 1.00 36.64 
Solution-7 78 76 79 77.66 1.52 37.80 
Solution-8 83 80 81 81.33 1.52 38.20 
Solution-9 67 68 65 66.66 1.52 36.47 
10% Me2SO 52 51 48 50.33 2.08 -- 
Optimised 
Solutionc) 
86 83 85 84.66 1.52 -- 
a)SD denotes Standard Deviation 
b) S/N ratio represents Signal to Noise ratio 
c)Optimized solution was comprised of 160mM NaCl/10% PVP/90mM ectoin/100µg/ml 
catalase 
 
6.2.3 Taguchi statistical analysis 
The Trypan blue assay results were used to calculate the signal-to-noise ratio (S/N). S/N 
ratio, expressed in decibels, is an important performance indicator of Taguchi statistical 
analysis. The S/N ratio was calculated based on Taguchi’s –“larger-the-better” approach 
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that means larger S/N value indicate superior viability results [201]. The results indicate 
that S/N ratio follows similar trends as that of the Trypan blue viability assay results 
(Table 6.3) obtained with cryopreserved hADSCs. Moreover, the main effects plot (data 
mean) for S/N ratios revealed the influence of individual column over the Taguchi results 
(Fig 6.8). The results indicate that there is a significant variation in viability with different 
concentrations of individual components in freezing solution. Overall, the trend suggests 
that the viability is increased with increase in the concentrations of NaCl and ectoin. 
Whereas among the concentrations tested, 10% PVP and 100 µg/ml catalase showed the 
maximum viability of cryopreserved hADSCs.  
 
Figure 6.8: Illustrates Main effect plot for mean of S/N ratios. S/N ratio increases 
with increase in the concentration of NaCl (A) and ectoin (C). PVP (B) and catalase 
(D) showed the highest S/N ratio at a concentration of 10% (w/v) and 100µg/ml 
respectively. 
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The response table of the mean was tabulated with mean response across levels of a factor 
to find out the influence of individual column over Taguchi results (Table 6.4). The 
influence was quantified by the value of Delta, which is the difference between the 
maximum and minimum mean response across levels of a factor. The higher is the value 
of Delta; the higher is the influence. The response table indicates that PVP showed the 
stronger influence over the viability results followed by NaCl, ectoin and catalase in that 
order.  
Table 6.4: Response table for mean viability of cryopreserved hADSCs 
Level NaCl PVP Ectoin Catalase 
1 67.11   65.78   68.11   67.44 
2 71.11   80.00   69.78   74.56 
3 75.22   67.67   75.56   71.44 
Delta 8.11   14.22    7.44    7.11 
Rank 2 1 3       4 
 
ANOVA analysis assessed the contribution of factors to the overall cryopreservation 
outcome. The highest contribution of PVP was also confirmed (55.12%) followed by 
NaCl (15.20%), ectoin (14.10%) and catalase (11.75%) as indicated in Table 6.5. 
However, the effect of concentration variation within a column is statistically 
insignificant. 
Table 6.5: ANOVA analysis of the four factors  
Factors Degree of 
Freedom 
Sum of 
squares 
Mean 
square 
F P Contribution 
(%) 
NaCl 2 98.69 49.34 0.56 0.60 15.20 
PVP 2 357.95 178.97 4.03 0.08 55.12 
Ectoine 2 91.58 45.79 0.51 0.62 14.10 
Catalase 2 76.25 38.12 0.42 0.68 11.75 
Error 2 24.88    03.83 
Total 10 649.35     
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The result signifies that the post-thaw viability using PVP as extracellular cryoprotectant 
was the highest, followed by NaCl as carrier media, ectoin as intracellular cryoprotectant 
and catalase as an antioxidant. Further, a small variation in the concentration of individual 
factors might have contributed towards non-significance of ANOVA results. 
6.2.4 Flow cytometry 
PI is excluded by viable cells because of its high molecular weight, i.e. 668.4 D. The cell 
membrane of necrotic cells becomes permeable to the dye and the dye binds with nucleic 
acids and becomes a fluorescent molecule inside the necrotic cells. This property is 
utilized by flow cytometry to detect and quantify the non-viable cells. The flow cytometry 
data is presented in Fig 6.9, which indicates a similar trend in the result as that of Trypan 
blue dye exclusion assay. The results confirm that the 160mM NaCl/10% PVP/30mM 
ectoine/150 µg/ml catalase is the most efficient freezing solution achieving maximum 
hADSCs viability of 81 %. 
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Figure 6.9:  Flow cytometry analysis of cryopreserved hADSCs using PI as a 
fluorescent dye. 10% Me2SO freezing solution was used as control (A). B-J 
represents the viability of cells using the freezing solutions formulated by Taguchi’s 
orthogonal design. The optimized solution (K) comprising of 160mM NaCl/10% 
PVP/90mM ectoin/100µg/ml catalase showed the maximum viability of ~85%. 
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6.2.5 MTT Assay 
MTT assay was used to assess the metabolic activity of cells and it is one of the most 
commonly used methods to determine cell viability. The experimental viability data is 
shown in Fig 6.10. 
 
Figure 6.10: MTT assay of cryopreserved hADSCs. 10% Me2SOwas used as control 
freezing solution. The optimized solution comprised of 160mM NaCl/10% 
PVP/90mM ectoin/100µg/ml catalase showed the higher metabolic activity of 
cryopreserved cells than other freezing solutions after 24h post-thaw culture. 
 
Overall, the trend in viability follows that of the flow cytometry results indicating solution 
8 achieves higher metabolic activity than other freezing solution. Furthermore, all the 
formulated freezing solutions superseded the viability obtained with control as 10% 
Me2SO in PBS. However, the higher metabolic activity, shown by the cryopreserved cells 
frozen in solution 1, was statistically insignificant to the metabolic activity shown by the 
control group. Similarly, the metabolic activity of hADSCs preserved in solution 8 was 
statistically insignificant to that of solution 5. 
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6.2.6 Validation of Taguchi results 
The experimental confirmation test is known to be the final step in verifying the results 
drawn based on Taguchi’s design approach. Thus, a confirmation experiment was 
conducted by utilizing the obtained optimal concentration of the control factors. The 
optimal concentration of the components was selected based on the main effect plot (Fig 
6.8). The result showed that the optimal concentration of the control factors is 160mM 
NaCl, 10% PVP, 90mM ectoin and 100µg/ml catalase. Therefore, for validation of the 
results obtained by the Taguchi’s design, a freezing solution comprised of the 
concentrations mentioned above of the individual components was prepared. The solution 
comprised of 160mM NaCl/ 10%PVP/90mM ectoin/100 µg/ml catalase achieved post-
thawed cell viability of 85% assessed by Trypan blue dye exclusion assay (Table 6.3). 
This result was further confirmed by flow cytometry and MTT assay (Fig 6.8K and 6.10), 
which showed the superior viability of 160mM NaCl/ 10%PVP/90mM ectoin/100 µg/ml 
catalase solution over solution 8. The obtained viability (85%) using the optimized 
freezing cocktail is the highest among the solutions used in the experiment. 
Overall, the study provides an optimal composition of a novel freezing solution that 
comprised of 160mM NaCl/10% PVP/90mM ectoin/100µg/ml catalase achieving 
maximum viability of 85%.  
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6.3 Evaluation of signaling pathway inhibitors for cryopreservation of hADSCs 
Apoptosis is one of the important mechanisms of cell death during cryopreservation. Low-
temperature stress induces apoptosis, the stepwise-programmed cell death [202]. The 
proteins over the cell surface receive the stress signal and send the signals downstream 
inside the cells to activate caspases. The activated caspases stimulate cascades of the 
proteolytic process to initiate the self-destruction process leading to DNA degradation and 
cell membrane disruption. Similar to apoptosis, altered cytoskeleton of cells during 
cryopreservation is another important cause of cell death [203-205]. The cytoskeleton 
provides strong support to cell plasma membrane maintains the organizational distribution 
of organelles and helps in executing signaling cascade properly. Thus, any alteration in the 
cytoskeleton because of ice-mediated mechanical damage during cryopreservation alters 
the morphology and functions of cells leading to altered rehydration and viability of post-
thawed cells.  
Supplementation of molecules that prevent or inhibit the caspases activation and maintains 
the stability of cytoskeleton, in freezing solution was reported to increase the viability of 
post-thaw cells. Z-VAD-FMK, an irreversible inhibitor of caspases, enhanced the viability 
of post-thawed human embryonic stem cells when supplemented in freezing solution and 
post-thaw culture. Supplementation of Z-VAD-FMK in freezing solution also improved 
the post-thaw viability of porcine hepatocytes and human amniotic fluid-derived 
mesenchymal stem cells [169, 206]. Another molecule Y-27632, a Rho kinase inhibitor, 
stabilizes the cytoskeleton and observed to improve the survival of post-thawed cells. Li X 
et al. demonstrated that Y-27632 added to the post-thaw culture medium for 24h post-
thaw increased human embryonic stem cell survival rate [207]. Studies by Martin-Ibanez 
et al. replicated this initial finding [208]. Furthermore, the effect of ROCK inhibitor Y-
27632 was shown to have similar effects on the recovery from cryopreservation of adult 
stem cells and bone marrow-derived MSCs as well as human induced pluripotent stem 
cells [37, 209, 210]. 
Given the beneficial effect of Z-VAD-FMK and Y-27632 on the recovery of post-thawed 
cells and in the effort to enhance the viability of cryopreserved human adipose-derived 
mesenchymal stem cells, it was hypothesized that the supplementation of the above two 
molecules might enhance the viability of post-thawed hADSCs. Thus, in this phase of 
work, we have supplemented 10Nm Z-VAD-FMK and 100mM Y-27632 with the most 
effective 160mM NaCl/ 10%PVP/90mM ectoin/100µg/ml catalase freezing solution 
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obtained in the previous chapter and the efficacy of the new freezing solutions was 
evaluated towards for cryopreservation of hADSCs. 
6.3.1 Trypan blue dye exclusion 
The immediate viability of post-thawed hADSCs was evaluated by Trypan blue dye 
exclusion assay. The results (Fig 6.11) reveal that the addition of 10nM Z-VAD-FMK and 
100mM Y-27632 has no impact on the viability of post-thawed hADSCs. Although, the 
mean viability obtained with Y-27632 (85.33± 3.78%) was higher than Z-VAD-FMK 
(84.67± 3.21%), the difference is statistically insignificant (p<0.05). Moreover, the 
difference in viability obtained with the ROCK inhibitor and the general caspases inhibitor 
was insignificant to the viability shown with control (84.67±2.08). 
 
Figure 6.11: Trypan blue assay results showing the effect of signaling pathway 
inhibitors supplemented with the formulated freezing solution on the cryopreserved 
hADSCs viability.  The results reveal that the addition of Z-VAD-FMK and Y-27632 
has no significant impact on the viability of post-thawed hADSCs. 
 
6.3.2 MTT assay 
Post-thaw recovery of the cells in culture was assessed after 24h by MTT assay (Fig 6.12). 
MTT assay also observed similar findings of no significant benefit with the addition of Z-
VAD-FMK and Y-27632 in the recovery of post-thawed hADSCs. 
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Figure 6.12: MTT assay showing the post-thaw viability of cryopreserved hADSCs 
using signaling pathway inhibitor supplemented with the developed freezing solution. 
As indicated, no significant benefit with the addition of Z-VAD-FMK and Y-27632 in 
the recovery of post-thawed hADSCs was obtained. 
The results corroborated with the findings of Lamas NJ et al., which stated that in contrast 
to other stem cell types, Y-27632 supplementation is not a suitable strategy to enhance 
hADSCs expansion in culture rather a continuous supplementation Y-27632 in culture led 
to decrease metabolic activity and numbers of hADSCs [211]. Similar negative findings 
on the use of Y-27632 were earlier reported for cord blood-derived hematopoietic 
progenitor cells [212].  However, Qu CQ et al. reported that addition of ROCK inhibitor 
along with glutathione increased the viability of cryopreserved porcine adipose-derived 
stem cells [213]. The beneficial effect may be due to glutathione than ROCK inhibitor. 
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6.4 Optimization of controlled rate freezing parameters for cryopreservation of 
hADSCs using the developed freezing solution 
The cooling rate is one of the most important factors that controls the viability of cells. 
While subjected to slow cooling rate leads to extracellular ice formation and the 
segregated solute concentration effect over cell membrane become an important cause of 
cryoinjury, fast cooling rate induces intracellular ice formation and ice crystals mediated 
injury thereby causes cell death. Thus, a trade-off between fast and slow cooling rate is 
essential to achieve an optimized cooling rate providing maximum cell viability. The 
problem is further complicated by the fact that the cryoprocessing steps are 
interdependent, and thus cannot be optimized independently. For example, the optimal 
cooling rate is dependent on the CPA types and concentration. 
In this part of research work, an attempt has been given to achieve an optimized cooling 
rate for the cryopreservation of hADSCs using the developed 160mM NaCl/ 
10%PVP/90mM ectoin/100µg/ml catalase freezing solution. 
6.4.1 Effect of cooling rate 
To achieve the optimized cooling rate, the cryopreservation experiment was carried out in 
different prenucleation cooling rate such as -0.5°C/min,-1°C/min,-2.5°C/min,-5°C/min 
from 4°C to -120°C. The samples were kept at 4°C for 1h incubation period before being 
subjected to controlled rate freezers. The one-hour incubation period was necessary for 
equilibrating the freezing solution with the cells. Upon completion of controlled freezing, 
the cryovials were transferred immediately into LN2 to avoid recrystallization injury to 
cells. The efficiency of the optimum freezing condition on the viability was assessed as 
described here. 
Trypan blue dye exclusion assay 
The viability and recovery of the post-thawed hADSCs were assessed by Trypan blue dye 
exclusion and MTT assay after 48h. The results (Fig 6.13) show that cooling at the rate of 
-1°C/min achieved the highest viability of 89.3± 3.8%. The viability is 8% higher than the 
viability obtained using -0.5°C/min (81.3±3.8%) and 4% better than the sample frozen at -
80°C freezer in Mr. Frosty, an isopropanol containing commercial container for 
cryostoring cells. Thirumala et al. also reported similar finding that -1°C/min provided the 
maximum viability of hADSCs compared to other cooling rates.  
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Figure 6.13: Trypan blue assays showing the effect of cooling rate on post-thaw 
viability of hADSCs cryopreserved in 160mM NaCl/ 10%PVP/90mM 
ectoin/100µg/ml catalase freezing solution. 
 
MTT assay 
The metabolic activity measured by MTT assay is shown in Fig 6.14. As indicated, the 
OD was increased by increasing rate from -0.5 to -1°C/min and then the OD was slowly 
decreased with the higher cooling rate. Thus, -1°C/min is confirmed as the most favorable 
cooling rate achieving maximum viability of frozen hADSCs. 
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Figure 6.14: Effect of cooling rate on post-thaw viability of hADSCs cryopreserved in 
160mM NaCl/ 10%PVP/90mM ectoin/100µg/ml catalase freezing solution assessed by 
MTT assay 
 
6.4.2 Effect of seeding temperature 
As described in the previous section, at low-temperature seeding causes the quick 
formation of extracellular ice that minimizes the detrimental effect of phase change from 
liquid to ice in the course of cooling thereby prevents ice-mediated damage. Seeding 
should be performed at the temperature above spontaneous intracellular ice formation, 
which is usually in the range of −7°C and −12°C. Thirumala et al. reported that for 
hADSCs, freezing usually does not start below -6°C. Therefore, to evaluate the effect of 
seeding temperature on the viability of hADSCs, the cells were frozen in a controlled rate 
freezer at -1°C/min cooling rate from 4°C to -120°C and the seeding was induced 
mechanically using the facilities of the CRF at -5°C,-7°C and -9°C. The vials were stored 
in LN2 and viability, and recovery of cells was assessed after 48h of storage.  
Trypan blue dye exclusion assay 
The results in Fig 6.15 indicate that among the seeding temperatures under study, the 
maximum cell viability of 89.4 ± 3.6% was obtained with seeding at -7°C. A comparative 
hADSCs viability was also shown at -9°C. Therefore,-7C was established as the most 
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favorable seeding temperature. However, compared to non-seeded samples, the seeded 
samples at -7°C showed no additional improvement in cell viability. 
 
Figure 6.15: Trypan blue assay showing the effect of seeding temperature on post-
thaw viability of hADSCs cryopreserved in the formulated 160mM 
NaCl/10%PVP/90mM ectoin/100µg/ml catalase freezing solution. 
 
MTT assay 
MTT assay (Fig 6.16) corroborates with the viability result obtained by Trypan blue assay 
that the seeding at -7°C achieved higher viability than other seeding temperature. Similar 
to Trypan blue assay, the viability results are not significantly different from each other 
indicating the negligible influence of seeding in improving the viability of hADSCs 
cryopreservation.  
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Figure 6.16: Effect of seeding temperature on post-thaw viability of hADSCs 
cryopreserved in 160mM NaCl/ 10%PVP/90mM ectoin/100µg/ml catalase freezing 
solution assessed by MTT assay. 
 
Overall, it has been demonstrated that -1°C/min cooling rate is effective in improving the 
viability of hADSCs cryopreserved with 160mM NaCl/ 10%PVP/90mM ectoin/100µg/ml 
catalase freezing solution. Furthermore, the study on the effect of seeding temperature 
indicates that the influence of seeding temperature on the post-thaw viability temperature 
of hADSCs is negligible.  
 
 
 
 
 
 
 
 
125 | P a g e  
 
6.5 Effect of long-term storage on cryopreserved hADSCs using the developed 
freezing solution 
The effect of long-term storage on the viability of hADSCs cryopreserved in 160mM 
NaCl/10% PVP/90mM ectoin/100 µg/ml catalase freezing solution. Long-term evaluation 
is necessary as free radical and apoptosis-mediated cell death cause loss of viability over 
time. The cells were equilibrated with the freezing solution for one hour at 4°C before 
being controlled rate frozen at -1°C/min from 4°C to -120°C and plunged into LN2.The 
vials were retrieved after 15 , 30 , 60  and 90 days of storage in LN2 and thawed rapidly to 
assess the viability and recovery of cells.  
 
6.5.1 Trypan blue dye exclusion assay 
The results in Fig 6.17 indicate the decrease in viability over time and thus, viability 
dropped from 88.6 ± 4.5% from 15 days to 85 ± 5% after 90 days of storage. The 
difference in viability over time is insignificant indicating the freezing solution is able to 
maintain viability for long-term. 
 
Figure 6.17: Long-term viability study on cryopreserved hADSCs using 160mM 
NaCl/10% PVP/90mM ectoin/100 µg/ml catalase freezing solution assessed by 
Trypan blue assay. The viability change over 90 days storage time is insignificant 
indicating the freezing solution is able to maintain hADSCs viability for long-time.  
126 | P a g e  
 
 
6.5.2 MTT assay  
The metabolic activity in term of OD measured during the 15-90 days of storage period is 
shown in Fig 6.18. No statistically significant difference in viability was noticed during 
this period thus proving the efficiency of the developed freezing solution in the 
maintenance of cryopreserved hADSCs. 
 
Figure 6.18: Long-term viability study on cryopreserved hADSCs using 160mM 
NaCl/10% PVP/90mM ectoin/100µg/ml catalase freezing solution assessed by MTT 
assay. Similar trend in viability as assessed by Trypan blue assay confirming the 
suitability of the developed freezing solution in preserving hADSCs for a long time. 
 
6.5.3 Morphology of cryopreserved hADSCs 
The regular fibroblastic morphology and adherancy to plastics are important features for 
the structural and functional integrity of hADSCs. Therefore, the morphological 
characteristics of cryopreserved (90 days) hADSCs were assessed by phase contrast 
microscopy. 
As observed in Fig 6.19, on retrieval, the cryopreserved hADSCs adhered to the surface 
and the changed to fibroblastic appearance before reaching confluency on 12th day like 
fresh mesenchymal stem cells proving that the developed freezing solution has no 
detrimental or adverse effect on the adherancy and morphology of cryopreserved 
hADSCs.   
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Figure 6.19: Morphological changes of cryopreserved (90 days storage) hADSCs in 
160mM NaCl/10% PVP/90mM ectoin/100µg/ml catalase freezing solution as 
observed under phase contrast microscope. 0-day (a), 6th day (b) and 12th day(c). 
(Scale bar 100µm) 
 
6.5.4 Cytoskeleton distribution of cryopreserved hADSCs 
The hADSCs were stained with Phalloidin-Alexa fluor-488 and Hoechst to stain the actin 
cytoskeleton and nucleus respectively and observed under CLSM. As can be observed in 
Fig 6.20, there is the peripheral distribution of actin, which is a regular feature of normal 
cells. Thus, the developed freezing solution and the cryopreservation strategy had no 
adverse effect over the cytoskeleton of hADSCs and retained the regular cytoskeletal 
distribution pattern like fresh cells. 
 
Figure 6.20: Cytoskeleton distribution of cryopreserved (90 days) hADSCs in 160mM 
NaCl/10% PVP/90mM ectoin/100 µg/ml catalase freezing solution. The peripheral F-
actin distribution represents regular arrangement of cytoskeleton.   
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6.5.5 Proliferation kinetics 
The proliferation kinetics of the cryopreserved (90 days) hADSCs was compared with 
non-cryopreserved hADSCs (P6) using Trypan blue assay (Fig 6.21). The cryopreserved 
hADSCs has been shown to retain the normal proliferation pattern indicating 
cryopreservation process, and the freezing solution has no adverse effect on the functional 
integrity of cryopreserved hADSCs. 
 
Figure 6.21: Proliferation kinetics of cryopreserved (90 days) hADSCs in 160mM 
NaCl/10% PVP/90mM ectoin/100 µg/ml catalase freezing solution. The hADSCs has 
shown to retain the normal proliferation pattern indicating the freezing solution has 
no adverse effect on the functional integrity of cryopreserved hADSCs. 
 
6.5.6 Differentiation ability 
The differentiation of cryopreserved (90 days) hADSCs into osteogenic and adipogenic 
lineages was performed to evaluate the maintenance of differentiation ability of 
cryopreserved hADSCs. 
The histological results of the osteogenic differentiation of hADSCs are shown in Fig 
6.22a. hADSCs cryopreserved in 160mM NaCl/10% PVP/90mM ectoin/100 µg/ml 
catalase freezing solution for 90 days is observed to be sufficiently differentiated into 
osteoblasts as shown by the deposition of calcium on 21 days of culture. Thus, the 
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cryopreserved hADSCs retained the differentiation ability to osteogenic lineages thereby 
proven the ability of formulated freezing solution in maintaining the differentiation 
potential of hADSCs.  Furthermore, as can be seen in Fig 22b, lipid droplets accumulated 
inside the hADSCs on 14th day culture in adipogenic differentiation media proving the 
cryopreserved hADSCs also retained the differential ability to adipogenic lineages.  
 
Figure 6.22: Differential ability of frozen (90 days storage) hADSCs in 160mM 
NaCl/10% PVP/90mM ectoin/100 µg/ml catalase freezing solution for osteogenesis (a) 
and adipogenesis (b) seen under fluorescent microscope. Calcium deposition in 
osteogenesis was evaluated by Alizarin red stain (a) and intracellular lipid 
accumulation in adipogenesis was assessed by Oil Red O stain.  (Scale bar 100µm) 
Overall, among the freezing solutions, 160mM NaCl/10% PVP/90mM ectoin/100µg/ml 
catalase was found to be the most effective in maintaining cryopreserved adipose tissue as 
indicated in Table 6.6 providing the maximum viability of 89%  by control rate freezing  
at -1°C/min cooling rate followed by storage in LN2. The developed 160mM NaCl/10% 
PVP/90mM ectoin/100µg/ml catalase freezing solution may be used for the 
cryopreservation of hADSCs thereby paving its future clinical application. 
 
Table 6.6 Comparison of hADSCs viability cryopreserved in various freezing 
solution 
Freezing solution Trypan blue 
 (% viability) 
PBS+10% Me2SO+20% FBS 60 
PBS+ 10% PVP 56 
0.9% NaCl+10% PVP 70 
0.9% NaCl+10% PVP+60mM ectoin 81 
160mM NaCl+10% PVP+90mM ectoin+100µg/ml catalase 85 
160mM NaCl+10% PVP+90mM ectoin+100µg/ml catalase: 
Cooling at -1°C/min and storage in LN2 for 48h 
89 
160mM NaCl+10% PVP+90mM ectoin+100µg/ml catalase: 
Cooling at -1°C/min and storage in LN2 for 3 months 
85 
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Chapter 7 
Summary & Conclusion 
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Lipofilling, which is an important surgical procedure, requires a lot of adipose tissue to fill 
up the depressed region or scar of patient body. Besides lipofilling, there is a growing 
demand of adipose tissue-derived stem cells for tissue engineering and stem cell therapy 
applications. Therefore, in recent past, research interest has been generated towards the 
harvesting of adipose tissue as well as production of stem cells, (mesenchymal stem cells 
in particular) isolated from adipose tissue. In this context, development of an effective 
cryopreservation strategy is of utmost importance for preserving adipose tissue and 
hADSCs with long shelve-life for the advancement of these products for clinical 
applications. Cryopreservation using conventional freezing solution consisting of dimethyl 
sulfoxide  and fetal bovine serum has several detrimental effects including, the acute and 
chronic toxicity of patients and genotoxicity of preserved cells.  Furthermore, the most 
commonly used DMEM carrier media having multicomponent constituents creates more 
complex and unpredictable cell environment at sub-zero temperature because of ice 
crystallization. 
 
Keeping the above issues in view, the present research aims to explore potential natural 
cryoprotective agents and suitable carrier media for developing a Me2SO-free and serum-
free freezing solution for preserving adipose tissue and adipose tissue derived stem cells 
with long storage life.  
  
The most interesting results obtained from the above research is summarized as follows- 
 
A. Cryopreservation of adipose tissue 
 
I.  In the first phase of the thesis work, the efficiency of various hydrocolloids and natural 
organic osmolytes as extracellular and intracellular CPAs as well as individual PBS 
components such as NaCl, Na2HPO4, KCl and KH2PO4 as possible carrier media were 
evaluated by performing cryopreservation experiments with adipose tissue. Based on the 
viability results measured by oil ratio as a preliminary screening criteria followed by XTT, 
G3PDH and TBARS analysis, trehalose, ectoin and NaCl were selected as the most 
efficient CPAs and carrier media respectively. 
 
II. The selected extracellular and intracellular CPAs in NaCl as carrier media were 
evaluated individually and in combination to formulate an freezing solution cocktail. To 
this end, different batches of freezing solutions namely 160mM NaCl/90mM trehalose, 
160mM NaCl/150mM ectoin and 160mM NaCl/90mM trehalose/150mM ectoin were 
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prepared and the conventional 10% Me2SO was used as control. Among these, freezing 
solution consisting of 160mM NaCl/90mM trehalose was found to be the most efficient 
achieving adipose tissue viability of 85%. The viability was comparable to the viability 
shown by 160mM NaCl/10% Me2SO as a control. Interestingly, ectoin in freezing 
solutions did not show any significant impact in cryopreserving adipose tissue, whereas a 
substantial tissue viability (84%)  was obtained using 160mM NaCl only.  
 
III. The oxidative stress mediated damage is a critical phenomenon in cryopreservation, 
which is expected to be higher in the case of adipose tissue than other body tissues. 
Therefore, it was hypothesized that supplementation of antioxidants in freezing solution 
might improve the cryopreservation outcome of adipose tissue. Therefore, 
cryopreservation experiments were performed with adipose tissue using the formulated 
160mM NaCl and 90mM trehalose/160mM NaCl freezing solutions supplemented with 
different antioxidants such as curcumin, carnitine, lipoic acid,Vit E, gallic acid, ellagic 
acid with varying concentration level. Among these, 1mg/ml curcumin and 3mg/ml 
carnitine were found to be the potential antioxidants improving the crypreservation 
outcome of both the freezing solutions and the measured viability was higher than the 
viability obtained with the conventional 10% Me2SO. Overall, freezing solutions 
supplemented with curcumin has shown higher viability than carnitine and 160mM 
NaCl/90mM trehalose/1mg/ml curcumin achieved the maximum viability of 90%. Thus, 
the study provides a Me2SO free superior freezing solution for adipose tissue 
cryopreservation.  
 
IV. An effort has been also given for further improvement of the cryopreservation 
efficiency by performing the cryopreservation of adipose tissue in a control rate freezer 
which resulted in 93% maximum  post-thaw tissue viability at -1°C/min as an optimum 
cooling rate. 
 
V. The maintenance of tissue viability for a long time is the most vital aspect of freezing 
solution to be used as cryopreservation strategy. Therefore, the efficiency of the 
formulated freezing solution towards maintaining tissue viability was evaluated during 90 
days of storage of cryopreserved adipose tissue in liquid nitrogen. The result revealed that 
a gradual decrease in tissue viability occurred over time. However, the viability after 90 
days of storage was not significantly different from viability after 7 days as evident by oil 
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ratio, XTT, G3PDH and TBARS assays representing the ability of the freezing solution in 
maintaining long-shelve life. The structural and functional integrity of cryopreserved 
adipose tissue were maintained by the freezing solution which are evident from the 
morphological characteristics (Laser Scanning Confocal Microscopic image analysis) as 
well as ability of frozen adipose tissue to provide hADSCs with retained metabolic 
activity (MTT assay), proliferation, and differentiation (Alizarin Red assay and Oil Red O 
staining) potential . 
 
Thus, it has been concluded that the formulated freezing solution comprising of 160mM 
NaCl/90mM trehalose/1mg/ml curcumin has the ability in maintaining the viability for a 
long time and cryopreserved adipose tissue provides hADSCs with desired metabolic 
acvitivy, proliferation and differentiation potential. 
 
B. Cryopreservation of hADSCs 
I. Besides adipose tissue cryopreservation, an effort has been given to isolate hADSCs 
from adipose tissue and develop a cryopreservation strategy for their preservation by 
formulating an effective freezing solution. Similar to adipose tissue, the efficiency of 
various hydrocolloids and natural organic osmolytes as extracellular and intracellular 
CPAs were evaluated for their efficacy in maintaining viability of adipose tissue by 
performing cryopreservation experiments. Based on the viability results measured by 
Trypan blue and MTT assays, among the hydrocolloids, 10% PVP in PBS as carrier media 
was found to be the most effective freezing solution achieving maximum cell viability of 
56% followed by tragacanth gum (43%). The viability obtained with 10% PVP/PBS was 
higher than 10%Me2SO/PBS solution (control).  
 
II. PBS as carrier media consists of NaCl, Na2HPO4, KCl and KH2PO4. The specific role 
of these components as carrier media in cryopreservation of stem cells has not been 
explored so far and hence these components were evaluated by supplemented with 10% 
PVP. Among the various compositions, 10%PVP/0.9%NaCl showed the maximum cell 
viability of 70% measured by Trypan Blus assay. The chloride based ionic compounds 
was found to perform better than phosphate based compounds indicating the freezing 
solution containing extracellular anions and cations provide better viability compared to 
the respective intracellular counterpart. These findings were also supported by MTT assay.   
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III. Efforts have been given for further improvement of the efficiency of the 
10%PVP/0.9%NaCl by the addition of ectoin and hydroxyectoin as the potential organic 
osmolytes. The experimental study has revealed that the addition of osmolytes in freezing 
solution increased the viability of cryopreserved hADSCs and the highest viability of 82% 
was achieved by developing 10%PVP/0.9%NaCl/60mM ectoin freezing solution. 
 
The cytoskeletal analysis from confocal microscopic images shows the normal 
cytoskeletal distribution pattern of F-actin, that indicate that hADSCs cryopreserved in 
10%PVP/0.9%NaCl/60mM ectoin was able to retain normal cell morphology like fresh 
hADSCs,  proving the suitability of the formulated freezing solution. 
The impact of the formulated 10%PVP/0.9%NaCl/60mM ectoin on the differentiation 
ability of frozen hADSCs was investigated. The study on the differentiation potential of 
cryopreserved hADSCs by incubating in osteogenic and adipogenic media for a period of 
21 and 14 days respectively has confirmed that the developed freezing solution is able to 
maintain the osteogenic and adipogenic differentiation ability of the cryopreserved 
hADSCs as assessed by Alizarin Red assay and Oil Red O staining. 
 
IV. The cryopreservation efficacy of the formulated 10%PVP/0.9%NaCl/60mM ectoin 
freezing solution was further optimized by adopting Taguchi orthogonal design 
methodology. Catalase, a natural antioxidant was also incorporated into the formulation of 
freezing solutions with different concentrations to mitigate free radicals mediated cell 
damage during freezing. The optimal composition of the freezing solution was obtained as 
160mM NaCl/10% PVP/90mM ectoin/100µg/ml catalase, providing the maximum post-
thaw viability of 85%. Furthermore, the addition of caspase and Rho-kinase inhibitors did 
not show any influence on the post- thaw viability of frozen hADSCs. Thus, 160mM 
NaCl/ 10% PVP/ 90mM ectoin/100µg/ml catalase was obtained as the most favorable 
freezing solution. 
 
V. To achieve better cryopreservation outcome, the cryopreservation experiment was 
carried out in a controlled rate freezer at different cooling rate such as -0.5C/min,-
1°C/min,-2.5°C/min,-5°C/min from 4°C to -120°C. The measured viability was enhanced 
to 89% in control rate freezing with the optimized cooling rate of -1°C/min.  
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The effect of long-term storage on the viability of hADSCs cryopreserved in 160mM 
NaCl/10%PVP/90mM ectoin/100µg/ml catalase freezing solution indicated a slow 
reduction of viability over time and the viability was dropped from 89% in 15 days to 85% 
after 90 days of storage. The decrease in viability is not significant representing the ability 
of the developed freezing solution in maintaining viability of adipose tissue for a long 
time. 
 
The structural and functional integrity of cryopreserved (90 days storage) hADSCs 
assessed by phase contrast and confocal microscopy, indicate that the cryopreserved 
hADSCs maintained the fibroblastic morphology and attained 80-85% confluence on 
12thday of culture. The cytoskeletal analysis has revealed the peripheral distribution of F-
actin thereby the maintenance of the structure of hADSCs. The study on the proliferation 
and differentiation to osteogenic and adipogenic lineages of 90 days storage cryopreserved 
hADSCs were performed and compared with fresh hADSCs. The cryopreserved hADSCs 
retained the normal proliferation and differentiation ability similar to fresh hADSCs 
confirming that the freezing solution has no adverse effect on the functional integrity of 
cryopreserved hADSCs.  
 
All the above taken together, the developed Me2SO free, serum free and non-toxic 160mM 
NaCl/10% PVP/90mM ectoin/100µg/ml catalase has been proven to be a potential 
freezing solution in maintenaning viability, proliferation and differentiation capability of 
hADSCs for long e time. 
 
Overall, a Me2SO free, serum free and non-toxic freezing solution was developed from 
natural cryoprotective agents, NaCl as carrier media and curcumin as antioxidant. The 
freezing solution comprising of 160mM NaCl/90mM trehalose/1mg/ml curcumin is 
effective for long-term preservation of adipose tissue with maintained tissue viability 
(89%)  and provide hADSCs with retained metabolic activity, proliferation, and 
differentiation ability. Similarly, a novel freezing solution that is devoid of the harmful 
Me2SO and serum was developed for the cryopreservation of hADSCs. The freezing 
solution comprising of 160mM NaCl/10% PVP/90mM ectoin/100µg/ml catalase is 
effective for cryopreservation of hADSCs with long-shelve life. It is, thus, concluded that 
these developed freezing solutions might provide effective cryopreservation strategies for 
the  supply of these products  for clinical applications in future. 
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Suggested further study 
The present research work offers effective freezing solutions for preserving adipose tissue 
and hADSCs. However, keeping in view of the limitation of the present work, the 
following future work has been suggested-  
 
I. Evaluation of the efficiency of the developed freezing solutions for longer period 
of storage time than 3 months period of study undertaken in the present work. 
 
II. Detail study on the parametric sensitivity of the control rate freezing process 
 
       III. In-vivo study must be performed using animal model, keeping in view of their 
cilinical application 
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